Selling, general and administrative expenses

$ 63,525

$ 62,799

$ 63,056

Cost of sales

28,785

28,209

28,731

Gross Profit

34,740

34,590

34,325

24,231

24,805

24,613

Venezuela impairment charges

1,359

Interest and Other Income

^[1]

10,509

9,785

8,353

Interest expense

(1,151)

(1,342)

(970)

244

110

Income before income taxes

9,602

8,553

7,442

Provision for income taxes (See Note 5)

4,694

2,174

1,941

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

4,908

6,379

5,501

Less: Net income attributable to noncontrolling interests

Net Income Attributable to PepsiCo

$ 4,857

$ 6,329

$ 5,452

Net Income Attributable to PepsiCo per Common Share

Basic

$ 3.40

$ 4.39

$ 3.71

Diluted

$ 3.38

$ 4.36

$ 3.67

Weighted-average common shares outstanding

Basic

^[2]

1,425

1,439

1,469

Diluted

^[2]

1,438

1,452

1,485

Cash dividends declared per common share

$ 3.1675

$ 2.96

$ 2.7625

[1]	For further unaudited information on certain items that impacted our financial performance, see “Item 6. Selected Financial Data.”
[2]	Weighted-average common shares outstanding (in millions).

Consolidated Statement of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 4,908	$ 6,379	$ 5,501
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	1,109	(302)	(2,827)
Other comprehensive loss
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(36)	46	3
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	(159)	(316)	171
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax	(68)	(24)	1
Pension and retiree medical:
Other Comprehensive Income, Other, Net of Tax	16	0	0
Other Comprehensive Income/(Loss), after-tax amount	862	(596)	(2,652)
Comprehensive income	5,770	5,783	2,849
Comprehensive income attributable to noncontrolling interests	(51)	(54)	(47)
Comprehensive Income Attributable to PepsiCo	$ 5,719	$ 5,729	$ 2,802

Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Operating Activities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 4,908	$ 6,379	$ 5,501
Depreciation and amortization	2,369	2,368	2,416
Share-based compensation expense	292	284	295
Restructuring and impairment charges	295	160	230
Cash payments for restructuring charges	(113)	(125)	(208)
Charges related to the transaction with Tingyi	0	373	73
Venezuela impairment charges	0	0	1,359
Pension and retiree medical plan expenses	221	501	467
Pension and retiree medical plan contributions	(220)	(695)	(205)
Deferred income taxes and other tax charges and credits	619	452	78
Provisional net tax expense related to the TCJ Act	2,451	0	0
Change in assets and liabilities [Abstract]
Accounts and notes receivable	(202)	(349)	(461)
Inventories	(168)	(75)	(244)
Prepaid expenses and other current assets	20	10	(50)
Accounts payable and other current liabilities	201	997	1,692
Income taxes payable	(338)	329	55
Other, net	(341)	64	(134)
Net Cash Provided by (Used in) Operating Activities	9,994	10,673	10,864
Investing Activities
Capital spending	(2,969)	(3,040)	(2,758)
Sales of property, plant and equipment	180	99	86
Acquisitions and investments in noncontrolled affiliates	(61)	(212)	(86)
Reduction of cash due to Venezuela deconsolidation	0	0	(568)
Divestitures	267	85	76
Short-term investments, by original maturity:
More than three months - purchases	(18,385)	(12,504)	(4,428)
More than three months - maturities	15,744	8,399	4,111
More than three months - sales	790	0	0
Three months or less, net	2	16	3
Other investing, net	29	9	(5)
Net Cash Used for Investing Activities	(4,403)	(7,148)	(3,569)
Financing Activities
Proceeds from issuances of long-term debt	7,509	7,818	8,702
Payments of long-term debt	(4,406)	(3,105)	(4,095)
Debt redemptions	0	(2,504)	0
Short-term borrowings, by original maturity
More than three months - proceeds	91	59	15
More than three months - payments	(128)	(27)	(43)
Three months or less, net	(1,016)	1,505	53
Cash dividends paid	(4,472)	(4,227)	(4,040)
Share repurchases - common	(2,000)	(3,000)	(5,000)
Share repurchases - preferred	(5)	(7)	(5)
Proceeds from exercises of stock options	462	465	504
Withholding tax payments on RSUs, PSUs and PEPunits converted	(145)	(130)	(151)
Other financing	(76)	(58)	(52)
Net Cash Used for Financing Activities	(4,186)	(3,211)	(4,112)
Effect of exchange rate changes on cash and cash equivalents	47	(252)	(221)
Cash and Cash Equivalents, Period Increase (Decrease)	1,452	62	2,962
Cash and Cash Equivalents, Beginning of Year	9,158	9,096	6,134
Cash and Cash Equivalents, End of Year	$ 10,610	$ 9,158	$ 9,096

Consolidated Balance Sheet - USD ($)
$ in Millions

Dec. 30, 2017

Dec. 31, 2016

ASSETS

Cash and cash equivalents

$ 10,610

$ 9,158

Accounts and notes receivable, net

8,900

6,967

7,024

6,694

Inventories

^[1]

2,947

2,723

Prepaid expenses and other current assets

1,546

908

Assets, Current

31,027

26,450

Property, Plant and Equipment, net

17,240

16,591

Amortizable Intangible Assets, net

1,268

1,237

Goodwill

14,744

14,430

Indefinite-Lived Intangible Assets (Excluding Goodwill)

12,570

12,196

Nonamortizable Intangible Assets

27,314

26,626

Equity Method Investments

2,042

1,950

Other Assets

913

636

79,804

73,490

Short-term debt obligations

^[2]

5,485

6,892

Accounts payable and other current liabilities

15,017

14,243

Liabilities, Current

20,502

21,135

Long-Term Debt Obligations

^[2]

33,796

30,053

Other Liabilities, Noncurrent

11,283

6,669

Deferred Income Taxes

3,242

4,434

Liabilities

68,823

62,291

Commitments and contingencies

Preferred Stock, no par value

PepsiCo Common Shareholders’ Equity

11,045

11,246

Common stock, par value 12/3¢ per share (authorized 3,600 shares, issued, net of repurchased common stock at par value: 1,420 and 1,428 shares, respectively)

Additional Paid in Capital, Common Stock

3,996

4,091

Retained Earnings (Accumulated Deficit)

52,839

52,518

Accumulated Other Comprehensive Income (Loss), Net of Tax

(13,057)

^[3]

(13,919)

Stockholders' Equity Attributable to Noncontrolling Interest

104

Total Equity

10,981

11,199

Liabilities and Equity

79,804

73,490

Preferred Stock

Additional Paid-in Capital [Member]

(197)

(192)

Retained Earnings [Member]

(3,996)

(4,091)

AOCI Attributable to Parent [Member]

(52,839)

(52,518)

13,057

13,919

Treasury Stock [Member]

(32,757)

(31,468)

Common Stock

Increase (Decrease) in Stockholders' Equity [Roll Forward]

$ (24)

[1]	Approximately 5% of the inventory cost in 2017 and 2016 were computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material.
[2]	Amounts are shown net of unamortized net discounts of $155 million and $142 million for 2017 and 2016, respectively.
[3]	Pension and retiree medical amounts are net of taxes of $1,260 million in 2014, $1,253 million in 2015, $1,280 million in 2016 and $1,338 million in 2017.

Consolidated Balance Sheet (Parenthetical) - $ / shares shares in Millions	Dec. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.0167	$ 0.0167
Common stock, authorized	3,600	3,600
Common stock, issued	1,420	1,428
Repurchased common stock, shares	446	438

Consolidated Statement of Equity - USD ($)
$ in Millions

Total

Preferred Stock

Repurchased Preferred Stock

Common Stock

Capital In Excess Of Par Value

Retained Earnings

Accumulated Other Comprehensive Loss

Repurchased Common Stock

Total Common Shareholders' Equity

Noncontrolling Interests

Stockholders' Equity Attributable to Noncontrolling Interest

$ 110

Stockholders' Equity Attributable to Parent at Dec. 27, 2014

$ 181

$ (25)

$ (4,115)

$ (49,092)

$ 10,669

$ 24,985

Stock Repurchased During Period, Value

$ (4,999)

Stock Repurchased During Period, Shares

(40,000,000)

(52,000,000)

Preferred Stock, Shares Issued, Beginning of year at Dec. 27, 2014

(700,000)

Preferred Stock, Shares Issued, End of year at Dec. 26, 2015

800,000

(700,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Redemptions (in shares)

Redemptions

$ (5)

Balance, outstanding, beginning of year (in shares) at Dec. 27, 2014

1,488,000,000

Balance, outstanding, end of year (in shares) at Dec. 26, 2015

1,448,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

299

Stock Options Exercises RSUs and Performance Stock Units Converted

^[1]

(182)

(151)

Balance, beginning of year (in shares) at Dec. 27, 2014

(5)

(378,000,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share repurchases

$ (1)

Stock option exercises (in shares)

12,000,000

Other (in shares)

Balance, end of year (in shares) at Dec. 26, 2015

(418,000,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock option exercises, RSUs, PSUs and PEPunits converted

$ 794

Other comprehensive income/(loss) attributable to PepsiCo

(2,650)

Net Income (Loss) Attributable to Noncontrolling Interest

$ 49

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(48)

Currency translation adjustment

(2)

Dividends, Common Stock, Cash

(2)

(4,071)

Dividends, Preferred Stock, Cash

(1)

Balance, end of year at Dec. 26, 2015

12,030

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stockholders' Equity Attributable to Parent at Dec. 26, 2015

5,452

$ 186

$ (24)

(4,076)

(50,472)

13,319

29,185

$ (12,068)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock option exercises/RSUs converted, tax benefit

107

Preferred Stock, Value, Outstanding

$ 41

Stockholders' Equity Attributable to Noncontrolling Interest

107

Stock Repurchased During Period, Value

$ (3,000)

Stock Repurchased During Period, Shares

(20,000,000)

(29,000,000)

Preferred Stock, Shares Issued, End of year at Dec. 31, 2016

803,953

(700,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Redemptions

$ (6)

Balance, outstanding, end of year (in shares) at Dec. 31, 2016

1,428,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

289

Stock Options Exercises RSUs and Performance Stock Units Converted

^[1]

(138)

(130)

Stock option exercises (in shares)

(6)

Share repurchases

$ 0

9,000,000

Balance, end of year (in shares) at Dec. 31, 2016

(438,000,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock option exercises, RSUs, PSUs and PEPunits converted

$ 712

Other comprehensive income/(loss) attributable to PepsiCo

(600)

Net Income (Loss) Attributable to Noncontrolling Interest

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(55)

Currency translation adjustment

Dividends, Common Stock, Cash

(2)

(4,282)

Dividends, Preferred Stock, Cash

(1)

Balance, end of year at Dec. 31, 2016

11,199

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stockholders' Equity Attributable to Parent at Dec. 31, 2016

6,329

11,246

$ 192

$ (24)

(4,091)

(52,518)

13,919

(31,468)

(11,246)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock option exercises/RSUs converted, tax benefit

110

Preferred Stock, Value, Outstanding

$ 41

Stockholders' Equity Attributable to Noncontrolling Interest

$ 104

104

Stock Repurchased During Period, Value

$ (2,000)

Stock Repurchased During Period, Shares

(8,000,000)

(18,000,000)

Preferred Stock, Shares Issued, End of year at Dec. 30, 2017

803,953

(700,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Redemptions (in shares)

Redemptions

$ (5)

Balance, outstanding, end of year (in shares) at Dec. 30, 2017

1,420,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

290

Stock Options Exercises RSUs and Performance Stock Units Converted

^[1]

(236)

(145)

Stock option exercises (in shares)

(4)

7,136,000

^[2]

10,000,000

Other (in shares)

Balance, end of year (in shares) at Dec. 30, 2017

(446,000,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock option exercises, RSUs, PSUs and PEPunits converted

$ 708

Other comprehensive income/(loss) attributable to PepsiCo

862

Net Income (Loss) Attributable to Noncontrolling Interest

$ 51

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(62)

Dividends, Common Stock, Cash

(1)

(4,536)

Balance, end of year at Dec. 30, 2017

10,981

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stockholders' Equity Attributable to Parent at Dec. 30, 2017

4,857

11,045

$ 197

$ (24)

$ (3,996)

$ (52,839)

$ 13,057

$ (32,757)

$ (11,045)

Preferred Stock, Value, Outstanding

$ 41

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stockholders' Equity Attributable to Noncontrolling Interest

$ 92

[1]	Includes total tax benefits of $110 million in 2016 and $107 million in 2015.
[2]	Options are in thousands and include options previously granted under the PBG plan. No additional options or shares were granted under the PBG plan after 2009.

Basis of Presentation and Our Divisions

12 Months Ended

Dec. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis Of Presentation and Our Divisions

Note 1 — Basis of Presentation and Our Divisions

Basis of Presentation

The accompanying financial statements have been prepared in accordance with U.S. GAAP and include the consolidated accounts of PepsiCo, Inc. and the affiliates that we control. In addition, we include our share of the results of certain other affiliates using the equity method based on our economic ownership interest, our ability to exercise significant influence over the operating or financial decisions of these affiliates or our ability to direct their economic resources. We do not control these other affiliates, as our ownership in these other affiliates is generally 50% or less. Intercompany balances and transactions are eliminated.

Raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, are included in cost of sales. The costs of moving, storing and delivering finished product are included in selling, general and administrative expenses.

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. Estimates are used in determining, among other items, sales incentives accruals, tax reserves, share-based compensation, pension and retiree medical accruals, amounts and useful lives for intangible assets and future cash flows associated with impairment testing for perpetual brands, goodwill and other long-lived assets. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as current economic conditions, and adjust or revise our estimates as circumstances change. As future events and their effect cannot be determined with precision, actual results could differ significantly from these estimates.

Effective as of the end of the third quarter of 2015, we deconsolidated our Venezuelan subsidiaries from our consolidated financial statements and began accounting for our investments in our wholly-owned Venezuelan subsidiaries and joint venture using the cost method of accounting. See subsequent discussion of “Venezuela.”

Our fiscal year ends on the last Saturday of each December, resulting in an additional week of results every five or six years. Our fiscal 2016 results included an extra week. While our North America results are reported on a weekly calendar basis, most of our international operations report on a monthly calendar basis. Certain operations in our ESSA segment report on a weekly calendar basis. The following chart details our quarterly reporting schedule:



Quarter	United States and Canada	International
First Quarter	12 weeks	January, February
Second Quarter	12 weeks	March, April and May
Third Quarter	12 weeks	June, July and August
Fourth Quarter	16 weeks (17 weeks for 2016)	September, October, November and December

See “Our Divisions” below, and for additional unaudited information on items affecting the comparability of our consolidated results, see further unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Unless otherwise noted, tabular dollars are in millions, except per share amounts. All per share amounts reflect common per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Certain reclassifications were made to the prior years’ financial statements to conform to the current year presentation, including the adoption of the recently issued accounting pronouncements disclosed in Note 2.

Our Divisions

Through our operations, authorized bottlers, contract manufacturers and other third parties, we make, market, distribute and sell a wide variety of convenient and enjoyable beverages, foods and snacks, serving customers and consumers in more than 200 countries and territories with our largest operations in North America, Mexico, Russia, the United Kingdom and Brazil. Division results are based on how our Chief Executive Officer assesses the performance of and allocates resources to our divisions and are considered our reportable segments. For additional unaudited information on our divisions, see “Our Operations” contained in “Item 1. Business.” The accounting policies for the divisions are the same as those described in Note 2, except for the following allocation methodologies:


•	share-based compensation expense;


•	pension and retiree medical expense; and


•	derivatives.

Share-Based Compensation Expense

Our divisions are held accountable for share-based compensation expense and, therefore, this expense is allocated to our divisions as an incremental employee compensation cost. The allocation of share-based compensation expense in 2017 was approximately 13% to FLNA, 1% to QFNA, 18% to NAB, 7% to Latin America, 9% to ESSA, 9% to AMENA and 43% to corporate unallocated expenses. In 2016, the allocation of share-based compensation expense was approximately 14% to FLNA, 2% to QFNA, 22% to NAB, 7% to Latin America, 11% to ESSA, 10% to AMENA and 34% to corporate unallocated expenses. We had similar allocations of share-based compensation expense to our divisions in 2015. The expense allocated to our divisions excludes any impact of changes in our assumptions during the year which reflect market conditions over which division management has no control. Therefore, any variances between allocated expense and our actual expense are recognized in corporate unallocated expenses.

Pension and Retiree Medical Expense

Pension and retiree medical service costs measured at fixed discount rates, as well as amortization of costs related to certain pension plan amendments and gains and losses due to demographics (including mortality assumptions and salary experience) are reflected in division results. Division results also include interest costs, measured at fixed discount rates, for retiree medical plans. Interest costs for the pension plans, pension asset returns and the impact of pension funding, and gains and losses other than those due to demographics, are all reflected in corporate unallocated expenses. In addition, corporate unallocated expenses include the difference between the service costs included in division results and total service costs determined using the plans’ discount rates as disclosed in Note 7.

Derivatives

We centrally manage commodity derivatives on behalf of our divisions. These commodity derivatives include agricultural products, energy and metals. Commodity derivatives that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit. Therefore, the divisions realize the economic effects of the derivative without experiencing any resulting mark-to-market volatility, which remains in corporate unallocated expenses. These derivatives hedge underlying commodity price risk and were not entered into for trading or speculative purposes.

Net revenue and operating profit/(loss) of each division are as follows:



	Net Revenue						Operating Profit/(Loss)^(a)
	2017		2016		2015		2017			2016			2015
FLNA	$	15,798	$	15,549	$	14,782	$	4,823		$	4,659		$	4,304
QFNA	2,503		2,564		2,543		642			653			560
NAB	20,936		21,312		20,618		2,707			2,959			2,785
Latin America	7,208		6,820		8,228		908			887			(206		)
ESSA	11,050		10,216		10,510		1,354			1,108			1,081
AMENA	6,030		6,338		6,375		1,073			619			941
Total division	63,525		62,799		63,056		11,507			10,885			9,465
Corporate unallocated	—		—		—		(998		)	(1,100		)	(1,112		)
	$	63,525	$	62,799	$	63,056	$	10,509		$	9,785		$	8,353


(a)	For further unaudited information on certain items that impacted our financial performance, see “Item 6. Selected Financial Data.”

Corporate Unallocated

Corporate unallocated includes costs of our corporate headquarters, centrally managed initiatives such as research and development projects, unallocated insurance and benefit programs, foreign exchange transaction gains and losses, commodity derivative gains and losses, our ongoing business transformation initiatives and certain other items.

Other Division Information

Total assets and capital spending of each division are as follows:



	Total Assets				Capital Spending
	2017		2016		2017		2016		2015
FLNA	$	5,979	$	5,731	$	665	$	801	$	608
QFNA	804		811		44		41		40
NAB	28,592		28,172		904		769		695
Latin America	4,976		4,568		481		507		368
ESSA	13,556		12,302		481		439		404
AMENA	5,668		5,261		308		381		441
Total division	59,575		56,845		2,883		2,938		2,556
Corporate^(a)	20,229		16,645		86		102		202
	$	79,804	$	73,490	$	2,969	$	3,040	$	2,758


(a)	Corporate assets consist principally of certain cash and cash equivalents, short-term investments, derivative instruments, property, plant and equipment and tax assets. In 2017, the change in total Corporate assets was primarily due to an increase in short-term investments and cash and cash equivalents.

Amortization of intangible assets and depreciation and other amortization of each division are as follows:



	Amortization of Intangible Assets						Depreciation and Other Amortization
	2017		2016		2015		2017		2016		2015
FLNA	$	7	$	7	$	7	$	449	$	435	$	427
QFNA	—		—		—		47		50		51
NAB	31		37		38		780		809		813
Latin America	5		5		7		245		211		238
ESSA	22		18		20		329		321		353
AMENA	3		3		3		257		294		293
Total division	68		70		75		2,107		2,120		2,175
Corporate	—		—		—		194		178		166
	$	68	$	70	$	75	$	2,301	$	2,298	$	2,341

Net revenue and long-lived assets by country are as follows:



	Net Revenue						Long-Lived Assets^(a)
	2017		2016		2015		2017		2016
United States	$	36,546	$	36,732	$	35,266	$	28,418	$	28,382
Mexico	3,650		3,431		3,687		1,205		998
Russia ^(b)	3,232		2,648		2,797		4,708		4,373
Canada	2,691		2,692		2,677		2,739		2,499
United Kingdom	1,650		1,737		1,966		817		852
Brazil	1,427		1,305		1,289		777		796
All other countries	14,329		14,254		15,374		9,200		8,504
	$	63,525	$	62,799	$	63,056	$	47,864	$	46,404


(a)	Long-lived assets represent property, plant and equipment, nonamortizable intangible assets, amortizable intangible assets and investments in noncontrolled affiliates. These assets are reported in the country where they are primarily used.


(b)	Change in net revenue and long-lived assets in 2017 primarily reflects appreciation of the Russian ruble.

Venezuela

Due to exchange restrictions and other conditions that significantly impact our ability to effectively manage our businesses in Venezuela and realize earnings generated by our Venezuelan businesses, effective at the end of the third quarter of 2015, we deconsolidated our Venezuelan subsidiaries and began accounting for our investments in our Venezuelan subsidiaries and joint venture using the cost method of accounting. We recorded pre- and after-tax charges of $1.4 billion in our income statement to reduce the value of the cost method investments to their estimated fair values, resulting in a full impairment. The factors that led to our conclusions at the end of the third quarter of 2015 continued to exist through the end of 2017.

We do not have any guarantees related to our Venezuelan entities, and our ongoing contractual commitments to our Venezuelan businesses are not material. We will recognize income from dividends and sales of inventory to our Venezuelan entities, which have not been and are not expected to be material, to the extent cash in U.S. dollars is received. We have not received any cash in U.S. dollars from our Venezuelan entities since our deconsolidation at the end of the third quarter of 2015. We continue to monitor the conditions in Venezuela and their impact on our accounting and disclosures. For further unaudited information, see “Our Business Risks,” “Items Affecting Comparability” and “Our Liquidity and Capital Resources” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Our Significant Accounting Policies

12 Months Ended

Dec. 30, 2017

Accounting Policies [Abstract]

Our Significant Accounting Policies

Revenue Recognition

We recognize revenue upon shipment or delivery to our customers based on written sales terms that do not allow for a right of return. However, our policy for DSD and certain chilled products is to remove and replace damaged and out-of-date products from store shelves to ensure that consumers receive the product quality and freshness they expect. Similarly, our policy for certain warehouse-distributed products is to replace damaged and out-of-date products. As a result, we record reserves, based on estimates, for anticipated damaged and out-of-date products.

Our products are sold for cash or on credit terms. Our credit terms, which are established in accordance with local and industry practices, typically require payment within 30 days of delivery in the United States, and generally within 30 to 90 days internationally, and may allow discounts for early payment.

We estimate and reserve for our bad debt exposure based on our experience with past due accounts and collectibility, the aging of accounts receivable and our analysis of customer data. Bad debt expense is classified within selling, general and administrative expenses in our income statement.

We are exposed to concentration of credit risk from our major customers, including Walmart. In 2017, sales to Walmart (including Sam’s) represented approximately 13% of our consolidated net revenue, including concentrate sales to our independent bottlers, which were used in finished goods sold by them to Walmart. We have not experienced credit issues with these customers.

Total Marketplace Spending

We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue and include payments to customers for performing activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. Sales incentives and discounts also include support provided to our independent bottlers.

A number of our sales incentives, such as bottler funding to independent bottlers and customer volume rebates, are based on annual targets, and accruals are established during the year for the expected payout. These accruals are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer participation and performance levels. Differences between estimated expense and actual incentive costs are normally insignificant and are recognized in earnings in the period such differences are determined. In addition, certain advertising and marketing costs are also based on annual targets and recognized during the year as incurred. The terms of most of our incentive arrangements do not exceed a year, and, therefore, do not require highly uncertain long-term estimates. Certain arrangements, such as fountain pouring rights, may extend beyond one year. Up-front payments to customers under these arrangements are recognized over the shorter of the economic or contractual life, primarily as a reduction of revenue, and the remaining balances of $262 million as of December 30, 2017 and $291 million as of December 31, 2016 are included in prepaid expenses and other current assets and other assets on our balance sheet. For additional unaudited information on our sales incentives, see “Our Customers” in “Item 1. Business” and “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

For interim reporting, our policy is to allocate our forecasted full-year sales incentives for most of our programs to each of our interim reporting periods in the same year that benefits from the programs. The allocation methodology is based on our forecasted sales incentives for the full year and the proportion of each interim period’s actual gross revenue or volume, as applicable, to our forecasted annual gross revenue or volume, as applicable. Based on our review of the forecasts at each interim period, any changes in estimates and the related allocation of sales incentives are recognized beginning in the interim period that they are identified. In addition, we apply a similar allocation methodology for interim reporting purposes for certain advertising and other marketing activities. Our annual financial statements are not impacted by this interim allocation methodology.

Advertising and other marketing activities, reported as selling, general and administrative expenses, totaled $4.1 billion in 2017, $4.2 billion in 2016 and $3.9 billion in 2015, including advertising expenses of $2.4 billion in 2017, $2.5 billion in 2016 and $2.4 billion in 2015. Deferred advertising costs are not expensed until the year first used and consist of:


•	media and personal service prepayments;


•	promotional materials in inventory; and


•	production costs of future media advertising.

Deferred advertising costs of $46 million and $32 million as of December 30, 2017 and December 31, 2016, respectively, are classified as prepaid expenses and other current assets on our balance sheet.

Distribution Costs

Distribution costs, including the costs of shipping and handling activities, which include certain merchandising activities, are reported as selling, general and administrative expenses. Shipping and handling expenses were $9.9 billion in 2017, $9.7 billion in 2016 and $9.4 billion in 2015.

Cash Equivalents

Cash equivalents are highly liquid investments with original maturities of three months or less.

Software Costs

We capitalize certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use when both the preliminary project stage is completed and it is probable that the software will be used as intended. Capitalized software costs include(i) external direct costs of materials and services utilized in developing or obtaining computer software, (ii) compensation and related benefits for employees who are directly associated with the software projects and (iii) interest costs incurred while developing internal-use computer software. Capitalized software costs are included in property, plant and equipment on our balance sheet and amortized on a straight-line basis when placed into service over the estimated useful lives of the software, which approximate five to 10 years. Software amortization totaled $224 million in 2017, $214 million in 2016 and $202 million in 2015. Net capitalized software and development costs were $686 million and $791 million as of December 30, 2017 and December 31, 2016, respectively.

Commitments and Contingencies

We are subject to various claims and contingencies related to lawsuits, certain taxes and environmental matters, as well as commitments under contractual and other commercial obligations. We recognize liabilities for contingencies and commitments when a loss is probable and estimable. For additional unaudited information on our commitments, see “Our Liquidity and Capital Resources” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Research and Development

We engage in a variety of research and development activities and continue to invest to accelerate growth and to drive innovation globally. Consumer research is excluded from research and development costs and included in other marketing costs. Research and development costs were $737 million, $760 million and $754 million in 2017, 2016 and 2015, respectively, and are reported within selling, general and administrative expenses.

See “Research and Development” in “Item 1. Business” for additional unaudited information about our research and development activities.

Goodwill and Other Intangible Assets

Indefinite-lived intangible assets and goodwill are not amortized and are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic, industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed.

In the quantitative assessment of indefinite-lived intangible assets, if the carrying amount of the indefinite-lived intangible asset exceeds its estimated fair value, as determined by its discounted cash flows, an impairment loss is recognized in an amount equal to that excess. Quantitative assessment of goodwill is performed using a two-step impairment test at the reporting unit level. A reporting unit can be a division or business within a division. The first step compares the carrying value of a reporting unit, including goodwill, with its estimated fair value, as determined by its discounted cash flows. If the carrying value of a reporting unit exceeds its estimated fair value, we complete the second step to determine the amount of goodwill impairment loss that we should record, if any. In the second step, we determine an implied fair value of the reporting unit’s goodwill by allocating the estimated fair value of the reporting unit to all of the assets and liabilities other than goodwill (including any unrecognized intangible assets). The amount of impairment loss is equal to the excess of the carrying value of the goodwill over the implied fair value of that goodwill. The quantitative assessment described above requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates, perpetuity growth assumptions and the selection of assumptions underlying a discount rate (weighted average cost of capital) based on market data available at the time. Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for nonamortizable intangible assets, such as forecasted growth rates and weighted-average cost of capital, are based on the best available market information and are consistent with our internal forecasts and operating plans.

Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows.

See also Note 4, and for additional unaudited information on goodwill and other intangible assets, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Other Significant Accounting Policies

Our other significant accounting policies are disclosed as follows:


•	Basis of Presentation – Note 1 - Basis of Presentation for a description of our policies regarding use of estimates, basis of presentation and consolidation.


•	Property, Plant and Equipment – Note 4.


•	Income Taxes – Note 5, and for additional unaudited information, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.


•	Share-Based Compensation – Note 6.


•	Pension, Retiree Medical and Savings Plans – Note 7, and for additional unaudited information, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.


•	Financial Instruments – Note 9, and for additional unaudited information, see “Our Business Risks” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.


•	Inventories – Note 13. Inventories are valued at the lower of cost or net realizable value. Cost is determined using the average; first-in, first-out (FIFO) or last-in, first-out (LIFO) methods.

•

Translation of Financial Statements of Foreign Subsidiaries – Financial statements of foreign subsidiaries are translated into U.S. dollars using period-end exchange rates for assets and liabilities and weighted-average exchange rates for revenues and expenses. Adjustments resulting from translating net assets are reported as a separate component of accumulated other comprehensive loss within common shareholders’ equity as currency translation adjustment.

Our Significant Accounting Policies Recently Issued Accounting Pronouncements (Notes)

12 Months Ended

Dec. 30, 2017

Accounting Policies [Abstract]

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Issued Accounting Pronouncements - Adopted

In 2017, the SEC issued guidance related to the TCJ Act which allows recording of provisional tax expense using a measurement period, not to exceed one year, when information necessary to complete the accounting for the effects of the TCJ Act is not available. We elected to apply the measurement period provisions of this guidance to certain income tax effects of the TCJ Act when it became effective during our fourth quarter of 2017, resulting in a provisional net tax expense of $2.5 billion. This provisional net tax expense was recorded based on information available to us prior to the issuance of our 2017 consolidated financial statements, may be subject to further revision as disclosed in Note 5, and will be finalized no later than the end of 2018.

In 2016, the Financial Accounting Standards Board (FASB) issued guidance that changes the accounting for certain aspects of share-based payments to employees. We adopted the provisions of this guidance during our first quarter of 2017, resulting in the following impacts to our financial statements:

•

Income tax effects of vested or settled awards were recognized in the provision for income taxes on our income statement on a prospective basis. Previously, these tax effects were recorded on our equity statement in capital in excess of par value. For the year ended December 30, 2017, our excess tax benefits were $115 million, resulting in a $0.08 increase to diluted net income attributable to PepsiCo per common share. For the years ended December 31, 2016 and December 26, 2015, our excess tax benefits recognized were $110 million and $107 million, respectively. If we had applied this standard in 2016 and 2015, there would have been a $0.07 increase to diluted net income attributable to PepsiCo per common share for both years. The ongoing impact on our financial statements is dependent on the timing of when awards vest or are exercised, our tax rate and the intrinsic value when awards vest or are exercised.

•

Excess tax benefits are retrospectively presented within operating activities and withholding tax payments upon vesting of RSUs, PSUs and PEPunits are retrospectively presented within financing activities in the cash flow statement. The adoption resulted in an increase of $295 million, $269 million and $284 million in our operating cash flow with a corresponding decrease in our financing cash flow for the years ended December 30, 2017, December 31, 2016 and December 26, 2015, respectively.

The guidance also allows for the employer to repurchase more of an employee’s shares, up to the maximum statutory rate, for tax withholding purposes and not classify the award as a liability that requires valuation on a mark-to-market basis. Our accounting treatment for outstanding awards was not impacted by our adoption of this provision. In addition, the guidance allows for a policy election to account for forfeitures as they occur. We will continue to apply our policy of estimating forfeitures.

In 2016, the FASB issued guidance that eliminates the requirement that an investor retrospectively apply equity method accounting for an investment originally accounted for by another method. The guidance requires that an equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor’s previously held interest and adopt the equity method of accounting as of the date the investor’s ability to exercise significant influence over the investment is achieved. We adopted the provisions of this guidance prospectively during our first quarter of 2017; the adoption did not impact our financial statements.

In 2015, the FASB issued guidance that requires companies to classify all deferred tax assets and liabilities as noncurrent on the balance sheet. We adopted the provisions of this guidance retrospectively during our first quarter of 2017, resulting in the reclassification of $639 million of deferred taxes from current to non-current on our balance sheet as of December 31, 2016.

Recently Issued Accounting Pronouncements - Not Yet Adopted

[In 2018, the FASB issued guidance related to the TCJ Act for the optional reclassification of the residual tax effects, arising from the change in the corporate tax rate, in accumulated other comprehensive loss to retained earnings. The reclassification would be the difference between the amount previously recorded in other comprehensive income at the historical U.S. federal tax rate that remains in accumulated other comprehensive loss at the time the TCJ Act was effective, and the amount that would have been recorded using the newly enacted rate. If elected, the guidance can be applied retrospectively to each period during which the impact of the TCJ Act is recognized or in the period of adoption. The guidance is effective in 2019 with early adoption permitted. We are currently evaluating the impact and adoption of this guidance.]

In 2017, the FASB issued guidance to amend and simplify the application of hedge accounting guidance to better portray the economic results of risk management activities in the financial statements. The guidance expands the ability to hedge nonfinancial and financial risk components, reduces complexity in fair value hedges of interest rate risk, eliminates the requirement to separately measure and report hedge ineffectiveness, as well as eases certain hedge effectiveness assessment requirements. The guidance is effective beginning in 2019 with early adoption permitted. We are currently evaluating the impact of this guidance, including transition elections and required disclosures, on our financial statements and the timing of adoption.

In 2017, the FASB issued guidance that requires companies to retrospectively present the service cost component of net periodic benefit cost for pension and retiree medical plans along with other compensation costs in operating profit and present the other components of net periodic benefit cost below operating profit in the income statement. The guidance also allows only the service cost component of net periodic benefit cost to be eligible for capitalization within inventory or fixed assets on a prospective basis. We will adopt the guidance when it becomes effective in the first quarter of 2018. We will also update our allocation of service costs to our divisions starting in 2018 to better approximate actual service cost. In connection with this adoption, we expect to record a decrease in operating profit of $233 million for the year ended December 30, 2017 and an increase in operating profit of $19 million for the year ended December 31, 2016, primarily impacting selling, general and administrative expenses. See Note 7 for further information on our service cost and other components of net periodic benefit cost for pension and retiree medical plans.

In 2016, the FASB issued guidance to clarify how restricted cash should be presented in the cash flow statement. We will adopt the guidance when it becomes effective in the first quarter of 2018. The guidance is not expected to have a material impact on our financial statements.

In 2016, the FASB issued guidance that requires companies to account for the income tax effects of intercompany transfers of assets, other than inventory, when the transfer occurs versus deferring income tax effects until the transferred asset is sold to an outside party or otherwise recognized. We will adopt the guidance when it becomes effective in the first quarter of 2018. The guidance is not expected to have a material impact on our financial statements.

In 2016, the FASB issued guidance that requires lessees to recognize most leases on the balance sheet, but record expenses on the income statement in a manner similar to current accounting. For lessors, the guidance modifies the classification criteria and the accounting for sales-type and direct financing leases. The guidance is effective beginning in 2019 with early adoption permitted. We are currently evaluating the impact of this guidance on our financial statements and related disclosures, including the increase in the assets and liabilities on our balance sheet and the impact on our current lease portfolio from both a lessor and lessee perspective. To facilitate this, we are utilizing a comprehensive approach to review our lease portfolio, as well as assessing system requirements and control implications. We have identified our significant leases by geography and by asset type that will be impacted by the new guidance, as well as a software tool to begin tracking the requirements of the guidance. In addition, we are currently evaluating the timing of adoption of this guidance. See Note 13 for our minimum lease payments under non-cancelable operating leases.

In 2016, the FASB issued guidance that requires companies to measure investments in certain equity securities at fair value and recognize any changes in fair value in net income. We will adopt the guidance when it becomes effective in the first quarter of 2018. The guidance is not expected to have a material impact on our financial statements. In the second quarter of 2017, we sold our minority stake in Britvic, representing all of our available-for-sale equity securities, which reduced the risk and volatility of these investments in our income statement in the future. See Note 9 for further information on our available-for-sale securities.

In 2014, the FASB issued guidance on revenue recognition, with final amendments issued in 2016. The guidance provides for a five-step model to determine the revenue recognized for the transfer of goods or services to customers that reflects the expected entitled consideration in exchange for those goods or services. It also provides clarification for principal versus agent considerations and identifying performance obligations. In addition, the FASB introduced practical expedients related to disclosures of remaining performance obligations, as well as other amendments related to guidance on collectibility, non-cash consideration and the presentation of sales and other similar taxes. Financial statement disclosures required under the guidance will enable users to understand the nature, amount, timing, judgments and uncertainty of revenue and cash flows relating to customer contracts. The two permitted transition methods under the guidance are the full retrospective approach or a cumulative effect adjustment to the opening retained earnings in the year of adoption (cumulative effect approach). We will adopt the guidance using the cumulative effect approach when it becomes effective in the first quarter of 2018.

We are utilizing a comprehensive approach to assess the impact of the guidance on our contract portfolio by reviewing our current accounting policies and practices to identify potential differences that would result from applying the new requirements to our revenue contracts, including evaluation of our performance obligations, principal versus agent considerations and variable consideration. We are substantially complete with our contract and business process reviews and implemented changes to our controls to support recognition and disclosures under the new guidance. As a result of implementing certain changes to our accounting policies upon adoption, we plan to record an adjustment to opening retained earnings to reflect marketplace spending that our customers and independent bottlers expect to be entitled to in line with revenue recognition; exclude all sales, use, value-added and certain excise taxes assessed by governmental authorities on revenue-producing transactions from net revenue and cost of sales; and to record shipping and handling activities that are performed after a customer obtains control of the product as a fulfillment cost. Based on the foregoing, we currently do not expect this guidance to have a material impact on our financial statements or disclosures.

Restructuring, Impairment and Integration Charges

12 Months Ended

Dec. 30, 2017

Restructuring and Related Activities [Abstract]

Restructuring, Impairment And Integration Charges

Restructuring and Impairment Charges

A summary of our restructuring and impairment charges and other productivity initiatives is as follows:



	2017		2016		2015
2014 Productivity Plan	$	295	$	160	$	169
2012 Productivity Plan	—		—		61
Total restructuring and impairment charges	295		160		230
Other productivity initiatives	16		12		90
Total restructuring and impairment charges and other productivity initiatives	$	311	$	172	$	320

2014 Multi-Year Productivity Plan

The 2014 Productivity Plan, publicly announced on February 13, 2014, includes the next generation of productivity initiatives that we believe will strengthen our food, snack and beverage businesses by: accelerating our investment in manufacturing automation; further optimizing our global manufacturing footprint, including closing certain manufacturing facilities; re-engineering our go-to-market systems in developed markets; expanding shared services; and implementing simplified organization structures to drive efficiency. To build on the successful implementation of the 2014 Productivity Plan to date, we expanded and extended the program through December 28, 2019 to take advantage of additional opportunities within the initiatives described above to further strengthen our food, snack and beverage businesses.

In 2017, 2016 and 2015, we incurred restructuring charges of $295 million ($224 million after-tax or $0.16 per share), $160 million ($131 million after-tax or $0.09 per share) and $169 million ($134 million after-tax or $0.09 per share), respectively, in conjunction with our 2014 Productivity Plan. All of these charges were recorded in selling, general and administrative expenses and primarily relate to severance and other employee-related costs, asset impairments (all non-cash), and other costs associated with the implementation of our initiatives, including contract termination costs. Substantially all of the restructuring accrual at December 30, 2017 is expected to be paid by the end of 2018.

A summary of our 2014 Productivity Plan charges is as follows:



	2017										2016									2015
	Severance and Other Employee Costs		Asset Impairments		Other Costs			Total			Severance and Other Employee Costs		Asset Impairments		Other Costs			Total		Severance and Other Employee Costs		Asset Impairments			Other Costs		Total
FLNA ^(a)	$	67	$	—	$	—		$	67		$	10	$	—	$	3		$	13	$	18	$	(1	)	$	9	$	26
QFNA	11		—		—			11			—		—		1			1		—		—			3		3
NAB	52		1		1			54			18		8		9			35		10		4			17		31
Latin America ^(a)	57		16		(10		)	63			29		—		(2		)	27		2		10			16		28
ESSA	46		4		3			53			21		22		17			60		26		11			25		62
AMENA ^(b)	2		—		(5		)	(3		)	4		6		4			14		2		—			8		10
Corporate	45		—		5			50			6		—		4			10		1		—			8		9
	$	280	$	21	$	(6	)	$	295		$	88	$	36	$	36		$	160	$	59	$	24		$	86	$	169


(a)	Income amounts represent adjustments for changes in estimates.


(b)	Income amount primarily reflects a gain on the sale of property, plant and equipment.

Since the inception of the 2014 Productivity Plan, we incurred restructuring charges of $1,034 million:



	2014 Productivity Plan Costs to Date
	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	131	$	9	$	23	$	163
QFNA	26		—		6		32
NAB	149		69		83		301
Latin America	109		29		14		152
ESSA	127		41		59		227
AMENA	23		6		15		44
Corporate	62		—		53		115
	$	627	$	154	$	253	$	1,034

A summary of our 2014 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs			Total
Liability as of December 27, 2014	$	89		$	—		$	24		$	113
2015 restructuring charges	59			24			86			169
Cash payments	(76		)	—			(87		)	(163		)
Non-cash charges and translation	(11		)	(24		)	(3		)	(38		)
Liability as of December 26, 2015	61			—			20			81
2016 restructuring charges	88			36			36			160
Cash payments	(46		)	—			(49		)	(95		)
Non-cash charges and translation	(15		)	(36		)	1			(50		)
Liability as of December 31, 2016	88			—			8			96
2017 restructuring charges	280			21			(6		)	295
Cash payments	(91		)	—			(22		)	(113		)
Non-cash charges and translation	(65		)	(21		)	34			(52		)
Liability as of December 30, 2017	$	212		$	—		$	14		$	226

2012 Multi-Year Productivity Plan

The 2012 Productivity Plan, publicly announced on February 9, 2012, included actions in every aspect of our business that we believe would strengthen our complementary food, snack and beverage businesses.

In 2015, we incurred restructuring charges of $61 million ($50 million after-tax or $0.03 per share) in conjunction with our 2012 Productivity Plan. All of these charges were recorded in selling, general and administrative expenses and primarily related to severance and other employee-related costs, asset impairments (all non-cash) and contract termination costs. The 2012 Productivity Plan was completed in 2016 and all cash payments were paid by the end of 2016.

A summary of our 2012 Productivity Plan charges in 2015 is as follows:



	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	—	$	—	$	—	$	—
QFNA	—		—		—		—
NAB	—		—		2		2
Latin America	6		1		1		8
ESSA	15		—		12		27
AMENA	15		3		2		20
Corporate	3		—		1		4
	$	39	$	4	$	18	$	61

Since the inception of the 2012 Productivity Plan, we incurred restructuring charges of $894 million:



	2012 Productivity Plan Costs to Date
	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	91	$	8	$	25	$	124
QFNA	18		—		10		28
NAB	107		44		48		199
Latin America	98		11		18		127
ESSA	136		23		66		225
AMENA	75		5		17		97
Corporate	35		—		59		94
	$	560	$	91	$	243	$	894

A summary of our 2012 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs			Total
Liability as of December 27, 2014	$	28		$	—		$	5		$	33
2015 restructuring charges	39			4			18			61
Cash payments	(24		)	—			(21		)	(45		)
Non-cash charges and translation	(8		)	(4		)	1			(11		)
Liability as of December 26, 2015	35			—			3			38
Cash payments	(28		)	—			(2		)	(30		)
Non-cash charges and translation	(7		)	—			(1		)	(8		)
Liability as of December 31, 2016	$	—		$	—		$	—		$	—

Other Productivity Initiatives

There were no material charges related to other productivity and efficiency initiatives outside the scope of the 2014 and 2012 Productivity Plans in 2017 and 2016. In 2015, we incurred charges of $90 million ($66 million after-tax or $0.04 per share) related to other productivity and efficiency initiatives outside the scope of the 2014 and 2012 Productivity Plans. These charges were recorded in selling, general and administrative expenses and primarily reflect severance and other employee-related costs and asset impairments (all non-cash). These initiatives were not included in items affecting comparability.

We regularly evaluate different productivity initiatives beyond the productivity plans and other initiatives described above.

See additional unaudited information in “Items Affecting Comparability” and “Results of Operations – Division Review” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Property, Plant and Equipment and Intangible Assets

12 Months Ended

Dec. 30, 2017

Property, Plant And Equipment And Intangible Assets [Abstract]

Property, Plant and Equipment and Intangible Assets

A summary of our property, plant and equipment is as follows:



	Average Useful Life (Years)	2017			2016			2015
Property, plant and equipment, net
Land		$	1,148		$	1,153
Buildings and improvements	15 - 44	8,796			8,306
Machinery and equipment, including fleet and software	5 - 15	27,018			25,277
Construction in progress		2,144			2,082
		39,106			36,818
Accumulated depreciation		(21,866		)	(20,227		)
		$	17,240		$	16,591
Depreciation expense		$	2,227		$	2,217		$	2,248

Property, plant and equipment is recorded at historical cost. Depreciation and amortization are recognized on a straight-line basis over an asset’s estimated useful life. Land is not depreciated and construction in progress is not depreciated until ready for service.

A summary of our amortizable intangible assets is as follows:



		2017							2016							2015
Amortizable intangible assets, net	Average Useful Life (Years)	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Acquired franchise rights	56 – 60	$	858	$	(128	)	$	730	$	827	$	(108	)	$	719
Reacquired franchise rights	5 – 14	106		(104		)	2		106		(102		)	4
Brands	20 – 40	1,322		(1,026		)	296		1,277		(977		)	300
Other identifiable intangibles	10 – 24	521		(281		)	240		522		(308		)	214
		$	2,807	$	(1,539	)	$	1,268	$	2,732	$	(1,495	)	$	1,237
Amortization expense							$	68						$	70	$	75

Amortization of intangible assets for each of the next five years, based on existing intangible assets as of December 30, 2017 and using average 2017 foreign exchange rates, is expected to be as follows:



	2018		2019		2020		2021		2022
Five-year projected amortization	$	69	$	64	$	64	$	62	$	60

Depreciable and amortizable assets are evaluated for impairment upon a significant change in the operating or macroeconomic environment. In these circumstances, if an evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on discounted future cash flows. Useful lives are periodically evaluated to determine whether events or circumstances have occurred which indicate the need for revision. For additional unaudited information on our policies for amortizable brands, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Nonamortizable Intangible Assets

We did not recognize any impairment charges for goodwill in each of the fiscal years ended December 30, 2017, December 31, 2016 and December 26, 2015. We recognized no material impairment charges for nonamortizable intangible assets in each of the fiscal years ended December 30, 2017, December 31, 2016 and December 26, 2015. As of December 30, 2017, the estimated fair values of our indefinite-lived reacquired and acquired franchise rights recorded at NAB exceeded their carrying values. However, there could be an impairment of the carrying value of NAB’s reacquired and acquired franchise rights if future revenues and their contribution to the operating results of NAB’s CSD business do not achieve our expected future cash flows or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value. We have also analyzed the impact of the macroeconomic conditions in Russia and Brazil on the estimated fair value of our indefinite-lived intangible assets in these countries and have concluded that there is no impairment as of December 30, 2017. However, there could be an impairment of the carrying value of certain brands in these countries if there is a deterioration in these conditions, if future revenues and their contributions to the operating results do not achieve our expected future cash flows or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value. For additional information on our policies for nonamortizable intangible assets, see Note 2.

The change in the book value of nonamortizable intangible assets is as follows:



	Balance, Beginning 2016		Translation and Other			Balance, End of 2016		Translation and Other			Balance, End of 2017
FLNA
Goodwill	$	267	$	3		$	270	$	10		$	280
Brands	22		1			23		2			25
	289		4			293		12			305
QFNA
Goodwill	175		—			175		—			175
NAB
Goodwill ^(a)	9,754		89			9,843		11			9,854
Reacquired franchise rights	7,042		22			7,064		62			7,126
Acquired franchise rights	1,507		5			1,512		13			1,525
Brands ^(a)	108		206			314		39			353
	18,411		322			18,733		125			18,858
Latin America
Goodwill	521		32			553		2			555
Brands	137		13			150		(9		)	141
	658		45			703		(7		)	696
ESSA ^(b)
Goodwill	3,042		135			3,177		275			3,452
Reacquired franchise rights	488		—			488		61			549
Acquired franchise rights	190		(6		)	184		11			195
Brands	2,212		146			2,358		187			2,545
	5,932		275			6,207		534			6,741
AMENA
Goodwill	418		(6		)	412		16			428
Brands	105		(2		)	103		8			111
	523		(8		)	515		24			539

Total goodwill	14,177		253			14,430		314			14,744
Total reacquired franchise rights	7,530		22			7,552		123			7,675
Total acquired franchise rights	1,697		(1		)	1,696		24			1,720
Total brands	2,584		364			2,948		227			3,175
	$	25,988	$	638		$	26,626	$	688		$	27,314


(a)	The change in 2016 is primarily related to our acquisition of KeVita, Inc.


(b)	The change in 2017 primarily reflects the currency appreciation of the Russian ruble and euro. The change in 2016 primarily reflects the currency appreciation of the Russian ruble.

Income Taxes

12 Months Ended

Dec. 30, 2017

Income Tax Disclosure [Abstract]

Income Taxes

The components of income before income taxes are as follows:



		2017			2016			2015
United States		$	3,452		$	2,630		$	2,879
Foreign		6,150			5,923			4,563
		$	9,602		$	8,553		$	7,442

The provision for income taxes consisted of the following:
		2017			2016			2015
Current:	U.S. Federal	$	4,925		$	1,219		$	1,143
	Foreign	724			824			773
	State	136			77			65
		5,785			2,120			1,981
Deferred:	U.S. Federal	(1,159		)	109			(14		)
	Foreign	(9		)	(33		)	(32		)
	State	77			(22		)	6
		(1,091		)	54			(40		)
		$	4,694		$	2,174		$	1,941

A reconciliation of the U.S. Federal statutory tax rate to our annual tax rate is as follows:



	2017		2016		2015
U.S. Federal statutory tax rate	35.0	%	35.0	%	35.0	%
State income tax, net of U.S. Federal tax benefit	0.9		0.4		0.6
Lower taxes on foreign results	(9.4	)	(8.0	)	(10.5	)
Impact of Venezuela impairment charges	—		—		6.4
Provisional one-time mandatory transition tax - TCJ Act	41.4		—		—
Provisional remeasurement of deferred taxes - TCJ Act	(15.9	)	—		—
Tax settlements	—		—		(3.1	)
Other, net	(3.1	)	(2.0	)	(2.3	)
Annual tax rate	48.9	%	25.4	%	26.1	%

Tax Cuts and Jobs Act

During the fourth quarter of 2017, the TCJ Act was enacted in the United States. Among its many provisions, the TCJ Act imposed a mandatory one-time transition tax on undistributed international earnings and reduced the U.S. corporate income tax rate from 35% to 21%, effective January 1, 2018. As a result of the enactment of the TCJ Act, we recognized a provisional net tax expense of $2.5 billion in the fourth quarter of 2017. See further unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Included in the provisional net tax expense of $2.5 billion is a provisional mandatory one-time transition tax of approximately $4 billion on undistributed international earnings, included in other liabilities. This provisional mandatory one-time transition tax was partially offset by a provisional $1.5 billion benefit resulting from the required remeasurement of our deferred tax assets and liabilities to the new, lower U.S. corporate income tax rate, effective January 1, 2018. The effect of the remeasurement was recorded in the fourth quarter of 2017, consistent with the enactment date of the TCJ Act, and reflected in our provision for income taxes.

The TCJ Act also creates a new requirement that certain income earned by foreign subsidiaries, known as GILTI, must be included in the gross income of their U.S. shareholder. The FASB allows an accounting policy election of either recognizing deferred taxes for temporary differences expected to reverse as GILTI in future years or recognizing such taxes as a current-period expense when incurred. Due to the complexity of calculating GILTI under the new law, we have not determined which method we will apply. Therefore, we have not made any adjustments related to potential GILTI tax in our financial statements. We expect to elect an accounting policy in the first quarter of 2018.

The components of the provisional net tax expense recorded in 2017 are based on currently available information and additional information needs to be prepared, obtained and/or analyzed to determine the final amounts. The provisional tax expense for the mandatory repatriation of undistributed international earnings will require further analysis of certain foreign exchange gains or losses, substantiation of foreign tax credits, as well as estimated cash and cash equivalents as of November 30, 2018, the tax year-end of our foreign subsidiaries. The provisional tax benefit for the remeasurement of deferred taxes will require additional information necessary for the preparation of our U.S. federal tax return, and further analysis and interpretation of certain provisions of the TCJ Act impacting deferred taxes, for example 100% expensing of qualified assets as well as our accounting policy election for recognizing deferred taxes for GILTI, could impact our deferred tax balance as of December 30, 2017.

Tax effects for these items will be recorded in subsequent quarters, as discrete adjustments to our income tax provision, once complete. The SEC has issued guidance that allows for a measurement period of up to one year after the enactment date of the TCJ Act to finalize the recording of the related tax impacts. We currently anticipate finalizing and recording any resulting adjustments by the end of 2018.

The recorded impact of the TCJ Act is provisional and the final amount may differ, possibly materially, due to, among other things, changes in estimates, interpretations and assumptions we have made, changes in IRS interpretations, the issuance of new guidance, legislative actions, changes in accounting standards or related interpretations in response to the TCJ Act and future actions by states within the United States that have not currently adopted the TCJ Act.

For further unaudited information and discussion of the potential impact of the TCJ Act, refer to “Item 1A. Risk Factors,” “Our Business Risks,” “Our Liquidity and Capital Resources” and “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Deferred tax liabilities and assets are comprised of the following:

Deferred Tax Liabilities



	2017			2016
Debt guarantee of wholly-owned subsidiary	$	578		$	839
Property, plant and equipment	1,397			1,967
Intangible assets other than nondeductible goodwill	3,169			4,124
Other	50			245
Gross deferred tax liabilities	5,194			7,175
Deferred tax assets
Net carryforwards	1,400			1,255
Share-based compensation	107			219
Retiree medical benefits	198			316
Other employee-related benefits	338			614
Pension benefits	22			419
Deductible state tax and interest benefits	157			189
Other	893			839
Gross deferred tax assets	3,115			3,851
Valuation allowances	(1,163		)	(1,110		)
Deferred tax assets, net	1,952			2,741
Net deferred tax liabilities	$	3,242		$	4,434

A summary of our valuation allowance activity is as follows:



	2017		2016			2015
Balance, beginning of year	$	1,110	$	1,136		$	1,230
Provision/(benefit)	33		13			(26		)
Other additions/(deductions)	20		(39		)	(68		)
Balance, end of year	$	1,163	$	1,110		$	1,136

For additional unaudited information on our income tax policies, including our reserves for income taxes, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Reserves

A number of years may elapse before a particular matter, for which we have established a reserve, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. Our major taxing jurisdictions and the related open tax audits are as follows:



Jurisdiction	Years Open to Audit	Years Currently Under Audit
United States	2012-2016	2012-2013
Mexico	2014-2016	2014
United Kingdom	2014-2016	None
Canada (Domestic)	2013-2016	2013-2014
Canada (International)	2010-2016	2010-2014
Russia	2012-2016	2012-2016

While it is often difficult to predict the final outcome or the timing of resolution of any particular tax matter, we believe that our reserves reflect the probable outcome of known tax contingencies. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual tax rate in the year of resolution. For further unaudited information on the impact of the resolution of open tax issues, see “Other Consolidated Results” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

In 2015, we reached an agreement with the IRS resolving substantially all open matters related to the audits of taxable years 2010 and 2011. The agreement resulted in a 2015 non-cash tax benefit totaling $230 million.

As of December 30, 2017, the total gross amount of reserves for income taxes, reported in other liabilities, was $2.2 billion. We accrue interest related to reserves for income taxes in our provision for income taxes and any associated penalties are recorded in selling, general and administrative expenses. The gross amount of interest accrued, reported in other liabilities, was $283 million as of December 30, 2017, of which $89 million of expense was recognized in 2017. The gross amount of interest accrued, reported in other liabilities, was $193 million as of December 31, 2016, of which $61 million of expense was recognized in 2016.

A reconciliation of unrecognized tax benefits, is as follows:



	2017			2016
Balance, beginning of year	$	1,885		$	1,547
Additions for tax positions related to the current year	309			349
Additions for tax positions from prior years	86			139
Reductions for tax positions from prior years	(51		)	(70		)
Settlement payments	(4		)	(26		)
Statutes of limitations expiration	(33		)	(27		)
Translation and other	20			(27		)
Balance, end of year	$	2,212		$	1,885

Carryforwards and Allowances

Operating loss carryforwards totaling $12.6 billion at year-end 2017 are being carried forward in a number of foreign and state jurisdictions where we are permitted to use tax operating losses from prior periods to reduce future taxable income. These operating losses will expire as follows: $0.2 billion in 2018, $11.1 billion between 2019 and 2037 and $1.3 billion may be carried forward indefinitely. We establish valuation allowances for our deferred tax assets if, based on the available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

Undistributed International Earnings

As of December 30, 2017, we had approximately $42.5 billion of undistributed international earnings. We intend to repatriate approximately $20 billion of our foreign earnings back to the United States and have recognized all tax expense on these earnings in the fourth quarter of 2017. We intend to continue to reinvest the remaining $22.5 billion of earnings outside the United States for the foreseeable future and while U.S. federal tax expense has been recognized as a result of the TCJ Act, no deferred tax liabilities with respect to items such as certain foreign exchange gains or losses, foreign withholding taxes or state taxes have been recognized. It is not practicable for us to determine the amount of unrecognized tax expense on these reinvested international earnings.

Share-Based Compensation

12 Months Ended

Dec. 30, 2017

Share-based Compensation [Abstract]

Stock-Based Compensation

-Based Compensation

Our share-based compensation program is designed to attract and retain employees while also aligning employees’ interests with the interests of our shareholders. PepsiCo has granted stock options, RSUs, PSUs, PEPunits and long-term cash awards to employees under the shareholder-approved PepsiCo, Inc. Long-Term Incentive Plan (LTIP). Executives who are awarded long-term incentives based on their performance may generally elect to receive their grant in the form of stock options or RSUs, or a combination thereof. Executives who elect stock options receive four stock options for every one RSU that would have otherwise been granted. Certain executive officers and other senior executives do not have a choice and, beginning in 2016, were granted 66% PSUs and 34% long-term cash, each of which are subject to pre-established performance targets. Previously, they were granted a combination of 60% PEPunits measuring both absolute and relative stock price performance and 40% long-term cash based on achievement of specific performance operating metrics.

The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs, PSUs and PEPunits.

As of December 30, 2017, 74 million shares were available for future share-based compensation grants under the LTIP.

The following table summarizes our total share-based compensation expense:



	2017				2016		2015
Share-based compensation expense - equity awards	$	292			$	284	$	295
Share-based compensation expense - liability awards	13				5		—
Restructuring and impairment (credits)/charges	(2		)		5		4
Total	$	303			$	294	$	299
Income tax benefits recognized in earnings related to share-based compensation	$	89		^(a)	$	91	$	77


(a)	Reflects tax rates effective for the 2017 tax year.

As of December 30, 2017, there was $314 million of total unrecognized compensation cost related to nonvested share-based compensation grants. This unrecognized compensation cost is expected to be recognized over a weighted-average period of two years.

Method of Accounting and Our Assumptions

The fair value of share-based award grants is amortized to expense over the vesting period, primarily three years. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. In addition, we use historical data to estimate forfeiture rates and record share-based compensation expense only for those awards that are expected to vest.

We do not backdate, reprice or grant share-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP.

Stock Options

A stock option permits the holder to purchase shares of PepsiCo common stock at a specified price. We account for our employee stock options under the fair value method of accounting using a Black-Scholes valuation model to measure stock option expense at the date of grant. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of grant and generally have a 10-year term.

Our weighted-average Black-Scholes fair value assumptions are as follows:



	2017		2016		2015
Expected life	5 years		6 years		7 years
Risk-free interest rate	2.0	%	1.4	%	1.8	%
Expected volatility	11	%	12	%	15	%
Expected dividend yield	2.7	%	2.7	%	2.7	%

The expected life is the period over which our employee groups are expected to hold their options. It is based on our historical experience with similar grants. The risk-free interest rate is based on the expected U.S. Treasury rate over the expected life. Volatility reflects movements in our stock price over the most recent historical period equivalent to the expected life. Dividend yield is estimated over the expected life based on our stated dividend policy and forecasts of net income, share repurchases and stock price.

A summary of our stock option activity for the year ended December 30, 2017 is as follows:



	Options^(a)		Weighted-Average Exercise Price		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(b)
Outstanding at December 31, 2016	25,190		$	69.88
Granted	1,481		$	110.15
Exercised	(7,136	)	$	65.31
Forfeited/expired	(522	)	$	88.36
Outstanding at December 30, 2017	19,013		$	74.23	4.22	$	868,750
Exercisable at December 30, 2017	14,589		$	65.60	3.02	$	792,560
Expected to vest as of December 30, 2017	3,994		$	102.50	8.15	$	69,578


(a)	Options are in thousands and include options previously granted under the PBG plan. No additional options or shares were granted under the PBG plan after 2009.


(b)	In thousands.

Restricted Stock Units and Performance Stock Units

Each RSU represents our obligation to deliver to the holder one share of PepsiCo common stock when the award vests at the end of the service period. PSUs are awards pursuant to which a number of shares are delivered to the holder upon vesting at the end of the service period based on PepsiCo’s performance against specified financial and/or operational performance metrics. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of these performance metrics in accordance with the terms established at the time of the award. During the vesting period, RSUs and PSUs accrue dividend equivalents that pay out in cash (without interest) if and when the applicable RSU or PSU vests and becomes payable.

The fair value of RSUs is measured at the market price of the Company’s stock on the date of grant. The fair value of PSUs is measured at the market price of the Company’s stock on the date of grant with the exception of awards with market conditions, for which we use the Monte-Carlo simulation model to determine the fair value. The Monte-Carlo simulation model uses the same input assumptions as the Black-Scholes model; however, it also further incorporates into the fair-value determination the possibility that the market condition may not be satisfied. Compensation costs related to these awards are recognized regardless of whether the market condition is satisfied, provided that the requisite service has been provided.

A summary of our RSU and PSU activity for the year ended December 30, 2017 is as follows:



	RSUs/PSUs^(a)		Weighted-Average Grant-Date Fair Value		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(a)
Outstanding at December 31, 2016	8,237		$	91.81
Granted ^(b)	2,824		$	109.92
Converted	(3,226	)	$	82.56
Forfeited	(608	)	$	100.17
Actual performance change ^(c)	66		$	100.33
Outstanding at December 30, 2017 ^(d)	7,293		$	102.30	1.33	$	874,517
Expected to vest as of December 30, 2017	6,695		$	102.00	1.26	$	802,826


(a)	In thousands.


(b)	Grant activity for all PSUs are disclosed at target.


(c)	Reflects the net number of PSUs above and below target levels based on actual performance measured at the end of the performance period.


(d)	The outstanding PSUs for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, 0.9 million and 1.5 million, respectively.

PEPunits

PEPunits provide an opportunity to earn shares of PepsiCo common stock with a value that adjusts based upon changes in PepsiCo’s absolute stock price as well as PepsiCo’s Total Shareholder Return relative to the S&P 500 over a three-year performance period.

The fair value of PEPunits is measured using the Monte-Carlo simulation model.

A summary of our PEPunit activity for the year ended December 30, 2017 is as follows:



	PEPunits^(a)		Weighted-Average Grant-Date Fair Value		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(a)
Outstanding at December 31, 2016	533		$	59.86
Converted	(363	)	$	49.11
Forfeited	(13	)	$	68.94
Actual performance change ^(b)	91		$	50.74
Outstanding at December 30, 2017 ^(c)	248		$	68.94	0.17	$	29,734
Expected to vest as of December 30, 2017	234		$	68.94	0.17	$	28,034


(a)	In thousands.


(b)	Reflects the net number of PEPunits above and below target levels based on actual performance measured at the end of the performance period.


(c)	The outstanding PEPunits for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, 0.2 million and 0.4 million, respectively.

Long-Term Cash

Beginning in 2016, certain executive officers and other senior executives were granted long-term cash awards for which final payout is based on PepsiCo’s Total Shareholder Return relative to a specific set of peer companies and achievement of a specified performance target over a three-year performance period.

Long-term cash awards that qualify as liability awards under share-based compensation guidance are valued through the end of the performance period on a mark-to-market basis using the Monte Carlo simulation model until actual performance is determined.

A summary of our long-term cash activity for the year ended December 30, 2017 is as follows:



	Long-Term Cash Award^(a)			Balance Sheet Date Fair Value^(a)		Contractual Life Remaining (years)
Outstanding at December 31, 2016	$	15,670
Granted^(b)	19,060
Forfeited	(1,530		)
Outstanding at December 30, 2017 ^(c)	$	33,200		$	32,592	1.73
Expected to vest as of December 30, 2017	$	29,590		$	29,092	1.71


(a)	In thousands.


(b)	Grant activity for all long-term cash awards are disclosed at target.


(c)	The outstanding long-term cash awards for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, $33.2 million and $66.4 million, respectively.

Other Share-Based Compensation Data

The following is a summary of other share-based compensation data:



	2017		2016		2015
Stock Options
Total number of options granted ^(a)	1,481		1,743		1,884
Weighted-average grant-date fair value of options granted	$	8.25	$	6.94	$	10.80
Total intrinsic value of options exercised ^(a)	$	327,860	$	290,131	$	366,188
Total grant-date fair value of options vested ^(a)	$	23,122	$	18,840	$	21,837
RSUs/PSUs
Total number of RSUs/PSUs granted ^(a)	2,824		3,054		2,759
Weighted-average grant-date fair value of RSUs/PSUs granted	$	109.92	$	99.06	$	99.17
Total intrinsic value of RSUs/PSUs converted ^(a)	$	380,269	$	359,401	$	375,510
Total grant-date fair value of RSUs/PSUs vested ^(a)	$	264,923	$	257,648	$	257,831
PEPunits
Total number of PEPunits granted ^(a)	—		—		300
Weighted-average grant-date fair value of PEPunits granted	$	—	$	—	$	68.94
Total intrinsic value of PEPunits converted ^(a)	$	39,782	$	38,558	$	37,705
Total grant-date fair value of PEPunits vested ^(a)	$	18,833	$	16,572	$	22,286


(a)	In thousands.

As of December 30, 2017 and December 31, 2016, there were approximately 250,000 and 254,000 outstanding awards, respectively, consisting primarily of phantom stock units that were granted under the PepsiCo Director Deferral Program and will be settled in shares of PepsiCo common stock pursuant to the LTIP at the end of the applicable deferral period, not included in the tables above.

Pension, Retiree Medical and Savings Plans

12 Months Ended

Dec. 30, 2017

Retirement Benefits, Description [Abstract]

Pension, Retiree Medical and Savings Plans

Effective January 1, 2017, the U.S. qualified defined benefit pension plans were reorganized into Plan A and Plan I. Actuarial gains and losses associated with Plan A are amortized over the average remaining service life of the active participants, while the actuarial gains and losses associated with Plan I are amortized over the remaining life expectancy of the inactive participants. As a result of this change, the pre-tax net periodic benefit cost decreased by $42 million ($27 million after-tax, reflecting tax rates effective for the 2017 tax year, or $0.02 per share) in 2017, primarily impacting corporate unallocated expenses. See “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

In 2016, the U.S. qualified defined benefit pension plans purchased a group annuity contract whereby an unrelated insurance company assumed the obligation to pay and administer future annuity payments for certain retirees. In 2016, we made discretionary contributions of $452 million primarily to fund the transfer of the obligation. This transaction triggered a pre-tax settlement charge of $242 million ($162 million after-tax or $0.11 per share). See additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Effective as of the beginning of 2016, we prospectively changed the method we use to estimate the service and interest cost components of net periodic benefit cost. The pre-tax reduction in net periodic benefit cost associated with this change in 2016 was $125 million ($81 million after-tax or $0.06 per share). See “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations for further unaudited information on this change in accounting estimate.

Gains and losses resulting from actual experience differing from our assumptions, including the difference between the actual return on plan assets and the expected return on plan assets, as well as changes in our assumptions, are determined at each measurement date. These differences are recognized as a component of net gain or loss in accumulated other comprehensive loss. If this net accumulated gain or loss exceeds 10% of the greater of the market-related value of plan assets or plan liabilities, a portion of the net gain or loss is included in expense for the following year based upon the average remaining service life for participants in Plan A (approximately 11 years) and retiree medical (approximately 7 years), or the remaining life expectancy for participants in Plan I (approximately 27 years). The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service (credit)/cost) is included in earnings on a straight-line basis over the average remaining service life for participants in Plan A or the remaining life expectancy for participants in Plan I.

We regularly evaluate different opportunities to reduce risk and volatility associated with our pension and retiree medical plans.

Selected financial information for our pension and retiree medical plans is as follows:



	Pension												Retiree Medical
	U.S.						International
	2017			2016			2017			2016			2017			2016
Change in projected benefit liability
Liability at beginning of year	$	13,192		$	13,033		$	3,124		$	2,872		$	1,208		$	1,300
Service cost	401			393			91			80			28			31
Interest cost	468			484			89			94			36			41
Plan amendments	10			18			2			—			(5		)	(15		)
Participant contributions	—			—			2			2			—			—
Experience loss/(gain)	1,529			614			5			560			21			(51		)
Benefit payments	(825		)	(347		)	(104		)	(83		)	(107		)	(100		)
Settlement/curtailment	(58		)	(1,014		)	(22		)	(19		)	—			—
Special termination benefits	60			11			—			1			2			1
Other, including foreign currency adjustment	—			—			303			(383		)	4			1
Liability at end of year	$	14,777		$	13,192		$	3,490		$	3,124		$	1,187		$	1,208

Change in fair value of plan assets
Fair value at beginning of year	$	11,458		$	11,397		$	2,894		$	2,823		$	320		$	354
Actual return on plan assets	1,935			880			288			409			52			30
Employer contributions/funding	60			541			104			118			56			36
Participant contributions	—			—			2			2			—			—
Benefit payments	(825		)	(347		)	(104		)	(83		)	(107		)	(100		)
Settlement	(46		)	(1,013		)	(18		)	(22		)	—			—
Other, including foreign currency adjustment	—			—			294			(353		)	—			—
Fair value at end of year	$	12,582		$	11,458		$	3,460		$	2,894		$	321		$	320
Funded status	$	(2,195	)	$	(1,734	)	$	(30	)	$	(230	)	$	(866	)	$	(888	)



Amounts recognized
Other assets	$	286		$	—		$	85		$	51		$	—		$	—
Other current liabilities	(74		)	(42		)	(1		)	(1		)	(75		)	(54		)
Other liabilities	(2,407		)	(1,692		)	(114		)	(280		)	(791		)	(834		)
Net amount recognized	$	(2,195	)	$	(1,734	)	$	(30	)	$	(230	)	$	(866	)	$	(888	)

Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	$	3,520		$	3,220		$	782		$	884		$	(189	)	$	(193	)
Prior service cost/(credit)	29			20			(3		)	(5		)	(71		)	(91		)
Total	$	3,549		$	3,240		$	779		$	879		$	(260	)	$	(284	)

Changes recognized in net loss/(gain) included in other comprehensive loss
Net loss/(gain) arising in current year	$	431		$	568		$	(115	)	$	314		$	(9	)	$	(57	)
Amortization and settlement recognition	(131		)	(413		)	(60		)	(46		)	12			1
Foreign currency translation loss/(gain)	—			—			73			(117		)	1			1
Total	$	300		$	155		$	(102	)	$	151		$	4		$	(55	)

Accumulated benefit obligation at end of year	$	13,732		$	12,211		$	2,985		$	2,642

The amounts we report as pension and retiree medical cost consist of the following components:


•	Service cost is the value of benefits earned by employees for working during the year.


•	Interest cost is the accrued interest on the projected benefit obligation due to the passage of time.


•	Expected return on plan assets is the long-term return we expect to earn on plan investments for our funded plans that will be used to settle future benefit obligations.


•	Amortization of prior service cost/(credit) represents the recognition in the income statement of benefit changes resulting from plan amendments.


•	Amortization of net loss/(gain) represents the recognition in the income statement of changes in the amount of plan assets and the projected benefit obligation based on changes in assumptions and actual experience.

•

Settlement/curtailment loss/(gain) represents the result of actions that effectively eliminate all or a portion of related projected benefit obligations. Settlements are triggered when payouts to settle the projected benefit obligation of a plan due to lump sums or other events exceed the annual service and interest cost. Settlements are recognized when actions are irrevocable and we are relieved of the primary responsibility and risk for projected benefit obligations. Curtailments are due to events such as plant closures or the sale of a business resulting in a reduction of future service or benefits. Curtailment losses are recognized when an event is probable and estimable, while curtailment gains are recognized when an event has occurred (when the related employees terminate or an amendment is adopted).


•	Special termination benefits are the additional benefits offered to employees upon departure due to actions such as restructuring.

The components of benefit expense are as follows:



	Pension																		Retiree Medical
	U.S.									International
	2017			2016			2015			2017			2016			2015			2017			2016			2015
Components of benefit expense
Service cost	$	401		$	393		$	435		$	91		$	80		$	99		$	28		$	31		$	35
Interest cost	468			484			546			89			94			115			36			41			52
Expected return on plan assets	(849		)	(834		)	(850		)	(176		)	(163		)	(174		)	(22		)	(24		)	(27		)
Amortization of prior service cost/(credit)	1			(1		)	(3		)	—			—			—			(25		)	(38		)	(39		)
Amortization of net loss/(gain)	123			168			205			53			40			71			(12		)	(1		)	2
	144			210			333			57			51			111			5			9			23
Settlement/curtailment loss/(gain) ^(a)	8			245			—			11			9			3			—			(14		)	—
Special termination benefits	60			11			18			—			1			1			2			1			1
Total	$	212		$	466		$	351		$	68		$	61		$	115		$	7		$	(4	)	$	24


(a)	U.S. includes a settlement charge of $242 million related to the group annuity contract purchase in 2016. See additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The estimated amounts to be amortized from accumulated other comprehensive loss/(gain) into pre-tax expense in 2018 for our pension and retiree medical plans are as follows:



	Pension				Retiree Medical
	U.S.		International
Net loss/(gain)	$	179	$	46	$	(10	)
Prior service cost/(credit)	3		—		(20		)
Total	$	182	$	46	$	(30	)

The following table provides the weighted-average assumptions used to determine projected benefit liability and benefit expense for our pension and retiree medical plans:



	Pension												Retiree Medical
	U.S.						International
	2017		2016		2015		2017		2016		2015		2017		2016		2015
Weighted-average assumptions
Liability discount rate	3.7	%	4.4	%	4.5	%	3.0	%	3.1	%	4.0	%	3.5	%	4.0	%	4.2	%
Expense discount rate ^(a)	n/a		n/a		4.2	%	n/a		n/a		3.8	%	n/a		n/a		3.8	%
Service cost discount rate ^(a)	4.5	%	4.6	%	n/a		3.6	%	4.1	%	n/a		4.0	%	4.3	%	n/a
Interest cost discount rate ^(a)	3.7	%	3.8	%	n/a		2.8	%	3.5	%	n/a		3.2	%	3.3	%	n/a
Expected return on plan assets	7.5	%	7.5	%	7.5	%	6.0	%	6.2	%	6.5	%	7.5	%	7.5	%	7.5	%
Liability rate of salary increases	3.1	%	3.1	%	3.1	%	3.7	%	3.6	%	3.6	%
Expense rate of salary increases	3.1	%	3.1	%	3.5	%	3.6	%	3.6	%	3.6	%


(a)	Effective as of the beginning of 2016, we prospectively changed the method we use to estimate the service and interest cost components of pension and retiree medical expense. See additional unaudited information in “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following table provides selected information about plans with accumulated benefit obligation and total projected benefit liability in excess of plan assets:



	Pension												Retiree Medical
	U.S.						International
	2017			2016			2017			2016			2017			2016
Selected information for plans with accumulated benefit obligation in excess of plan assets
Liability for service to date	$	(8,355	)	$	(12,211	)	$	(161	)	$	(134	)
Fair value of plan assets	$	6,919		$	11,458		$	119		$	110
Selected information for plans with projected benefit liability in excess of plan assets
Benefit liability	$	(9,400	)	$	(13,192	)	$	(1,273	)	$	(2,773	)	$	(1,187	)	$	(1,208	)
Fair value of plan assets	$	6,919		$	11,458		$	1,158		$	2,492		$	321		$	320

Of the total projected pension benefit liability as of December 30, 2017, approximately $905 million relates to plans that we do not fund because the funding of such plans does not receive favorable tax treatment.

Future Benefit Payments

Our estimated future benefit payments are as follows:



	2018		2019		2020		2021		2022		2023 - 27
Pension	$	890	$	985	$	825	$	875	$	925	$	5,210
Retiree medical ^(a)	$	120	$	120	$	110	$	110	$	105	$	455


(a)	Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $2 million for each of the years from 2018 through 2022 and approximately $6 million in total for 2023 through 2027.

These future benefit payments to beneficiaries include payments from both funded and unfunded plans.

Funding

Contributions to our pension and retiree medical plans were as follows:



	Pension						Retiree Medical
	2017		2016		2015		2017		2016		2015
Discretionary ^(a)	$	6	$	459	$	—	$	—	$	—	$	—
Non-discretionary	158		200		162		56		36		43
Total	$	164	$	659	$	162	$	56	$	36	$	43


(a)	Includes $452 million in 2016 relating to the funding of the group annuity contract purchase from an unrelated insurance company.

In February 2018, we received approval from our Board of Directors to make discretionary contributions of $1.4 billion to our U.S. pension plans in 2018 that we intend to invest in fixed income securities. As of February 13, 2018, we contributed $750 million of the approved amount; we expect to contribute the remaining $650 million in the first quarter of 2018. These contributions are reflected in our 2018 long-term expected rate of return on plan assets and target investment allocations. In addition, in 2018, we expect to make non-discretionary contributions of approximately $175 million to our U.S. and international plans for pension benefits and approximately $75 million for retiree medical benefits.

Plan Assets

Our pension plan investment strategy includes the use of actively managed accounts and is reviewed periodically in conjunction with plan liabilities, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments. This strategy is also applicable to funds held for the retiree medical plans. Our investment objective includes ensuring that funds are available to meet the plans’ benefit obligations when they become due. Assets contributed to our pension plans are no longer controlled by us, but become the property of our individual pension plans. However, we are indirectly impacted by changes in these plan assets as compared to changes in our projected liabilities. Our overall investment policy is to prudently invest plan assets in a well-diversified portfolio of equity and high-quality debt securities and real estate to achieve our long-term return expectations. Our investment policy also permits the use of derivative instruments, such as futures and forward contracts, to reduce interest rate and foreign currency risks. Futures contracts represent commitments to purchase or sell securities at a future date and at a specified price. Forward contracts consist of currency forwards.

For 2018 and 2017, our expected long-term rate of return on U.S. plan assets is 7.2% and 7.5%, respectively. Our target investment allocations for U.S. plan assets are as follows:



	2018		2017
Fixed income	47	%	40	%
U.S. equity	29	%	33	%
International equity	20	%	22	%
Real estate	4	%	5	%

Actual investment allocations may vary from our target investment allocations due to prevailing market conditions. We regularly review our actual investment allocations and periodically rebalance our investments.

The expected return on plan assets is based on our investment strategy and our expectations for long-term rates of return by asset class, taking into account volatility and correlation among asset classes and our historical experience. We also review current levels of interest rates and inflation to assess the reasonableness of the long-term rates. We evaluate our expected return assumptions annually to ensure that they are reasonable. To calculate the expected return on plan assets, our market-related value of assets for fixed income is the actual fair value. For all other asset categories, such as equity securities, we use a method that recognizes investment gains or losses (the difference between the expected and actual return based on the market-related value of assets) over a five-year period. This has the effect of reducing year-to-year volatility.

Plan assets measured at fair value as of fiscal year-end 2017 and 2016 are categorized consistently by level, and are as follows:



	2017								2016
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
U.S. plan assets ^(a)
Equity securities, including preferred stock ^(b)	$	6,904	$	6,896	$	8	$	—	$	6,489
Government securities ^(c)	1,365		—		1,365		—		1,173
Corporate bonds ^(c)	3,429		—		3,429		—		3,012
Mortgage-backed securities ^(c)	217		—		217		—		187
Contracts with insurance companies ^(d)	8		—		—		8		7
Cash and cash equivalents	236		236		—		—		196
Sub-total U.S. plan assets	12,159		$	7,132	$	5,019	$	8	11,064
Real estate commingled funds measured at net asset value ^(e)	675								651
Dividends and interest receivable, net of payables	69								63
Total U.S. plan assets	$	12,903							$	11,778
International plan assets
Equity securities ^(b)	$	1,928	$	1,895	$	33	$	—	$	1,556
Government securities ^(c)	492		—		492		—		432
Corporate bonds ^(c)	493		—		493		—		453
Fixed income commingled funds ^(f)	383		383		—		—		316
Contracts with insurance companies ^(d)	36		—		—		36		35
Cash and cash equivalents	19		19		—		—		12
Sub-total international plan assets	3,351		$	2,297	$	1,018	$	36	2,804
Real estate commingled funds measured at net asset value ^(e)	102								84
Dividends and interest receivable	7								6
Total international plan assets	$	3,460							$	2,894


(a)	2017 and 2016 amounts include $321 million and $320 million, respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries.

(b)

The equity securities portfolio was invested in U.S. and international common stock and commingled funds, and the preferred stock portfolio in the U.S. was invested in domestic and international corporate preferred stock investments. The common stock is based on quoted prices in active markets. The U.S. commingled funds are based on fair values of the investments owned by these funds that are benchmarked against various U.S. large, mid-cap and small company indices, and includes one large-cap fund that represents 19% of total U.S. plan assets for 2017 and 2016. The international commingled funds are based on the fair values of the investments owned by these funds that track various non-U.S. equity indices. The preferred stock investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets.


(c)	These investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. Corporate bonds of U.S.-based companies represent 23% and 22% of total U.S. plan assets for 2017 and 2016, respectively.


(d)	Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. The changes in Level 3 amounts were not significant in the years ended December 30, 2017 and December 31, 2016.


(e)	The real estate commingled funds include investments in limited partnerships. These funds are based on the net asset value of the appraised value of investments owned by these funds as determined by independent third parties using inputs that are not observable. The majority of the funds are redeemable quarterly subject to availability of cash and have notice periods ranging from 45 to 90 days.


(f)	Based on the fair value of the investments owned by these funds that track various government and corporate bond indices.

Retiree Medical Cost Trend Rates



	2018		2017
Average increase assumed	6	%	6	%
Ultimate projected increase	5	%	5	%
Year of ultimate projected increase	2039		2039

These assumed health care cost trend rates have an impact on the retiree medical plan expense and liability, however the cap on our share of retiree medical costs limits the impact. A 1-percentage-point change in the assumed health care trend rate would have the following effects:



	1% Increase		1% Decrease
2017 service and interest cost components	$	3	$	(3	)
2017 benefit liability	$	39	$	(34	)

Savings Plan

Certain U.S. employees are eligible to participate in 401(k) savings plans, which are voluntary defined contribution plans. The plans are designed to help employees accumulate additional savings for retirement, and we make Company matching contributions for certain employees on a portion of eligible pay based on years of service.

Certain U.S. salaried employees, who are not eligible to participate in a defined benefit pension plan, are also eligible to receive an employer contribution to the 401(k) savings plan based on age and years of service regardless of employee contribution.

In 2017, 2016 and 2015, our total Company contributions were $176 million, $164 million and $148 million, respectively.

For additional unaudited information on our pension and retiree medical plans and related accounting policies and assumptions, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Debt Obligations and Commitments

12 Months Ended

Dec. 30, 2017

Debt Obligations and Commitments [Abstract]

Debt Obligations And Commitments

Debt Obligations

The following table summarizes the Company’s debt obligations:



	2017^(a)			2016^(a)
Short-term debt obligations^(b)
Current maturities of long-term debt	$	4,020		$	4,401
Commercial paper (1.3% and 0.6%)	1,385			2,257
Other borrowings (4.7% and 4.4%)	80			234
	$	5,485		$	6,892
Long-term debt obligations ^(b)
Notes due 2017 (1.4%)	$	—		$	4,398
Notes due 2018 (2.4% and 2.3%)	4,016			2,561
Notes due 2019 (2.1% and 1.7%)	3,933			2,837
Notes due 2020 (3.1% and 2.6%)	3,792			3,816
Notes due 2021 (2.4% and 2.4%)	3,300			2,249
Notes due 2022 (2.6% and 2.8%)	3,853			2,655
Notes due 2023-2047 (3.7% and 3.8%)	18,891			15,903
Other, due 2017-2026 (1.3% and 1.4%)	31			35
	37,816			34,454
Less: current maturities of long-term debt obligations	(4,020		)	(4,401		)
Total	$	33,796		$	30,053


(a)	Amounts are shown net of unamortized net discounts of $155 million and $142 million for 2017 and 2016, respectively.


(b)	The interest rates presented reflect weighted-average rates at year-end. Certain of our fixed rate indebtedness have been swapped to floating rates through the use of interest rate derivative instruments. See Note 9 for additional information regarding our interest rate derivative instruments.

In 2017, we issued the following senior notes:



Interest Rate		Maturity Date	Amount^(a)
Floating rate		May 2019	$	350
Floating rate		May 2022	$	400
1.550	%	May 2019	$	750
2.250	%	May 2022	$	750
4.000	%	May 2047	$	750
2.150	%	May 2024	C$	750	^(b)
Floating rate		October 2018	$	1,500
2.000	%	April 2021	$	1,000
3.000	%	October 2027	$	1,500


(a)	Represents gross proceeds from issuances of long-term debt excluding debt issuance costs, discounts and premiums.


(b)	These notes, issued in Canadian dollars, were designated as a net investment hedge to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper.

In 2017, we entered into a new five-year unsecured revolving credit agreement (Five-Year Credit Agreement) which expires on June 5, 2022. The Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $3.75 billion, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $4.5 billion. Additionally, we may, once a year, request renewal of the agreement for an additional one-year period.

Also in 2017, we entered into a new 364-day unsecured revolving credit agreement (364-Day Credit Agreement) which expires on June 4, 2018. The 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $3.75 billion, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $4.5 billion. We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which would mature no later than the anniversary of the then effective termination date. The Five-Year Credit Agreement and the 364-Day Credit Agreement together replaced our $3.7225 billion five-year credit agreement and our $3.7225 billion 364-day credit agreement both dated as of June 6, 2016. Funds borrowed under the Five-Year Credit Agreement and the 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of December 30, 2017, there were no outstanding borrowings under the Five-Year Credit Agreement or the 364-Day Credit Agreement.

In 2016, we paid $2.5 billion to redeem all of our outstanding 7.900% senior notes due 2018 and 5.125% senior notes due 2019 for the principal amounts of $1.5 billion and $750 million, respectively, and terminated certain interest rate swaps. As a result, we recorded a pre-tax charge of $233 million ($156 million after-tax or $0.11 per share) to interest expense, primarily representing the premium paid in accordance with the “make-whole” redemption provisions. See further unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

In addition, as of December 30, 2017, our international debt of $73 million was related to borrowings from external parties including various lines of credit. These lines of credit are subject to normal banking terms and conditions and are fully committed at least to the extent of our borrowings.

See “Our Liquidity and Capital Resources” in Management’s Discussion and Analysis of Financial Condition and Results of Operations for further unaudited information on our borrowings and long-term contractual commitments.

Financial Instruments

12 Months Ended

Dec. 30, 2017

Derivative Instruments and Hedges, Assets [Abstract]

Financial Instruments

Derivatives and Hedging

We are exposed to market risks arising from adverse changes in:


•	commodity prices, affecting the cost of our raw materials and energy;


•	foreign exchange rates and currency restrictions; and


•	interest rates.

In the normal course of business, we manage commodity price, foreign exchange and interest rate risks through a variety of strategies, including productivity initiatives, global purchasing programs and hedging. Ongoing productivity initiatives involve the identification and effective implementation of meaningful cost-saving opportunities or efficiencies, including the use of derivatives. Our global purchasing programs include fixed-price contracts and purchase orders and pricing agreements.

Our hedging strategies include the use of derivatives and, in the case of our net investment hedges, debt instruments. Certain derivatives are designated as either cash flow or fair value hedges and qualify for hedge accounting treatment, while others do not qualify and are marked to market through earnings. Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the cash flow statement. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item. See “Our Business Risks” in Management’s Discussion and Analysis of Financial Condition and Results of Operations for further unaudited information on our business risks.

We do not use derivative instruments for trading or speculative purposes. We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk.

Commodity Prices

We are subject to commodity price risk because our ability to recover increased costs through higher pricing may be limited in the competitive environment in which we operate. This risk is managed through the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, which include swaps and futures. In addition, risk to our supply of certain raw materials is mitigated through purchases from multiple geographies and suppliers. We use derivatives, with terms of no more than three years, to economically hedge price fluctuations related to a portion of our anticipated commodity purchases, primarily for agricultural products, energy and metals. Ineffectiveness for those derivatives that qualify for hedge accounting treatment was not material for all periods presented. Derivatives used to hedge commodity price risk that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit.

Our commodity derivatives had a total notional value of $0.9 billion as of December 30, 2017 and $0.8 billion as of December 31, 2016.

Foreign Exchange

Our operations outside of the United States generated 42% of our net revenue in 2017, with Mexico, Russia, Canada, the United Kingdom and Brazil comprising approximately 20% of our net revenue in 2017. As a result, we are exposed to foreign exchange risks in the international markets in which our products are made, manufactured, distributed or sold.

Additionally, we are exposed to foreign exchange risk from net investments in foreign subsidiaries, foreign currency purchases and foreign currency assets and liabilities created in the normal course of business. We manage this risk through sourcing purchases from local suppliers, negotiating contracts in local currencies with foreign suppliers and through the use of derivatives, primarily forward contracts with terms of no more than two years. Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses in our income statement as incurred. We also use net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

Our foreign currency derivatives had a total notional value of $1.6 billion as of December 30, 2017 and December 31, 2016. The total notional amount of our debt instruments designated as net investment hedges was $1.5 billion as of December 30, 2017 and $0.8 billion as of December 31, 2016. Ineffectiveness for derivatives and non-derivatives that qualify for hedge accounting treatment was not material for all periods presented. For foreign currency derivatives that do not qualify for hedge accounting treatment, all gains and losses were offset by changes in the underlying hedged items, resulting in no material net impact on earnings.

Interest Rates

We centrally manage our debt and investment portfolios considering investment opportunities and risks, tax consequences and overall financing strategies. We use various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, Treasury locks and swap locks to manage our overall interest expense and foreign exchange risk. These instruments effectively change the interest rate and currency of specific debt issuances. Certain of our fixed rate indebtedness have been swapped to floating rates. The notional amount, interest payment and maturity date of the interest rate and cross-currency interest rate swaps match the principal, interest payment and maturity date of the related debt. Our Treasury locks and swap locks are entered into to protect against unfavorable interest rate changes relating to forecasted debt transactions.

Our interest rate derivatives had a total notional value of $14.2 billion as of December 30, 2017 and $11.2 billion as of December 31, 2016. Ineffectiveness for derivatives that qualify for cash flow hedge accounting treatment was not material for all periods presented.

As of December 30, 2017, approximately 43% of total debt, after the impact of the related interest rate derivative instruments, was subject to variable rates, compared to approximately 38% as of December 31, 2016.

Available-for-Sale Securities

Investments in debt and marketable equity securities, other than investments accounted for under the equity method, are classified as available-for-sale. All highly liquid investments with original maturities of three months or less are classified as cash equivalents. Our investments in available-for-sale securities are reported at fair value. Unrealized gains and losses related to changes in the fair value of available-for-sale securities are recognized in accumulated other comprehensive loss within common shareholders’ equity. Unrealized gains and losses on our investments in debt securities as of December 30, 2017 were not material. In 2017, we recorded a pre-tax gain of $95 million ($85 million after-tax or $0.06 per share), net of discount and fees, associated with the sale of our minority stake in Britvic. This gain was recorded in our ESSA segment in selling, general and administrative expenses. The pre-tax unrealized gain on these available-for-sale equity securities was $72 million as of December 31, 2016. See Note 2 for additional information on investments in certain equity securities.

Changes in the fair value of available-for-sale securities impact net income only when such securities are sold or an other-than-temporary impairment is recognized. We regularly review our investment portfolio to determine if any security is other-than-temporarily impaired. In making this judgment, we evaluate, among other things, the duration and extent to which the fair value of a security is less than its cost; the financial condition of the issuer and any changes thereto; and our intent to sell, or whether we will more likely than not be required to sell, the security before recovery of its amortized cost basis. Our assessment of whether a security is other-than-temporarily impaired could change in the future due to new developments or changes in assumptions related to any particular security. We recorded no other-than-temporary impairment charges on our available-for-sale securities for the years ended December 30, 2017, December 31, 2016 and December 26, 2015.

Tingyi-Asahi Beverages Holding Co. Ltd.

During 2016, we concluded that the decline in estimated fair value of our 5% indirect equity interest in TAB was other than temporary based on significant negative economic trends in China and changes in assumptions associated with TAB’s future financial performance arising from the disclosure by TAB’s parent company, Tingyi, regarding the operating results of its beverage business. As a result, we recorded a pre- and after-tax impairment charge of $373 million ($0.26 per share) in 2016 in the AMENA segment. This charge was recorded in selling, general and administrative expenses in our income statement and reduced the value of our 5% indirect equity interest in TAB to its estimated fair value. The estimated fair value was derived using both an income and market approach, and is considered a non-recurring Level 3 measurement within the fair value hierarchy. The carrying value of the investment in TAB was $166 million as of December 30, 2017 and December 31, 2016. We continue to monitor the impact of economic and other developments on the remaining value of our investment in TAB.

In connection with our transaction with Tingyi in 2012, we received a call option to increase our holding in TAB to 20% with an expiration date in 2015. Prior to its expiration, we concluded that the probability of exercising the option was remote and, accordingly, we recorded a pre- and after-tax charge of $73 million ($0.05 per share) to write off the recorded value of this call option in 2015.

See further unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Fair Value Measurements

The fair values of our financial assets and liabilities as of December 30, 2017 and December 31, 2016 are categorized as follows:



		2017				2016
	Fair Value Hierarchy Levels^(a)	Assets^(a)		Liabilities^(a)		Assets^(a)		Liabilities^(a)
Available-for-sale securities:
Equity securities ^(b)	1	$	—	$	—	$	82	$	—
Debt securities ^(c)	2	14,510		—		11,369		—
		$	14,510	$	—	$	11,451	$	—
Short-term investments ^(d)	1	$	228	$	—	$	193	$	—
Prepaid forward contracts ^(e)	2	$	27	$	—	$	25	$	—
Deferred compensation ^(f)	2	$	—	$	503	$	—	$	472
Derivatives designated as fair value hedging instruments:
Interest rate ^(g)	2	$	24	$	130	$	66	$	71
Derivatives designated as cash flow hedging instruments:
Foreign exchange ^(h)	2	$	15	$	31	$	51	$	8
Interest rate ^(h)	2	—		213		—		408
Commodity ⁽ⁱ⁾	1	—		2		—		1
Commodity ^(j)	2	2		—		2		—
		$	17	$	246	$	53	$	417
Derivatives not designated as hedging instruments:
Foreign exchange ^(h)	2	$	10	$	3	$	2	$	15
Commodity ⁽ⁱ⁾	1	—		19		1		1
Commodity ^(j)	2	85		12		60		25
		$	95	$	34	$	63	$	41
Total derivatives at fair value ^(k)		$	136	$	410	$	182	$	529
Total		$	14,901	$	913	$	11,851	$	1,001


(a)	Fair value hierarchy levels are defined in Note 7. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.


(b)	Based on the price of common stock. These equity securities were classified as investments in noncontrolled affiliates.

(c)

Based on quoted broker prices or other significant inputs derived from or corroborated by observable market data. As of December 30, 2017, $5.8 billion and $8.7 billion of debt securities were classified as cash equivalents and short-term investments, respectively. As of December 31, 2016, $4.6 billion and $6.8 billion of debt securities were classified as cash equivalents and short-term investments, respectively. All of our available-for-sale debt securities have maturities of one year or less.


(d)	Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.


(e)	Based primarily on the price of our common stock.


(f)	Based on the fair value of investments corresponding to employees’ investment elections.


(g)	Based on LIBOR forward rates.


(h)	Based on recently reported market transactions of spot and forward rates.


(i)	Based on quoted contract prices on futures exchange markets.


(j)	Based on recently reported market transactions of swap arrangements.


(k)	Unless otherwise noted, derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on the balance sheet as of December 30, 2017 and December 31, 2016 were not material. Collateral received against any of our asset positions was not material.

The carrying amounts of our cash and cash equivalents and short-term investments approximate fair value due to their short-term maturity. The fair value of our debt obligations as of December 30, 2017 and December 31, 2016 was $41 billion and $38 billion, respectively, based upon prices of similar instruments in the marketplace, which are considered Level 2 inputs.

Losses/(gains) on our hedging instruments are categorized as follows:



	Fair Value/Non- designated Hedges						Cash Flow and Net Investment Hedges
	Losses/(Gains) Recognized in Income Statement^(a)						Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss						Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement^(b)
	2017			2016			2017			2016			2017			2016
Foreign exchange	$	(15	)	$	74		$	62		$	(24	)	$	10		$	(44	)
Interest rate	101			105			(195		)	97			(184		)	187
Commodity	(48		)	(52		)	3			1			3			7
Net investment	—			—			157			(39		)	—			—
Total	$	38		$	127		$	27		$	35		$	(171	)	$	150

(a)

Foreign exchange derivative losses/gains are primarily included in selling, general and administrative expenses. Interest rate derivative losses/gains are primarily from fair value hedges and are included in interest expense. These losses/gains are substantially offset by decreases/increases in the value of the underlying debt, which are also included in interest expense. Commodity derivative losses/gains are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.


(b)	Foreign exchange derivative losses/gains are primarily included in cost of sales. Interest rate derivative losses/gains are included in interest expense. Commodity derivative losses/gains are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.

Based on current market conditions, we expect to reclassify net losses of $33 million related to our cash flow hedges from accumulated other comprehensive loss into net income during the next 12 months.

Net Income Attributable to PepsiCo per Common Share

12 Months Ended

Dec. 30, 2017

Net Income Attributable To PepsiCo Per Common Share

Net Income Attributable to PepsiCo per Common Share

The computations of basic and diluted net income attributable to PepsiCo per common share are as follows:



	2017				2016				2015
	Income			Shares^(a)	Income			Shares^(a)	Income			Shares^(a)
Net income attributable to PepsiCo	$	4,857			$	6,329			$	5,452
Preferred shares:
Dividends	—				(1		)		(1		)
Redemption premium	(4		)		(5		)		(5		)
Net income available for PepsiCo common shareholders	$	4,853		1,425	$	6,323		1,439	$	5,446		1,469
Basic net income attributable to PepsiCo per common share	$	3.40			$	4.39			$	3.71
Net income available for PepsiCo common shareholders	$	4,853		1,425	$	6,323		1,439	$	5,446		1,469
Dilutive securities:
Stock options, RSUs, PSUs, PEPunits and Other	—			12	1			12	—			15
ESOP convertible preferred stock	4			1	5			1	6			1
Diluted	$	4,857		1,438	$	6,329		1,452	$	5,452		1,485
Diluted net income attributable to PepsiCo per common share	$	3.38			$	4.36			$	3.67


(a)	Weighted-average common shares outstanding (in millions).

Out-of-the-money options excluded from the calculation of diluted earnings per common share are as follows:



	2017		2016		2015
Out-of-the-money options ^(a)	0.4		0.7		1.5
Average exercise price per option	$	110.12	$	99.98	$	99.25


(a)	In millions.

Accumulated Other Comprehensive Loss Attributable to Pepsico

12 Months Ended

Dec. 30, 2017

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Comprehensive Income (Loss) Note [Text Block]

Accumulated Other Comprehensive Loss Attributable to PepsiCo

The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows:



	Currency Translation Adjustment			Cash Flow Hedges			Pension and Retiree Medical			Available-For-Sale Securities			Other			Accumulated Other Comprehensive Loss Attributable to PepsiCo
Balance as of December 27, 2014 ^(a)	$	(8,255	)	$	34		$	(2,500	)	$	87		$	(35	)	$	(10,669	)
Other comprehensive (loss)/income before reclassifications ^(b)	(2,936		)	(95		)	(88		)	3			—			(3,116		)
Amounts reclassified from accumulated other comprehensive loss	111			97			266			—			—			474
Net current year other comprehensive (loss)/income	(2,825		)	2			178			3			—			(2,642		)
Tax amounts	—			1			(7		)	(2		)	—			(8		)
Balance as of December 26, 2015^(a)	(11,080		)	37			(2,329		)	88			(35		)	(13,319		)
Other comprehensive (loss)/income before reclassifications	(313		)	(74		)	(750		)	(43		)	—			(1,180		)
Amounts reclassified from accumulated other comprehensive loss	—			150			407			—			—			557
Net current year other comprehensive (loss)/income	(313		)	76			(343		)	(43		)	—			(623		)
Tax amounts	7			(30		)	27			19			—			23
Balance as of December 31, 2016 ^(a)	(11,386		)	83			(2,645		)	64			(35		)	(13,919		)
Other comprehensive (loss)/income before reclassifications ^(c)	1,049			130			(375		)	25			—			829
Amounts reclassified from accumulated other comprehensive loss	—			(171		)	158			(99		)	—			(112		)
Net current year other comprehensive (loss)/income	1,049			(41		)	(217		)	(74		)	—			717
Tax amounts	60			5			58			6			16			145
Balance as of December 30, 2017 ^(a)	$	(10,277	)	$	47		$	(2,804	)	$	(4	)	$	(19	)	$	(13,057	)


(a)	Pension and retiree medical amounts are net of taxes of $1,260 million in 2014, $1,253 million in 2015, $1,280 million in 2016 and $1,338 million in 2017.


(b)	Currency translation adjustment primarily reflects the depreciation of the Russian ruble, Brazilian real and Canadian dollar.


(c)	Currency translation adjustment primarily reflects the appreciation of the euro, Russian ruble, Pound sterling and Canadian dollar.

The following table summarizes the reclassifications from accumulated other comprehensive loss to the income statement:



	Amount Reclassified from Accumulated Other Comprehensive Loss									Affected Line Item in the Income Statement
	2017			2016			2015
Currency translation:
Venezuelan entities	$	—		$	—		$	111		Venezuela impairment charges

Cash flow hedges:
Foreign exchange contracts	$	—		$	2		$	(3	)	Net revenue
Foreign exchange contracts	10			(46		)	(94		)	Cost of sales
Interest rate derivatives	(184		)	187			174			Interest expense
Commodity contracts	4			3			9			Cost of sales
Commodity contracts	(1		)	4			11			Selling, general and administrative expenses
Net (gains)/losses before tax	(171		)	150			97
Tax amounts	64			(63		)	(47		)
Net (gains)/losses after tax	$	(107	)	$	87		$	50

Pension and retiree medical items:
Amortization of net prior service credit ^(a)	$	(24	)	$	(39	)	$	(41	)
Amortization of net losses^(a)	167			209			281
Settlement/curtailment ^(a)	15			237			6
Net losses before tax	158			407			246
Tax amounts	(44		)	(144		)	(74		)
Net losses after tax	$	114		$	263		$	172

Venezuelan entities	$	—		$	—		$	20		Venezuela impairment charges
Tax amount	—			—			(4		)
Net losses after tax	$	—		$	—		$	16

Available-for-sale securities:
Sale of Britvic securities	$	(99	)	$	—		$	—		Selling, general and administrative expenses
Tax amount	10			—			—
Net gain after tax	$	(89	)	$	—		$	—

Total net (gains)/losses reclassified for the year, net of tax	$	(82	)	$	350		$	349


(a)	These items are included in the components of net periodic benefit cost for pension and retiree medical plans (see Note 7 for additional details).

Supplemental Financial Information

12 Months Ended

Dec. 30, 2017

Additional Financial Information Disclosure [Text Block]

Balance Sheet



	2017			2016			2015
Accounts and notes receivable
Trade receivables	$	5,956		$	5,709
Other receivables	1,197			1,119
	7,153			6,828
Allowance, beginning of year	134			130			$	137
Net amounts charged to expense	26			37			43
Deductions ^(a)	(35		)	(30		)	(27		)
Other ^(b)	4			(3		)	(23		)
Allowance, end of year	129			134			$	130
Net receivables	$	7,024		$	6,694

Inventories ^(c)
Raw materials and packaging	$	1,344		$	1,315
Work-in-process	167			150
Finished goods	1,436			1,258
	$	2,947		$	2,723

Other assets
Noncurrent notes and accounts receivable	$	59		$	105
Deferred marketplace spending	134			140
Pension plans ^(d)	374			53
Other	346			338
	$	913		$	636

Accounts payable and other current liabilities
Accounts payable	$	6,727		$	6,158
Accrued marketplace spending	2,390			2,444
Accrued compensation and benefits	1,785			1,770
Dividends payable	1,161			1,097
Other current liabilities	2,954			2,774
	$	15,017		$	14,243


(a)	Includes accounts written off.


(b)	Includes adjustments related primarily to currency translation and other adjustments.


(c)	Approximately 5% of the inventory cost in 2017 and 2016 were computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material.


(d)	See Note 7 for additional information regarding our pension plans.

Statement of Cash Flows



	2017		2016		2015
Interest paid ^(a)	$	1,123	$	1,102	$	952
Income taxes paid, net of refunds	$	1,962	$	1,393	$	1,808


(a)	In 2016, interest paid excludes the premium paid in accordance with the “make-whole” provisions of the debt redemption discussed in

Note 8.

Lease Information



	2017		2016		2015
Rent expense	$	742	$	701	$	696

Minimum lease payments under non-cancelable operating leases by period



	Operating Lease Payments
2018	$	452
2019	403
2020	297
2021	215
2022	160
2023 and beyond	367
Total minimum operating lease payments	$	1,894

Divestitures (Notes)	12 Months Ended
Divestitures (Notes)	Dec. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	Divestitures Refranchising in Jordan During the fourth quarter of 2017, we refranchised our beverage business in Jordan by selling a controlling interest in our Jordan bottling operations. We recorded a pre-tax gain of $140 million ($107 million after-tax or $0.07 per share) in selling, general and administrative expenses in our AMENA segment as a result of this transaction. Refranchising in Thailand During the fourth quarter of 2017, we entered into an agreement to refranchise our beverage business in Thailand by selling a controlling interest in our Thailand bottling operations (included within our AMENA segment). The transaction is expected to be completed in 2018. Refranchising in Czech Republic, Hungary, and Slovakia (CHS) During the first quarter of 2018, we entered into an agreement to refranchise our entire beverage bottling operations and snack distribution operations in CHS (included within our ESSA segment). The transaction is expected to be completed in 2018.

Our Significant Accounting Policies (Policies)

12 Months Ended

Dec. 30, 2017

Accounting Policies [Abstract]

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

Sales Incentives And Other Marketplace Spending, Policy [Policy Text Block]

Total Marketplace Spending


•	media and personal service prepayments;


•	promotional materials in inventory; and


•	production costs of future media advertising.

Shipping and Handling Cost, Policy [Policy Text Block]

Distribution Costs

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash Equivalents

Cash equivalents are highly liquid investments with original maturities of three months or less.

Internal Use Software, Policy [Policy Text Block]

Software Costs

Commitments and Contingencies, Policy [Policy Text Block]

Commitments and Contingencies

Research and Development Expense, Policy [Policy Text Block]

Research and Development

See “Research and Development” in “Item 1. Business” for additional unaudited information about our research and development activities.

Goodwill and Intangible Assets, Policy [Policy Text Block]

Goodwill and Other Intangible Assets

Other Significant Accounting Policies [Policy Text Block]

Other Significant Accounting Policies

Our other significant accounting policies are disclosed as follows:


•	Basis of Presentation – Note 1 - Basis of Presentation for a description of our policies regarding use of estimates, basis of presentation and consolidation.


•	Property, Plant and Equipment – Note 4.


•	Income Taxes – Note 5, and for additional unaudited information, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.


•	Share-Based Compensation – Note 6.


•	Pension, Retiree Medical and Savings Plans – Note 7, and for additional unaudited information, see “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.


•	Financial Instruments – Note 9, and for additional unaudited information, see “Our Business Risks” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.


•	Inventories – Note 13. Inventories are valued at the lower of cost or net realizable value. Cost is determined using the average; first-in, first-out (FIFO) or last-in, first-out (LIFO) methods.

•

Basis of Presentation and Our Divisions (Tables)

12 Months Ended

Dec. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule Of Quarterly Reporting

The following chart details our quarterly reporting schedule:



Quarter	United States and Canada	International
First Quarter	12 weeks	January, February
Second Quarter	12 weeks	March, April and May
Third Quarter	12 weeks	June, July and August
Fourth Quarter	16 weeks (17 weeks for 2016)	September, October, November and December

Schedule of Segment Reporting Information, by Segment

Net revenue and operating profit/(loss) of each division are as follows:



	Net Revenue						Operating Profit/(Loss)^(a)
	2017		2016		2015		2017			2016			2015
FLNA	$	15,798	$	15,549	$	14,782	$	4,823		$	4,659		$	4,304
QFNA	2,503		2,564		2,543		642			653			560
NAB	20,936		21,312		20,618		2,707			2,959			2,785
Latin America	7,208		6,820		8,228		908			887			(206		)
ESSA	11,050		10,216		10,510		1,354			1,108			1,081
AMENA	6,030		6,338		6,375		1,073			619			941
Total division	63,525		62,799		63,056		11,507			10,885			9,465
Corporate unallocated	—		—		—		(998		)	(1,100		)	(1,112		)
	$	63,525	$	62,799	$	63,056	$	10,509		$	9,785		$	8,353


(a)	For further unaudited information on certain items that impacted our financial performance, see “Item 6. Selected Financial Data.”

Segment Reporting Information By Total Assets And Capital Spending

Total assets and capital spending of each division are as follows:



	Total Assets				Capital Spending
	2017		2016		2017		2016		2015
FLNA	$	5,979	$	5,731	$	665	$	801	$	608
QFNA	804		811		44		41		40
NAB	28,592		28,172		904		769		695
Latin America	4,976		4,568		481		507		368
ESSA	13,556		12,302		481		439		404
AMENA	5,668		5,261		308		381		441
Total division	59,575		56,845		2,883		2,938		2,556
Corporate^(a)	20,229		16,645		86		102		202
	$	79,804	$	73,490	$	2,969	$	3,040	$	2,758


(a)	Corporate assets consist principally of certain cash and cash equivalents, short-term investments, derivative instruments, property, plant and equipment and tax assets. In 2017, the change in total Corporate assets was primarily due to an increase in short-term investments and cash and cash equivalents.

Segment Reporting Information By Amortization Of Intangible Assets And Depreciation And Other Amortization

Amortization of intangible assets and depreciation and other amortization of each division are as follows:



	Amortization of Intangible Assets						Depreciation and Other Amortization
	2017		2016		2015		2017		2016		2015
FLNA	$	7	$	7	$	7	$	449	$	435	$	427
QFNA	—		—		—		47		50		51
NAB	31		37		38		780		809		813
Latin America	5		5		7		245		211		238
ESSA	22		18		20		329		321		353
AMENA	3		3		3		257		294		293
Total division	68		70		75		2,107		2,120		2,175
Corporate	—		—		—		194		178		166
	$	68	$	70	$	75	$	2,301	$	2,298	$	2,341

Segment Reporting Information By Net Revenue And Long-Lived Assets

Net revenue and long-lived assets by country are as follows:



	Net Revenue						Long-Lived Assets^(a)
	2017		2016		2015		2017		2016
United States	$	36,546	$	36,732	$	35,266	$	28,418	$	28,382
Mexico	3,650		3,431		3,687		1,205		998
Russia ^(b)	3,232		2,648		2,797		4,708		4,373
Canada	2,691		2,692		2,677		2,739		2,499
United Kingdom	1,650		1,737		1,966		817		852
Brazil	1,427		1,305		1,289		777		796
All other countries	14,329		14,254		15,374		9,200		8,504
	$	63,525	$	62,799	$	63,056	$	47,864	$	46,404


(a)	Long-lived assets represent property, plant and equipment, nonamortizable intangible assets, amortizable intangible assets and investments in noncontrolled affiliates. These assets are reported in the country where they are primarily used.


(b)	Change in net revenue and long-lived assets in 2017 primarily reflects appreciation of the Russian ruble

Restructuring, Impairment and Integration Charges (Tables)

12 Months Ended

Dec. 30, 2017

Restructuring, Impairment, and Other Activities Disclosure [Text Block]

Restructuring and Impairment Charges

A summary of our restructuring and impairment charges and other productivity initiatives is as follows:



	2017		2016		2015
2014 Productivity Plan	$	295	$	160	$	169
2012 Productivity Plan	—		—		61
Total restructuring and impairment charges	295		160		230
Other productivity initiatives	16		12		90
Total restructuring and impairment charges and other productivity initiatives	$	311	$	172	$	320

2014 Multi-Year Productivity Plan

A summary of our 2014 Productivity Plan charges is as follows:



	2017										2016									2015
	Severance and Other Employee Costs		Asset Impairments		Other Costs			Total			Severance and Other Employee Costs		Asset Impairments		Other Costs			Total		Severance and Other Employee Costs		Asset Impairments			Other Costs		Total
FLNA ^(a)	$	67	$	—	$	—		$	67		$	10	$	—	$	3		$	13	$	18	$	(1	)	$	9	$	26
QFNA	11		—		—			11			—		—		1			1		—		—			3		3
NAB	52		1		1			54			18		8		9			35		10		4			17		31
Latin America ^(a)	57		16		(10		)	63			29		—		(2		)	27		2		10			16		28
ESSA	46		4		3			53			21		22		17			60		26		11			25		62
AMENA ^(b)	2		—		(5		)	(3		)	4		6		4			14		2		—			8		10
Corporate	45		—		5			50			6		—		4			10		1		—			8		9
	$	280	$	21	$	(6	)	$	295		$	88	$	36	$	36		$	160	$	59	$	24		$	86	$	169


(a)	Income amounts represent adjustments for changes in estimates.


(b)	Income amount primarily reflects a gain on the sale of property, plant and equipment.

Since the inception of the 2014 Productivity Plan, we incurred restructuring charges of $1,034 million:



	2014 Productivity Plan Costs to Date
	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	131	$	9	$	23	$	163
QFNA	26		—		6		32
NAB	149		69		83		301
Latin America	109		29		14		152
ESSA	127		41		59		227
AMENA	23		6		15		44
Corporate	62		—		53		115
	$	627	$	154	$	253	$	1,034

A summary of our 2014 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs			Total
Liability as of December 27, 2014	$	89		$	—		$	24		$	113
2015 restructuring charges	59			24			86			169
Cash payments	(76		)	—			(87		)	(163		)
Non-cash charges and translation	(11		)	(24		)	(3		)	(38		)
Liability as of December 26, 2015	61			—			20			81
2016 restructuring charges	88			36			36			160
Cash payments	(46		)	—			(49		)	(95		)
Non-cash charges and translation	(15		)	(36		)	1			(50		)
Liability as of December 31, 2016	88			—			8			96
2017 restructuring charges	280			21			(6		)	295
Cash payments	(91		)	—			(22		)	(113		)
Non-cash charges and translation	(65		)	(21		)	34			(52		)
Liability as of December 30, 2017	$	212		$	—		$	14		$	226

2012 Multi-Year Productivity Plan

A summary of our 2012 Productivity Plan charges in 2015 is as follows:



	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	—	$	—	$	—	$	—
QFNA	—		—		—		—
NAB	—		—		2		2
Latin America	6		1		1		8
ESSA	15		—		12		27
AMENA	15		3		2		20
Corporate	3		—		1		4
	$	39	$	4	$	18	$	61

Since the inception of the 2012 Productivity Plan, we incurred restructuring charges of $894 million:



	2012 Productivity Plan Costs to Date
	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	91	$	8	$	25	$	124
QFNA	18		—		10		28
NAB	107		44		48		199
Latin America	98		11		18		127
ESSA	136		23		66		225
AMENA	75		5		17		97
Corporate	35		—		59		94
	$	560	$	91	$	243	$	894

A summary of our 2012 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs			Total
Liability as of December 27, 2014	$	28		$	—		$	5		$	33
2015 restructuring charges	39			4			18			61
Cash payments	(24		)	—			(21		)	(45		)
Non-cash charges and translation	(8		)	(4		)	1			(11		)
Liability as of December 26, 2015	35			—			3			38
Cash payments	(28		)	—			(2		)	(30		)
Non-cash charges and translation	(7		)	—			(1		)	(8		)
Liability as of December 31, 2016	$	—		$	—		$	—		$	—

Other Productivity Initiatives

We regularly evaluate different productivity initiatives beyond the productivity plans and other initiatives described above.

Summary Of Total Restructuring Activity [Table Text Block]

A summary of our restructuring and impairment charges and other productivity initiatives is as follows:



	2017		2016		2015
2014 Productivity Plan	$	295	$	160	$	169
2012 Productivity Plan	—		—		61
Total restructuring and impairment charges	295		160		230
Other productivity initiatives	16		12		90
Total restructuring and impairment charges and other productivity initiatives	$	311	$	172	$	320

Summary Of 2014 Productivity Plan Activity [Table Text Block] [Table Text Block]

2014 Multi-Year Productivity Plan

A summary of our 2014 Productivity Plan charges is as follows:



	2017										2016									2015
	Severance and Other Employee Costs		Asset Impairments		Other Costs			Total			Severance and Other Employee Costs		Asset Impairments		Other Costs			Total		Severance and Other Employee Costs		Asset Impairments			Other Costs		Total
FLNA ^(a)	$	67	$	—	$	—		$	67		$	10	$	—	$	3		$	13	$	18	$	(1	)	$	9	$	26
QFNA	11		—		—			11			—		—		1			1		—		—			3		3
NAB	52		1		1			54			18		8		9			35		10		4			17		31
Latin America ^(a)	57		16		(10		)	63			29		—		(2		)	27		2		10			16		28
ESSA	46		4		3			53			21		22		17			60		26		11			25		62
AMENA ^(b)	2		—		(5		)	(3		)	4		6		4			14		2		—			8		10
Corporate	45		—		5			50			6		—		4			10		1		—			8		9
	$	280	$	21	$	(6	)	$	295		$	88	$	36	$	36		$	160	$	59	$	24		$	86	$	169


(a)	Income amounts represent adjustments for changes in estimates.


(b)	Income amount primarily reflects a gain on the sale of property, plant and equipment.

Since the inception of the 2014 Productivity Plan, we incurred restructuring charges of $1,034 million:



	2014 Productivity Plan Costs to Date
	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	131	$	9	$	23	$	163
QFNA	26		—		6		32
NAB	149		69		83		301
Latin America	109		29		14		152
ESSA	127		41		59		227
AMENA	23		6		15		44
Corporate	62		—		53		115
	$	627	$	154	$	253	$	1,034

A summary of our 2014 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs			Total
Liability as of December 27, 2014	$	89		$	—		$	24		$	113
2015 restructuring charges	59			24			86			169
Cash payments	(76		)	—			(87		)	(163		)
Non-cash charges and translation	(11		)	(24		)	(3		)	(38		)
Liability as of December 26, 2015	61			—			20			81
2016 restructuring charges	88			36			36			160
Cash payments	(46		)	—			(49		)	(95		)
Non-cash charges and translation	(15		)	(36		)	1			(50		)
Liability as of December 31, 2016	88			—			8			96
2017 restructuring charges	280			21			(6		)	295
Cash payments	(91		)	—			(22		)	(113		)
Non-cash charges and translation	(65		)	(21		)	34			(52		)
Liability as of December 30, 2017	$	212		$	—		$	14		$	226

Summary Of Productivity Plan Activity

2012 Multi-Year Productivity Plan

A summary of our 2012 Productivity Plan charges in 2015 is as follows:



	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	—	$	—	$	—	$	—
QFNA	—		—		—		—
NAB	—		—		2		2
Latin America	6		1		1		8
ESSA	15		—		12		27
AMENA	15		3		2		20
Corporate	3		—		1		4
	$	39	$	4	$	18	$	61

Since the inception of the 2012 Productivity Plan, we incurred restructuring charges of $894 million:



	2012 Productivity Plan Costs to Date
	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total
FLNA	$	91	$	8	$	25	$	124
QFNA	18		—		10		28
NAB	107		44		48		199
Latin America	98		11		18		127
ESSA	136		23		66		225
AMENA	75		5		17		97
Corporate	35		—		59		94
	$	560	$	91	$	243	$	894

A summary of our 2012 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs			Total
Liability as of December 27, 2014	$	28		$	—		$	5		$	33
2015 restructuring charges	39			4			18			61
Cash payments	(24		)	—			(21		)	(45		)
Non-cash charges and translation	(8		)	(4		)	1			(11		)
Liability as of December 26, 2015	35			—			3			38
Cash payments	(28		)	—			(2		)	(30		)
Non-cash charges and translation	(7		)	—			(1		)	(8		)
Liability as of December 31, 2016	$	—		$	—		$	—		$	—

Property, Plant and Equipment and Intangible Assets (Tables)

12 Months Ended

Dec. 30, 2017

Property, Plant And Equipment And Intangible Assets [Abstract]

Property, Plant and Equipment

A summary of our property, plant and equipment is as follows:



	Average Useful Life (Years)	2017			2016			2015
Property, plant and equipment, net
Land		$	1,148		$	1,153
Buildings and improvements	15 - 44	8,796			8,306
Machinery and equipment, including fleet and software	5 - 15	27,018			25,277
Construction in progress		2,144			2,082
		39,106			36,818
Accumulated depreciation		(21,866		)	(20,227		)
		$	17,240		$	16,591
Depreciation expense		$	2,227		$	2,217		$	2,248

Amortizable Intangible Assets, Net

A summary of our amortizable intangible assets is as follows:



		2017							2016							2015
Amortizable intangible assets, net	Average Useful Life (Years)	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Acquired franchise rights	56 – 60	$	858	$	(128	)	$	730	$	827	$	(108	)	$	719
Reacquired franchise rights	5 – 14	106		(104		)	2		106		(102		)	4
Brands	20 – 40	1,322		(1,026		)	296		1,277		(977		)	300
Other identifiable intangibles	10 – 24	521		(281		)	240		522		(308		)	214
		$	2,807	$	(1,539	)	$	1,268	$	2,732	$	(1,495	)	$	1,237
Amortization expense							$	68						$	70	$	75

Future Amortization of Intangible Assets



	2018		2019		2020		2021		2022
Five-year projected amortization	$	69	$	64	$	64	$	62	$	60

Change in Book Value of Nonamortizable Intangible Assets

The change in the book value of nonamortizable intangible assets is as follows:



	Balance, Beginning 2016		Translation and Other			Balance, End of 2016		Translation and Other			Balance, End of 2017
FLNA
Goodwill	$	267	$	3		$	270	$	10		$	280
Brands	22		1			23		2			25
	289		4			293		12			305
QFNA
Goodwill	175		—			175		—			175
NAB
Goodwill ^(a)	9,754		89			9,843		11			9,854
Reacquired franchise rights	7,042		22			7,064		62			7,126
Acquired franchise rights	1,507		5			1,512		13			1,525
Brands ^(a)	108		206			314		39			353
	18,411		322			18,733		125			18,858
Latin America
Goodwill	521		32			553		2			555
Brands	137		13			150		(9		)	141
	658		45			703		(7		)	696
ESSA ^(b)
Goodwill	3,042		135			3,177		275			3,452
Reacquired franchise rights	488		—			488		61			549
Acquired franchise rights	190		(6		)	184		11			195
Brands	2,212		146			2,358		187			2,545
	5,932		275			6,207		534			6,741
AMENA
Goodwill	418		(6		)	412		16			428
Brands	105		(2		)	103		8			111
	523		(8		)	515		24			539

Total goodwill	14,177		253			14,430		314			14,744
Total reacquired franchise rights	7,530		22			7,552		123			7,675
Total acquired franchise rights	1,697		(1		)	1,696		24			1,720
Total brands	2,584		364			2,948		227			3,175
	$	25,988	$	638		$	26,626	$	688		$	27,314


(a)	The change in 2016 is primarily related to our acquisition of KeVita, Inc.


(b)	The change in 2017 primarily reflects the currency appreciation of the Russian ruble and euro. The change in 2016 primarily reflects the currency appreciation of the Russian ruble.

Income Taxes (Tables)

12 Months Ended

Dec. 30, 2017

Income Tax Contingency [Line Items]

Summary of Income Tax Contingencies [Table Text Block]

Reserves



Jurisdiction	Years Open to Audit	Years Currently Under Audit
United States	2012-2016	2012-2013
Mexico	2014-2016	2014
United Kingdom	2014-2016	None
Canada (Domestic)	2013-2016	2013-2014
Canada (International)	2010-2016	2010-2014
Russia	2012-2016	2012-2016

Income Taxes

The components of income before income taxes are as follows:



		2017			2016			2015
United States		$	3,452		$	2,630		$	2,879
Foreign		6,150			5,923			4,563
		$	9,602		$	8,553		$	7,442

The provision for income taxes consisted of the following:
		2017			2016			2015
Current:	U.S. Federal	$	4,925		$	1,219		$	1,143
	Foreign	724			824			773
	State	136			77			65
		5,785			2,120			1,981
Deferred:	U.S. Federal	(1,159		)	109			(14		)
	Foreign	(9		)	(33		)	(32		)
	State	77			(22		)	6
		(1,091		)	54			(40		)
		$	4,694		$	2,174		$	1,941

A reconciliation of the U.S. Federal statutory tax rate to our annual tax rate is as follows:



	2017		2016		2015
U.S. Federal statutory tax rate	35.0	%	35.0	%	35.0	%
State income tax, net of U.S. Federal tax benefit	0.9		0.4		0.6
Lower taxes on foreign results	(9.4	)	(8.0	)	(10.5	)
Impact of Venezuela impairment charges	—		—		6.4
Provisional one-time mandatory transition tax - TCJ Act	41.4		—		—
Provisional remeasurement of deferred taxes - TCJ Act	(15.9	)	—		—
Tax settlements	—		—		(3.1	)
Other, net	(3.1	)	(2.0	)	(2.3	)
Annual tax rate	48.9	%	25.4	%	26.1	%

Tax Cuts and Jobs Act

Deferred tax liabilities and assets are comprised of the following:

Deferred Tax Liabilities



	2017			2016
Debt guarantee of wholly-owned subsidiary	$	578		$	839
Property, plant and equipment	1,397			1,967
Intangible assets other than nondeductible goodwill	3,169			4,124
Other	50			245
Gross deferred tax liabilities	5,194			7,175
Deferred tax assets
Net carryforwards	1,400			1,255
Share-based compensation	107			219
Retiree medical benefits	198			316
Other employee-related benefits	338			614
Pension benefits	22			419
Deductible state tax and interest benefits	157			189
Other	893			839
Gross deferred tax assets	3,115			3,851
Valuation allowances	(1,163		)	(1,110		)
Deferred tax assets, net	1,952			2,741
Net deferred tax liabilities	$	3,242		$	4,434

A summary of our valuation allowance activity is as follows:



	2017		2016			2015
Balance, beginning of year	$	1,110	$	1,136		$	1,230
Provision/(benefit)	33		13			(26		)
Other additions/(deductions)	20		(39		)	(68		)
Balance, end of year	$	1,163	$	1,110		$	1,136

Reserves Rollforward

A reconciliation of unrecognized tax benefits, is as follows:



	2017			2016
Balance, beginning of year	$	1,885		$	1,547
Additions for tax positions related to the current year	309			349
Additions for tax positions from prior years	86			139
Reductions for tax positions from prior years	(51		)	(70		)
Settlement payments	(4		)	(26		)
Statutes of limitations expiration	(33		)	(27		)
Translation and other	20			(27		)
Balance, end of year	$	2,212		$	1,885

Share-Based Compensation Share-Based Compensation (Tables)

12 Months Ended

Dec. 30, 2017

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Liability Award Vested and Expected to Vest [Table Text Block]



	Long-Term Cash Award^(a)			Balance Sheet Date Fair Value^(a)		Contractual Life Remaining (years)
Outstanding at December 31, 2016	$	15,670
Granted^(b)	19,060
Forfeited	(1,530		)
Outstanding at December 30, 2017 ^(c)	$	33,200		$	32,592	1.73
Expected to vest as of December 30, 2017	$	29,590		$	29,092	1.71


(a)	In thousands.


(b)	Grant activity for all long-term cash awards are disclosed at target.


(c)	The outstanding long-term cash awards for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, $33.2 million and $66.4 million, respectively

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]

The following table summarizes our total share-based compensation expense:



	2017				2016		2015
Share-based compensation expense - equity awards	$	292			$	284	$	295
Share-based compensation expense - liability awards	13				5		—
Restructuring and impairment (credits)/charges	(2		)		5		4
Total	$	303			$	294	$	299
Income tax benefits recognized in earnings related to share-based compensation	$	89		^(a)	$	91	$	77

Summary of Compensation Costs

Note 6 — Share-Based Compensation

The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs, PSUs and PEPunits.

As of December 30, 2017, 74 million shares were available for future share-based compensation grants under the LTIP.

The following table summarizes our total share-based compensation expense:



	2017				2016		2015
Share-based compensation expense - equity awards	$	292			$	284	$	295
Share-based compensation expense - liability awards	13				5		—
Restructuring and impairment (credits)/charges	(2		)		5		4
Total	$	303			$	294	$	299
Income tax benefits recognized in earnings related to share-based compensation	$	89		^(a)	$	91	$	77


(a)	Reflects tax rates effective for the 2017 tax year.

Method of Accounting and Our Assumptions

We do not backdate, reprice or grant share-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP.

Stock Options

Schedule Of Weighted-Average Black-Scholes Fair Value Assumptions

Our weighted-average Black-Scholes fair value assumptions are as follows:



	2017		2016		2015
Expected life	5 years		6 years		7 years
Risk-free interest rate	2.0	%	1.4	%	1.8	%
Expected volatility	11	%	12	%	15	%
Expected dividend yield	2.7	%	2.7	%	2.7	%

Our Stock Option Activity

A summary of our stock option activity for the year ended December 30, 2017 is as follows:



	Options^(a)		Weighted-Average Exercise Price		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(b)
Outstanding at December 31, 2016	25,190		$	69.88
Granted	1,481		$	110.15
Exercised	(7,136	)	$	65.31
Forfeited/expired	(522	)	$	88.36
Outstanding at December 30, 2017	19,013		$	74.23	4.22	$	868,750
Exercisable at December 30, 2017	14,589		$	65.60	3.02	$	792,560
Expected to vest as of December 30, 2017	3,994		$	102.50	8.15	$	69,578


(a)	Options are in thousands and include options previously granted under the PBG plan. No additional options or shares were granted under the PBG plan after 2009.


(b)	In thousands.

Our RSU and PSU Activity



	RSUs/PSUs^(a)		Weighted-Average Grant-Date Fair Value		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(a)
Outstanding at December 31, 2016	8,237		$	91.81
Granted ^(b)	2,824		$	109.92
Converted	(3,226	)	$	82.56
Forfeited	(608	)	$	100.17
Actual performance change ^(c)	66		$	100.33
Outstanding at December 30, 2017 ^(d)	7,293		$	102.30	1.33	$	874,517
Expected to vest as of December 30, 2017	6,695		$	102.00	1.26	$	802,826


(a)	In thousands.


(b)	Grant activity for all PSUs are disclosed at target.


(c)	Reflects the net number of PSUs above and below target levels based on actual performance measured at the end of the performance period.


(d)	The outstanding PSUs for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, 0.9 million and 1.5 million, respectively.

Our PEPunit Activity

PEPunits

The fair value of PEPunits is measured using the Monte-Carlo simulation model.

A summary of our PEPunit activity for the year ended December 30, 2017 is as follows:



	PEPunits^(a)		Weighted-Average Grant-Date Fair Value		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(a)
Outstanding at December 31, 2016	533		$	59.86
Converted	(363	)	$	49.11
Forfeited	(13	)	$	68.94
Actual performance change ^(b)	91		$	50.74
Outstanding at December 30, 2017 ^(c)	248		$	68.94	0.17	$	29,734
Expected to vest as of December 30, 2017	234		$	68.94	0.17	$	28,034


(a)	In thousands.


(b)	Reflects the net number of PEPunits above and below target levels based on actual performance measured at the end of the performance period.


(c)	The outstanding PEPunits for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, 0.2 million and 0.4 million, respectively.

Other Share-Based Compensation Data

The following is a summary of other share-based compensation data:



	2017		2016		2015
Stock Options
Total number of options granted ^(a)	1,481		1,743		1,884
Weighted-average grant-date fair value of options granted	$	8.25	$	6.94	$	10.80
Total intrinsic value of options exercised ^(a)	$	327,860	$	290,131	$	366,188
Total grant-date fair value of options vested ^(a)	$	23,122	$	18,840	$	21,837
RSUs/PSUs
Total number of RSUs/PSUs granted ^(a)	2,824		3,054		2,759
Weighted-average grant-date fair value of RSUs/PSUs granted	$	109.92	$	99.06	$	99.17
Total intrinsic value of RSUs/PSUs converted ^(a)	$	380,269	$	359,401	$	375,510
Total grant-date fair value of RSUs/PSUs vested ^(a)	$	264,923	$	257,648	$	257,831
PEPunits
Total number of PEPunits granted ^(a)	—		—		300
Weighted-average grant-date fair value of PEPunits granted	$	—	$	—	$	68.94
Total intrinsic value of PEPunits converted ^(a)	$	39,782	$	38,558	$	37,705
Total grant-date fair value of PEPunits vested ^(a)	$	18,833	$	16,572	$	22,286


(a)	In thousands.

Pension, Retiree Medical and Savings Plans (Tables)

12 Months Ended

Dec. 30, 2017

Schedule Of Plan Assets Measured At Fair Value Table Text Block

Plan assets measured at fair value as of fiscal year-end 2017 and 2016 are categorized consistently by level, and are as follows:



	2017								2016
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
U.S. plan assets ^(a)
Equity securities, including preferred stock ^(b)	$	6,904	$	6,896	$	8	$	—	$	6,489
Government securities ^(c)	1,365		—		1,365		—		1,173
Corporate bonds ^(c)	3,429		—		3,429		—		3,012
Mortgage-backed securities ^(c)	217		—		217		—		187
Contracts with insurance companies ^(d)	8		—		—		8		7
Cash and cash equivalents	236		236		—		—		196
Sub-total U.S. plan assets	12,159		$	7,132	$	5,019	$	8	11,064
Real estate commingled funds measured at net asset value ^(e)	675								651
Dividends and interest receivable, net of payables	69								63
Total U.S. plan assets	$	12,903							$	11,778
International plan assets
Equity securities ^(b)	$	1,928	$	1,895	$	33	$	—	$	1,556
Government securities ^(c)	492		—		492		—		432
Corporate bonds ^(c)	493		—		493		—		453
Fixed income commingled funds ^(f)	383		383		—		—		316
Contracts with insurance companies ^(d)	36		—		—		36		35
Cash and cash equivalents	19		19		—		—		12
Sub-total international plan assets	3,351		$	2,297	$	1,018	$	36	2,804
Real estate commingled funds measured at net asset value ^(e)	102								84
Dividends and interest receivable	7								6
Total international plan assets	$	3,460							$	2,894


(a)	2017 and 2016 amounts include $321 million and $320 million, respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries.

(b)


(c)	These investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. Corporate bonds of U.S.-based companies represent 23% and 22% of total U.S. plan assets for 2017 and 2016, respectively.


(d)	Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. The changes in Level 3 amounts were not significant in the years ended December 30, 2017 and December 31, 2016.


(e)	The real estate commingled funds include investments in limited partnerships. These funds are based on the net asset value of the appraised value of investments owned by these funds as determined by independent third parties using inputs that are not observable. The majority of the funds are redeemable quarterly subject to availability of cash and have notice periods ranging from 45 to 90 days.


(f)	Based on the fair value of the investments owned by these funds that track various government and corporate bond indices.

Selected Financial Information For Pension And Retiree Medical Plans

Pension, Retiree Medical and Savings Plans

We regularly evaluate different opportunities to reduce risk and volatility associated with our pension and retiree medical plans.

Selected financial information for our pension and retiree medical plans is as follows:



	Pension												Retiree Medical
	U.S.						International
	2017			2016			2017			2016			2017			2016
Change in projected benefit liability
Liability at beginning of year	$	13,192		$	13,033		$	3,124		$	2,872		$	1,208		$	1,300
Service cost	401			393			91			80			28			31
Interest cost	468			484			89			94			36			41
Plan amendments	10			18			2			—			(5		)	(15		)
Participant contributions	—			—			2			2			—			—
Experience loss/(gain)	1,529			614			5			560			21			(51		)
Benefit payments	(825		)	(347		)	(104		)	(83		)	(107		)	(100		)
Settlement/curtailment	(58		)	(1,014		)	(22		)	(19		)	—			—
Special termination benefits	60			11			—			1			2			1
Other, including foreign currency adjustment	—			—			303			(383		)	4			1
Liability at end of year	$	14,777		$	13,192		$	3,490		$	3,124		$	1,187		$	1,208

Change in fair value of plan assets
Fair value at beginning of year	$	11,458		$	11,397		$	2,894		$	2,823		$	320		$	354
Actual return on plan assets	1,935			880			288			409			52			30
Employer contributions/funding	60			541			104			118			56			36
Participant contributions	—			—			2			2			—			—
Benefit payments	(825		)	(347		)	(104		)	(83		)	(107		)	(100		)
Settlement	(46		)	(1,013		)	(18		)	(22		)	—			—
Other, including foreign currency adjustment	—			—			294			(353		)	—			—
Fair value at end of year	$	12,582		$	11,458		$	3,460		$	2,894		$	321		$	320
Funded status	$	(2,195	)	$	(1,734	)	$	(30	)	$	(230	)	$	(866	)	$	(888	)



Amounts recognized
Other assets	$	286		$	—		$	85		$	51		$	—		$	—
Other current liabilities	(74		)	(42		)	(1		)	(1		)	(75		)	(54		)
Other liabilities	(2,407		)	(1,692		)	(114		)	(280		)	(791		)	(834		)
Net amount recognized	$	(2,195	)	$	(1,734	)	$	(30	)	$	(230	)	$	(866	)	$	(888	)

Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	$	3,520		$	3,220		$	782		$	884		$	(189	)	$	(193	)
Prior service cost/(credit)	29			20			(3		)	(5		)	(71		)	(91		)
Total	$	3,549		$	3,240		$	779		$	879		$	(260	)	$	(284	)

Changes recognized in net loss/(gain) included in other comprehensive loss
Net loss/(gain) arising in current year	$	431		$	568		$	(115	)	$	314		$	(9	)	$	(57	)
Amortization and settlement recognition	(131		)	(413		)	(60		)	(46		)	12			1
Foreign currency translation loss/(gain)	—			—			73			(117		)	1			1
Total	$	300		$	155		$	(102	)	$	151		$	4		$	(55	)

Accumulated benefit obligation at end of year	$	13,732		$	12,211		$	2,985		$	2,642

Estimated Amounts To Be Amortized From Accumulated Other Comprehensive Loss Into Benefit Expense In 2012 For Pension And Retiree Medical Plans

The estimated amounts to be amortized from accumulated other comprehensive loss/(gain) into pre-tax expense in 2018 for our pension and retiree medical plans are as follows:



	Pension				Retiree Medical
	U.S.		International
Net loss/(gain)	$	179	$	46	$	(10	)
Prior service cost/(credit)	3		—		(20		)
Total	$	182	$	46	$	(30	)

Weighted-Average Assumptions Used To Determine Projected Benefit Liability And Benefit Expense For Pension And Retiree Medical Plans

The following table provides the weighted-average assumptions used to determine projected benefit liability and benefit expense for our pension and retiree medical plans:



	Pension												Retiree Medical
	U.S.						International
	2017		2016		2015		2017		2016		2015		2017		2016		2015
Weighted-average assumptions
Liability discount rate	3.7	%	4.4	%	4.5	%	3.0	%	3.1	%	4.0	%	3.5	%	4.0	%	4.2	%
Expense discount rate ^(a)	n/a		n/a		4.2	%	n/a		n/a		3.8	%	n/a		n/a		3.8	%
Service cost discount rate ^(a)	4.5	%	4.6	%	n/a		3.6	%	4.1	%	n/a		4.0	%	4.3	%	n/a
Interest cost discount rate ^(a)	3.7	%	3.8	%	n/a		2.8	%	3.5	%	n/a		3.2	%	3.3	%	n/a
Expected return on plan assets	7.5	%	7.5	%	7.5	%	6.0	%	6.2	%	6.5	%	7.5	%	7.5	%	7.5	%
Liability rate of salary increases	3.1	%	3.1	%	3.1	%	3.7	%	3.6	%	3.6	%
Expense rate of salary increases	3.1	%	3.1	%	3.5	%	3.6	%	3.6	%	3.6	%

Future Benefit Payments

Our estimated future benefit payments are as follows:



	2018		2019		2020		2021		2022		2023 - 27
Pension	$	890	$	985	$	825	$	875	$	925	$	5,210
Retiree medical ^(a)	$	120	$	120	$	110	$	110	$	105	$	455


(a)	Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $2 million for each of the years from 2018 through 2022 and approximately $6 million in total for 2023 through 2027.

These future benefit payments to beneficiaries include payments from both funded and unfunded plans.

Target Investment Allocation

Plan Assets

For 2018 and 2017, our expected long-term rate of return on U.S. plan assets is 7.2% and 7.5%, respectively. Our target investment allocations for U.S. plan assets are as follows:



	2018		2017
Fixed income	47	%	40	%
U.S. equity	29	%	33	%
International equity	20	%	22	%
Real estate	4	%	5	%

Effects Of 1-Percentage-Point Change In The Assumed Health Care Trend Rate

Retiree Medical Cost Trend Rates



	2018		2017
Average increase assumed	6	%	6	%
Ultimate projected increase	5	%	5	%
Year of ultimate projected increase	2039		2039



	1% Increase		1% Decrease
2017 service and interest cost components	$	3	$	(3	)
2017 benefit liability	$	39	$	(34	)

Savings Plan

In 2017, 2016 and 2015, our total Company contributions were $176 million, $164 million and $148 million, respectively.

Schedule of Net Benefit Costs [Table Text Block]

The components of benefit expense are as follows:



	Pension																		Retiree Medical
	U.S.									International
	2017			2016			2015			2017			2016			2015			2017			2016			2015
Components of benefit expense
Service cost	$	401		$	393		$	435		$	91		$	80		$	99		$	28		$	31		$	35
Interest cost	468			484			546			89			94			115			36			41			52
Expected return on plan assets	(849		)	(834		)	(850		)	(176		)	(163		)	(174		)	(22		)	(24		)	(27		)
Amortization of prior service cost/(credit)	1			(1		)	(3		)	—			—			—			(25		)	(38		)	(39		)
Amortization of net loss/(gain)	123			168			205			53			40			71			(12		)	(1		)	2
	144			210			333			57			51			111			5			9			23
Settlement/curtailment loss/(gain) ^(a)	8			245			—			11			9			3			—			(14		)	—
Special termination benefits	60			11			18			—			1			1			2			1			1
Total	$	212		$	466		$	351		$	68		$	61		$	115		$	7		$	(4	)	$	24

Debt Obligations and Commitments (Tables)

12 Months Ended

Dec. 30, 2017

Debt Obligations and Commitments [Abstract]

Schedule of Long and Short-Term Debt Contractural Commitments

Debt Obligations

The following table summarizes the Company’s debt obligations:



	2017^(a)			2016^(a)
Short-term debt obligations^(b)
Current maturities of long-term debt	$	4,020		$	4,401
Commercial paper (1.3% and 0.6%)	1,385			2,257
Other borrowings (4.7% and 4.4%)	80			234
	$	5,485		$	6,892
Long-term debt obligations ^(b)
Notes due 2017 (1.4%)	$	—		$	4,398
Notes due 2018 (2.4% and 2.3%)	4,016			2,561
Notes due 2019 (2.1% and 1.7%)	3,933			2,837
Notes due 2020 (3.1% and 2.6%)	3,792			3,816
Notes due 2021 (2.4% and 2.4%)	3,300			2,249
Notes due 2022 (2.6% and 2.8%)	3,853			2,655
Notes due 2023-2047 (3.7% and 3.8%)	18,891			15,903
Other, due 2017-2026 (1.3% and 1.4%)	31			35
	37,816			34,454
Less: current maturities of long-term debt obligations	(4,020		)	(4,401		)
Total	$	33,796		$	30,053


(a)	Amounts are shown net of unamortized net discounts of $155 million and $142 million for 2017 and 2016, respectively.


(b)	The interest rates presented reflect weighted-average rates at year-end. Certain of our fixed rate indebtedness have been swapped to floating rates through the use of interest rate derivative instruments. See Note 9 for additional information regarding our interest rate derivative instruments.

In 2017, we issued the following senior notes:



Interest Rate		Maturity Date	Amount^(a)
Floating rate		May 2019	$	350
Floating rate		May 2022	$	400
1.550	%	May 2019	$	750
2.250	%	May 2022	$	750
4.000	%	May 2047	$	750
2.150	%	May 2024	C$	750	^(b)
Floating rate		October 2018	$	1,500
2.000	%	April 2021	$	1,000
3.000	%	October 2027	$	1,500

Schedule Of Long-Term Contractual Commitments

Financial Instruments (Tables)

12 Months Ended

Dec. 30, 2017

Derivative Instruments and Hedges, Assets [Abstract]

Fair Values Of Financial Assets And Liabilities

Fair Value Measurements

The fair values of our financial assets and liabilities as of December 30, 2017 and December 31, 2016 are categorized as follows:



		2017				2016
	Fair Value Hierarchy Levels^(a)	Assets^(a)		Liabilities^(a)		Assets^(a)		Liabilities^(a)
Available-for-sale securities:
Equity securities ^(b)	1	$	—	$	—	$	82	$	—
Debt securities ^(c)	2	14,510		—		11,369		—
		$	14,510	$	—	$	11,451	$	—
Short-term investments ^(d)	1	$	228	$	—	$	193	$	—
Prepaid forward contracts ^(e)	2	$	27	$	—	$	25	$	—
Deferred compensation ^(f)	2	$	—	$	503	$	—	$	472
Derivatives designated as fair value hedging instruments:
Interest rate ^(g)	2	$	24	$	130	$	66	$	71
Derivatives designated as cash flow hedging instruments:
Foreign exchange ^(h)	2	$	15	$	31	$	51	$	8
Interest rate ^(h)	2	—		213		—		408
Commodity ⁽ⁱ⁾	1	—		2		—		1
Commodity ^(j)	2	2		—		2		—
		$	17	$	246	$	53	$	417
Derivatives not designated as hedging instruments:
Foreign exchange ^(h)	2	$	10	$	3	$	2	$	15
Commodity ⁽ⁱ⁾	1	—		19		1		1
Commodity ^(j)	2	85		12		60		25
		$	95	$	34	$	63	$	41
Total derivatives at fair value ^(k)		$	136	$	410	$	182	$	529
Total		$	14,901	$	913	$	11,851	$	1,001


(a)	Fair value hierarchy levels are defined in Note 7. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.


(b)	Based on the price of common stock. These equity securities were classified as investments in noncontrolled affiliates.

(c)


(d)	Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.


(e)	Based primarily on the price of our common stock.


(f)	Based on the fair value of investments corresponding to employees’ investment elections.


(g)	Based on LIBOR forward rates.


(h)	Based on recently reported market transactions of spot and forward rates.


(i)	Based on quoted contract prices on futures exchange markets.


(j)	Based on recently reported market transactions of swap arrangements.


(k)	Unless otherwise noted, derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on the balance sheet as of December 30, 2017 and December 31, 2016 were not material. Collateral received against any of our asset positions was not material.

Effective Portion Of Pre-Tax (Gains)/Losses On Derivative Instruments

Losses/(gains) on our hedging instruments are categorized as follows:



	Fair Value/Non- designated Hedges						Cash Flow and Net Investment Hedges
	Losses/(Gains) Recognized in Income Statement^(a)						Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss						Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement^(b)
	2017			2016			2017			2016			2017			2016
Foreign exchange	$	(15	)	$	74		$	62		$	(24	)	$	10		$	(44	)
Interest rate	101			105			(195		)	97			(184		)	187
Commodity	(48		)	(52		)	3			1			3			7
Net investment	—			—			157			(39		)	—			—
Total	$	38		$	127		$	27		$	35		$	(171	)	$	150

(a)


(b)	Foreign exchange derivative losses/gains are primarily included in cost of sales. Interest rate derivative losses/gains are included in interest expense. Commodity derivative losses/gains are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.

Net Income Attributable to PepsiCo per Common Share (Tables)

12 Months Ended

Dec. 30, 2017

Basic And Diluted Net Income Attributable To PepsiCo Per Common Share

The computations of basic and diluted net income attributable to PepsiCo per common share are as follows:



	2017				2016				2015
	Income			Shares^(a)	Income			Shares^(a)	Income			Shares^(a)
Net income attributable to PepsiCo	$	4,857			$	6,329			$	5,452
Preferred shares:
Dividends	—				(1		)		(1		)
Redemption premium	(4		)		(5		)		(5		)
Net income available for PepsiCo common shareholders	$	4,853		1,425	$	6,323		1,439	$	5,446		1,469
Basic net income attributable to PepsiCo per common share	$	3.40			$	4.39			$	3.71
Net income available for PepsiCo common shareholders	$	4,853		1,425	$	6,323		1,439	$	5,446		1,469
Dilutive securities:
Stock options, RSUs, PSUs, PEPunits and Other	—			12	1			12	—			15
ESOP convertible preferred stock	4			1	5			1	6			1
Diluted	$	4,857		1,438	$	6,329		1,452	$	5,452		1,485
Diluted net income attributable to PepsiCo per common share	$	3.38			$	4.36			$	3.67


(a)	Weighted-average common shares outstanding (in millions).

Out-of-the-money options excluded from the calculation of diluted earnings per common share are as follows:



	2017		2016		2015
Out-of-the-money options ^(a)	0.4		0.7		1.5
Average exercise price per option	$	110.12	$	99.98	$	99.25


(a)	In millions.

Accumulated Other Comprehensive Loss Attributable to Pepsico (Tables)

12 Months Ended

Dec. 30, 2017

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule Of Accumulated Other Comprehensive Income

The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows:



	Currency Translation Adjustment			Cash Flow Hedges			Pension and Retiree Medical			Available-For-Sale Securities			Other			Accumulated Other Comprehensive Loss Attributable to PepsiCo
Balance as of December 27, 2014 ^(a)	$	(8,255	)	$	34		$	(2,500	)	$	87		$	(35	)	$	(10,669	)
Other comprehensive (loss)/income before reclassifications ^(b)	(2,936		)	(95		)	(88		)	3			—			(3,116		)
Amounts reclassified from accumulated other comprehensive loss	111			97			266			—			—			474
Net current year other comprehensive (loss)/income	(2,825		)	2			178			3			—			(2,642		)
Tax amounts	—			1			(7		)	(2		)	—			(8		)
Balance as of December 26, 2015^(a)	(11,080		)	37			(2,329		)	88			(35		)	(13,319		)
Other comprehensive (loss)/income before reclassifications	(313		)	(74		)	(750		)	(43		)	—			(1,180		)
Amounts reclassified from accumulated other comprehensive loss	—			150			407			—			—			557
Net current year other comprehensive (loss)/income	(313		)	76			(343		)	(43		)	—			(623		)
Tax amounts	7			(30		)	27			19			—			23
Balance as of December 31, 2016 ^(a)	(11,386		)	83			(2,645		)	64			(35		)	(13,919		)
Other comprehensive (loss)/income before reclassifications ^(c)	1,049			130			(375		)	25			—			829
Amounts reclassified from accumulated other comprehensive loss	—			(171		)	158			(99		)	—			(112		)
Net current year other comprehensive (loss)/income	1,049			(41		)	(217		)	(74		)	—			717
Tax amounts	60			5			58			6			16			145
Balance as of December 30, 2017 ^(a)	$	(10,277	)	$	47		$	(2,804	)	$	(4	)	$	(19	)	$	(13,057	)


(a)	Pension and retiree medical amounts are net of taxes of $1,260 million in 2014, $1,253 million in 2015, $1,280 million in 2016 and $1,338 million in 2017.


(b)	Currency translation adjustment primarily reflects the depreciation of the Russian ruble, Brazilian real and Canadian dollar.


(c)	Currency translation adjustment primarily reflects the appreciation of the euro, Russian ruble, Pound sterling and Canadian dollar.

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

The following table summarizes the reclassifications from accumulated other comprehensive loss to the income statement:



	Amount Reclassified from Accumulated Other Comprehensive Loss									Affected Line Item in the Income Statement
	2017			2016			2015
Currency translation:
Venezuelan entities	$	—		$	—		$	111		Venezuela impairment charges

Cash flow hedges:
Foreign exchange contracts	$	—		$	2		$	(3	)	Net revenue
Foreign exchange contracts	10			(46		)	(94		)	Cost of sales
Interest rate derivatives	(184		)	187			174			Interest expense
Commodity contracts	4			3			9			Cost of sales
Commodity contracts	(1		)	4			11			Selling, general and administrative expenses
Net (gains)/losses before tax	(171		)	150			97
Tax amounts	64			(63		)	(47		)
Net (gains)/losses after tax	$	(107	)	$	87		$	50

Pension and retiree medical items:
Amortization of net prior service credit ^(a)	$	(24	)	$	(39	)	$	(41	)
Amortization of net losses^(a)	167			209			281
Settlement/curtailment ^(a)	15			237			6
Net losses before tax	158			407			246
Tax amounts	(44		)	(144		)	(74		)
Net losses after tax	$	114		$	263		$	172

Venezuelan entities	$	—		$	—		$	20		Venezuela impairment charges
Tax amount	—			—			(4		)
Net losses after tax	$	—		$	—		$	16

Available-for-sale securities:
Sale of Britvic securities	$	(99	)	$	—		$	—		Selling, general and administrative expenses
Tax amount	10			—			—
Net gain after tax	$	(89	)	$	—		$	—

Total net (gains)/losses reclassified for the year, net of tax	$	(82	)	$	350		$	349


(a)	These items are included in the components of net periodic benefit cost for pension and retiree medical plans (see Note 7 for additional details).

Supplemental Financial Information (Tables)

12 Months Ended

Dec. 30, 2017

Additional Financial Information Disclosure [Text Block]

Balance Sheet



	2017			2016			2015
Accounts and notes receivable
Trade receivables	$	5,956		$	5,709
Other receivables	1,197			1,119
	7,153			6,828
Allowance, beginning of year	134			130			$	137
Net amounts charged to expense	26			37			43
Deductions ^(a)	(35		)	(30		)	(27		)
Other ^(b)	4			(3		)	(23		)
Allowance, end of year	129			134			$	130
Net receivables	$	7,024		$	6,694

Inventories ^(c)
Raw materials and packaging	$	1,344		$	1,315
Work-in-process	167			150
Finished goods	1,436			1,258
	$	2,947		$	2,723

Other assets
Noncurrent notes and accounts receivable	$	59		$	105
Deferred marketplace spending	134			140
Pension plans ^(d)	374			53
Other	346			338
	$	913		$	636

Accounts payable and other current liabilities
Accounts payable	$	6,727		$	6,158
Accrued marketplace spending	2,390			2,444
Accrued compensation and benefits	1,785			1,770
Dividends payable	1,161			1,097
Other current liabilities	2,954			2,774
	$	15,017		$	14,243


(a)	Includes accounts written off.


(b)	Includes adjustments related primarily to currency translation and other adjustments.


(c)	Approximately 5% of the inventory cost in 2017 and 2016 were computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material.


(d)	See Note 7 for additional information regarding our pension plans.

Statement of Cash Flows



	2017		2016		2015
Interest paid ^(a)	$	1,123	$	1,102	$	952
Income taxes paid, net of refunds	$	1,962	$	1,393	$	1,808


(a)	In 2016, interest paid excludes the premium paid in accordance with the “make-whole” provisions of the debt redemption discussed in

Note 8.

Lease Information



	2017		2016		2015
Rent expense	$	742	$	701	$	696

Minimum lease payments under non-cancelable operating leases by period



	Operating Lease Payments
2018	$	452
2019	403
2020	297
2021	215
2022	160
2023 and beyond	367
Total minimum operating lease payments	$	1,894

Basis of Presentation and Our Divisions (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 30, 2017 USD ($) country	Dec. 31, 2016 USD ($)	Dec. 26, 2015 USD ($)
Basis Of Presentation And Our Divisions [Line Items]
Venezuela impairment charges \| $	$ 0	$ 0	$ 1,359
Manufacture and sell in (number of countries) \| country	200
FLNA
Basis Of Presentation And Our Divisions [Line Items]
Stock-based compensation percentage	13.00%	14.00%
QFNA
Basis Of Presentation And Our Divisions [Line Items]
Stock-based compensation percentage	1.00%	2.00%
NAB
Basis Of Presentation And Our Divisions [Line Items]
Stock-based compensation percentage	18.00%	22.00%
Latin America
Basis Of Presentation And Our Divisions [Line Items]
Stock-based compensation percentage	7.00%	7.00%
ESSA
Basis Of Presentation And Our Divisions [Line Items]
Stock-based compensation percentage	9.00%	11.00%
AMENA
Basis Of Presentation And Our Divisions [Line Items]
Stock-based compensation percentage	9.00%	10.00%
Corporate
Basis Of Presentation And Our Divisions [Line Items]
Stock-based compensation percentage	43.00%	34.00%
Maximum
Basis Of Presentation And Our Divisions [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	50.00%

Basis of Presentation and Our Divisions (Schedule of Segment Reporting Information, by Segment) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

$ 63,525

$ 62,799

$ 63,056

^[1]

10,509

9,785

8,353

FLNA

15,798

15,549

14,782

^[1]

4,823

4,659

4,304

QFNA

2,503

2,564

2,543

^[1]

642

653

560

NAB

20,936

21,312

20,618

^[1]

2,707

2,959

2,785

Latin America

7,208

6,820

8,228

^[1]

908

887

(206)

ESSA

11,050

10,216

10,510

^[1]

1,354

1,108

1,081

AMENA

6,030

6,338

6,375

^[1]

1,073

619

941

Total Division

^[1]

11,507

10,885

9,465

Corporate

^[1]

$ (998)

$ (1,100)

$ (1,112)

[1]	For further unaudited information on certain items that impacted our financial performance, see “Item 6. Selected Financial Data.”

Basis of Presentation and Our Divisions (Segment Reporting Information by Total Assets and Capital Spending) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

$ 79,804

$ 73,490

2,969

3,040

$ 2,758

FLNA

5,979

5,731

665

801

608

QFNA

804

811

NAB

28,592

28,172

904

769

695

Latin America

4,976

4,568

481

507

368

ESSA

13,556

12,302

481

439

404

AMENA

5,668

5,261

308

381

441

Total Division

59,575

56,845

2,883

2,938

2,556

Corporate

^[1]

20,229

16,645

^[1]

$ 86

$ 102

$ 202

[1]

Corporate assets consist principally of certain cash and cash equivalents, short-term investments, derivative instruments, property, plant and equipment and tax assets. In 2017, the change in total Corporate assets was primarily due to an increase in short-term investments and cash and cash equivalents.

Basis of Presentation and Our Divisions (Segment Reporting Information by Amortization of Intangible Assets and Depreciation and Other Amortization) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	$ 68	$ 70	$ 75
Depreciation and Other Amortization	2,301	2,298	2,341
FLNA
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	7	7	7
Depreciation and Other Amortization	449	435	427
QFNA
Segment Reporting Information [Line Items]
Depreciation and Other Amortization	47	50	51
NAB
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	31	37	38
Depreciation and Other Amortization	780	809	813
Latin America
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	5	5	7
Depreciation and Other Amortization	245	211	238
ESSA
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	22	18	20
Depreciation and Other Amortization	329	321	353
AMENA
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	3	3	3
Depreciation and Other Amortization	257	294	293
Total Division
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	68	70	75
Depreciation and Other Amortization	2,107	2,120	2,175
Corporate
Segment Reporting Information [Line Items]
Depreciation and Other Amortization	$ 194	$ 178	$ 166

Basis of Presentation and Our Divisions (Segment Reporting Information by Net Revenue and Long-Lived Assets) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

$ 63,525

$ 62,799

$ 63,056

Venezuela impairment charges

^[1]

47,864

46,404

1,359

UNITED STATES

36,546

36,732

35,266

^[1]

28,418

28,382

MEXICO

3,650

3,431

3,687

^[1]

1,205

998

CANADA

2,691

2,692

2,677

^[1]

2,739

2,499

Russia [Member]

3,232

^[2]

2,648

2,797

^[1]

4,708

^[2]

4,373

UNITED KINGDOM

1,650

1,737

1,966

^[1]

817

852

BRAZIL

1,427

1,305

1,289

All Other Countries [Member]

^[1]

777

796

14,329

14,254

$ 15,374

^[1]

$ 9,200

$ 8,504

[1]	Long-lived assets represent property, plant and equipment, nonamortizable intangible assets, amortizable intangible assets and investments in noncontrolled affiliates. These assets are reported in the country where they are primarily used.
[2]	Change in net revenue and long-lived assets in 2017 primarily reflects appreciation of the Russian ruble.

Our Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Property, Plant and Equipment [Line Items]
Capitalized Computer Software, Amortization	$ 224	$ 214	$ 202
Capitalized Computer Software, Net	$ 686	$ 791
Minimum \| Software
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Maximum \| Software
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years

Our Significant Accounting Policies (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		$ 639,000,000
Capitalized Computer Software, Net	$ 686,000,000	791,000,000
Capitalized Computer Software, Amortization	224,000,000	214,000,000	$ 202,000,000
Shipping and handling expenses	9,900,000,000	9,700,000,000	9,400,000,000
Research and development costs	737,000,000	760,000,000	754,000,000
Amount of prepaid incentive arrangements	262,000,000	291,000,000
Advertising and other marketing activities	4,100,000,000	4,200,000,000	3,900,000,000
Advertising expenses	2,400,000,000	2,500,000,000	$ 2,400,000,000
Deferred advertising costs	46,000,000	32,000,000
Earnings per Share [Member]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 0.08	$ 0.07

Our Significant Accounting Policies (Concentration of Credit Risk) (Details)	12 Months Ended
	Dec. 30, 2017
Customer Concentration Risk \| Wal-Mart \| Revenue, Net
Concentration Risk [Line Items]
Concentration risk, percentage	13.00%

Our Significant Accounting Policies Recently Issued Accounting Pronouncements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation		$ 110	$ 107
Income Statement Location [Member]
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation	$ 115	110	107
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	233	19
Cash Flow Statement Location [Member]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 295	$ 269	$ 284

Our Significant Accounting Policies Recently Issued Accounting Pronouncements [Line Items] (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Provisional net tax expense related to the TCJ Act	$ 2,451	$ 0	$ 0
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation		110	107
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		639
Income Statement Location [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation	115	110	107
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	233	19
Cash Flow Statement Location [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 295	$ 269	$ 284

Restructuring, Impairment and Integration Charges (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Restructuring Cost and Reserve [Line Items]
Total restructuring and impairment charges and other productivity initiatives	$ 311	$ 172	$ 320
Restructuring, Settlement and Impairment Provisions	295	160	230
Other Productivity Initiatives	16	12	90
2014 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	295	160	169
2012 Productivity Plan
Restructuring Cost and Reserve [Line Items]
Restructuring, Settlement and Impairment Provisions	$ 0	$ 0	$ 61

Restructuring, Impairment and Integration Charges Restructuring, Impairment and Integration Charges (Summary of 2014 Productivity Plan Charges) (Details) - USD ($)
$ / shares in Units, $ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Dec. 27, 2014

Restructuring, Settlement and Impairment Provisions

$ 295

$ 160

$ 230

Other Productivity Initiatives

(113)

(125)

(208)

Other Productivity Initiatives, After Tax

$ 66

Other Productivity Initiatives, Net of Tax, Per Share Amount

$ 0.04

2014 Productivity Plan

Restructuring, Settlement and Impairment Provisions

295

160

$ 169

Restructuring Charges After Tax

224

131

134

(113)

(95)

(163)

(52)

(50)

(38)

Restructuring and impairment provisions, after-tax impact per share

$ 226

$ 96

$ 81

$ 113

$ 0.16

$ 0.09

Restructuring and Related Cost, Cost Incurred to Date

$ 1,034

2014 Productivity Plan | Severance And Other Employee Costs

Restructuring, Settlement and Impairment Provisions

280

$ 88

$ 59

(91)

(46)

(76)

(65)

(15)

(11)

Restructuring and Related Cost, Cost Incurred to Date

212

627

2014 Productivity Plan | Asset Impairments

Restructuring, Settlement and Impairment Provisions

(21)

(36)

(24)

Restructuring and Related Cost, Cost Incurred to Date

154

2014 Productivity Plan | Other Restructuring [Member]

Restructuring, Settlement and Impairment Provisions

(6)

(22)

(49)

(87)

(3)

Restructuring and Related Cost, Cost Incurred to Date

$ 24

253

2014 Productivity Plan | FLNA

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

163

2014 Productivity Plan | FLNA | Severance And Other Employee Costs

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

131

2014 Productivity Plan | FLNA | Asset Impairments

Restructuring, Settlement and Impairment Provisions

(1)

^[1]

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | FLNA | Other Restructuring [Member]

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | QFNA

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | QFNA | Severance And Other Employee Costs

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | QFNA | Asset Impairments

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | QFNA | Other Restructuring [Member]

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | NAB

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

301

2014 Productivity Plan | NAB | Severance And Other Employee Costs

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

149

2014 Productivity Plan | NAB | Asset Impairments

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | NAB | Other Restructuring [Member]

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | Latin America

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

152

2014 Productivity Plan | Latin America | Severance And Other Employee Costs

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

109

2014 Productivity Plan | Latin America | Asset Impairments

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | Latin America | Other Restructuring [Member]

Restructuring, Settlement and Impairment Provisions

(10)

^[1]

(2)

^[1]

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | ESSA

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

227

2014 Productivity Plan | ESSA | Severance And Other Employee Costs

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

127

2014 Productivity Plan | ESSA | Asset Impairments

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | ESSA | Other Restructuring [Member]

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | AMENA

Restructuring, Settlement and Impairment Provisions

(3)

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | AMENA | Severance And Other Employee Costs

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | AMENA | Asset Impairments

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | AMENA | Other Restructuring [Member]

Restructuring, Settlement and Impairment Provisions

(5)

^[2]

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | Corporate

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

115

2014 Productivity Plan | Corporate | Severance And Other Employee Costs

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | Corporate | Asset Impairments

Restructuring, Settlement and Impairment Provisions

Restructuring and Related Cost, Cost Incurred to Date

2014 Productivity Plan | Corporate | Other Restructuring [Member]

Restructuring, Settlement and Impairment Provisions

$ 4

$ 8

Restructuring and Related Cost, Cost Incurred to Date

$ 53

[1]	Income amounts represent adjustments for changes in estimates.
[2]	Income amount primarily reflects a gain on the sale of property, plant and equipment.

Property, Plant and Equipment and Intangible Assets (Schedule of Property, Plant and Equipment and Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Property, Plant and Equipment [Line Items]
Nonamortizable Intangible Assets	$ 27,314	$ 26,626	$ 25,988
Goodwill and Indefinite-lived Intangible Assets, Translation and Purchase Accounting Adjustments	688	638
Property, plant and equipment, net:
Property, plant and equipment, gross	39,106	36,818
Accumulated depreciation	(21,866)	(20,227)
Property, Plant and Equipment, net	17,240	16,591
Depreciation	2,227	2,217	2,248
Amortizable intangible assets, net:
Amortizable intangible assets, gross	2,807	2,732
Accumulated amortization	(1,539)	(1,495)
Amortizable intangible assets, net	1,268	1,237
Amortization of intangible assets	68	70	75
Land [Member]
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 1,148	1,153
Land [Member] \| Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	0 years
Land [Member] \| Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	0 years
Buildings And Improvements
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 8,796	8,306
Buildings And Improvements \| Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	15 years
Buildings And Improvements \| Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	44 years
Machinery And Equipment, Including Fleet And Software
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 27,018	25,277
Machinery And Equipment, Including Fleet And Software \| Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	5 years
Machinery And Equipment, Including Fleet And Software \| Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	15 years
Construction In Progress
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 2,144	2,082
Acquired Franchise Rights
Amortizable intangible assets, net:
Amortizable intangible assets, gross	858	827
Accumulated amortization	(128)	(108)
Amortizable intangible assets, net	$ 730	719
Acquired Franchise Rights \| Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	56 years
Acquired Franchise Rights \| Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	60 years
Reacquired Franchise Rights
Amortizable intangible assets, net:
Amortizable intangible assets, gross	$ 106	106
Accumulated amortization	(104)	(102)
Amortizable intangible assets, net	$ 2	4
Reacquired Franchise Rights \| Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	5 years
Reacquired Franchise Rights \| Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	14 years
Other Identifiable Intangibles
Amortizable intangible assets, net:
Amortizable intangible assets, gross	$ 521	522
Accumulated amortization	(281)	(308)
Amortizable intangible assets, net	$ 240	214
Other Identifiable Intangibles \| Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	10 years
Other Identifiable Intangibles \| Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	24 years
ESSA
Property, Plant and Equipment [Line Items]
Nonamortizable Intangible Assets	$ 6,741	6,207	5,932
Goodwill and Indefinite-lived Intangible Assets, Translation and Purchase Accounting Adjustments	534	275
Amortizable intangible assets, net:
Amortization of intangible assets	22	18	20
AMENA
Property, Plant and Equipment [Line Items]
Nonamortizable Intangible Assets	539	515	523
Goodwill and Indefinite-lived Intangible Assets, Translation and Purchase Accounting Adjustments	24	(8)
Amortizable intangible assets, net:
Amortization of intangible assets	3	3	3
Goodwill [Member]
Property, Plant and Equipment [Line Items]
Nonamortizable Intangible Assets	14,744	14,430	14,177
Goodwill and Indefinite-lived Intangible Assets, Translation and Purchase Accounting Adjustments	314	253
Goodwill [Member] \| ESSA
Property, Plant and Equipment [Line Items]
Nonamortizable Intangible Assets	3,452	3,177	3,042
Goodwill and Indefinite-lived Intangible Assets, Translation and Purchase Accounting Adjustments	275	135
Goodwill [Member] \| AMENA
Property, Plant and Equipment [Line Items]
Nonamortizable Intangible Assets	428	412	$ 418
Goodwill and Indefinite-lived Intangible Assets, Translation and Purchase Accounting Adjustments	$ 16	$ (6)

Property, Plant and Equipment and Intangible Assets (Future Amortization) (Details) $ in Millions	Dec. 30, 2017 USD ($)
Property, Plant And Equipment And Intangible Assets [Abstract]
2016	$ 69
2017	64
2018	64
2019	62
2020	$ 60

Property, Plant and Equipment and Intangible Assets (Schedule of Change in Book Value of Nonamortizable Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Net	$ 1,268	$ 1,237
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	26,626	25,988
Translation and Other	688	638
Balance, Ending	27,314	26,626
Finite-Lived Intangible Assets, Gross	2,807	2,732
Finite-Lived Intangible Assets, Accumulated Amortization	1,539	1,495
FLNA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	293	289
Translation and Other	12	4
Balance, Ending	305	293
NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	18,733	18,411
Translation and Other	125	322
Balance, Ending	18,858	18,733
Latin America
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	703	658
Translation and Other	(7)	45
Balance, Ending	696	703
ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	6,207	5,932
Translation and Other	534	275
Balance, Ending	6,741	6,207
AMENA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	515	523
Translation and Other	24	(8)
Balance, Ending	539	515
Goodwill [Member]
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	14,430	14,177
Translation and Other	314	253
Balance, Ending	14,744	14,430
Goodwill [Member] \| FLNA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	270	267
Translation and Other	10	3
Balance, Ending	280	270
Goodwill [Member] \| QFNA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	175	175
Translation and Other	0	0
Balance, Ending	175	175
Goodwill [Member] \| NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	9,843	9,754
Translation and Other	11	89
Balance, Ending	9,854	9,843
Goodwill [Member] \| Latin America
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	553	521
Translation and Other	2	32
Balance, Ending	555	553
Goodwill [Member] \| ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	3,177	3,042
Translation and Other	275	135
Balance, Ending	3,452	3,177
Goodwill [Member] \| AMENA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	412	418
Translation and Other	16	(6)
Balance, Ending	428	412
Reacquired Franchise Rights
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	7,552	7,530
Translation and Other	123	22
Balance, Ending	7,675	7,552
Reacquired Franchise Rights \| NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	7,064	7,042
Translation and Other	62	22
Balance, Ending	7,126	7,064
Reacquired Franchise Rights \| ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	488	488
Translation and Other	61
Balance, Ending	549	488
Acquired Franchise Rights
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	1,696	1,697
Translation and Other	24	(1)
Balance, Ending	1,720	1,696
Acquired Franchise Rights \| NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	1,512	1,507
Translation and Other	13	5
Balance, Ending	1,525	1,512
Acquired Franchise Rights \| ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	184	190
Translation and Other	11	(6)
Balance, Ending	195	184
Brands [Member]
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	2,948	2,584
Translation and Other	227	364
Balance, Ending	3,175	2,948
Brands [Member] \| FLNA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	23	22
Translation and Other	2	1
Balance, Ending	25	23
Brands [Member] \| NAB
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	314	108
Translation and Other	39	206
Balance, Ending	353	314
Brands [Member] \| Latin America
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	150	137
Translation and Other	(9)	13
Balance, Ending	141	150
Brands [Member] \| ESSA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	2,358	2,212
Translation and Other	187	146
Balance, Ending	2,545	2,358
Brands [Member] \| AMENA
Intangible Assets (Including Goodwill) [Roll Forward]
Balance, Beginning	103	105
Translation and Other	8	(2)
Balance, Ending	111	103
Brands [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Assets, Net	296	300
Intangible Assets (Including Goodwill) [Roll Forward]
Finite-Lived Intangible Assets, Gross	1,322	1,277
Finite-Lived Intangible Assets, Accumulated Amortization	$ 1,026	$ 977
Minimum \| Brands [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Maximum \| Brands [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Asset, Useful Life	40 years

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Millions	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Income Tax Contingency [Line Items]
Federal Statutory Tax Rate, Pre TCJ Act	35.00%
Federal Statutory Tax Rate, Post TCJ Act	0.00%
Provisional net tax expense related to the TCJ Act	$ 2,451	$ 0	$ 0
Total gross amount of reserves for income taxes	2,200
Interest accrued	283	193
Interest accrued recognized	89	$ 61
Operating loss carryforwards	12,600
Income tax undistributed international earnings	42,500
Mandatory OneTime Repatriation TCJ ACT	4,000
Remeasurement of Deferred Taxes TCJ Act	1,500
Foreign Earnings Repatriated	$ 20,000
Effective Income Tax Rate Reconciliation, Percent	48.90%	25.40%	26.10%
undistributed earnings of foreign subsidiaries, post distribution	$ 22,500
Expire in 2016
Income Tax Contingency [Line Items]
Operating loss carryforwards	200
Expire Between 2017 and 2035 Years
Income Tax Contingency [Line Items]
Operating loss carryforwards	11,100
Carried Forward Indefinitely
Income Tax Contingency [Line Items]
Operating loss carryforwards	$ 1,300

Income Taxes (Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Income Tax Contingency [Line Items]
Mandatory OneTime Repatriation TCJ ACT	$ 4,000
Federal Statutory Tax Rate, Pre TCJ Act				35.00%
Income before income taxes in U.S	3,452	$ 2,630	$ 2,879
Income before income taxes in Foreign	6,150	5,923	4,563
Income before income taxes	9,602	8,553	7,442
Provision for income taxes
Current: U.S. Federal	4,925	1,219	1,143
Current: Foreign	724	824	773
Current: State	136	77	65
Provision for income taxes, Current total	5,785	2,120	1,981
Deferred: U.S. Federal	(1,159)	109	(14)
Deferred: Foreign	(9)	(33)	(32)
Deferred: State	77	(22)	6
Provision for income taxes, Deferred total	(1,091)	54	(40)
Provision for income taxes	$ 4,694	$ 2,174	$ 1,941
U.S. Federal statutory tax rate
U.S. Federal statutory tax rate	35.00%	35.00%	35.00%
State income tax, net of U.S. Federal tax benefit	0.90%	0.40%	0.60%
Lower taxes on foreign results	(9.40%)	(8.00%)	(10.50%)
Impact of Venezuela impairment charges	0.00%	0.00%	6.40%
Provisional One Time Mandatory Repatriation TCJ Act, Percent	41.40%	0.00%	0.00%
Remeasurement of Deferred Taxes TCJ Act, Percent	(15.90%)	0.00%	0.00%
Tax benefits	0.00%	0.00%	(3.10%)
Other, net	(3.10%)	(2.00%)	(2.30%)
Annual tax rate	48.90%	25.40%	26.10%
Deferred tax liabilities
Debt guarantee of wholly-owned subsidiary				$ 578	$ 839
Property, plant and equipment				1,397	1,967
Intangible assets other than nondeductible goodwill				3,169	4,124
Other				50	245
Gross deferred tax liabilities				5,194	7,175
Deferred tax assets
Net carryforwards				1,400	1,255
Share-based compensation				107	219
Retiree medical benefits				198	316
Other employee-related benefits				338	614
Pension benefits				22	419
Deductible state tax and interest benefits				157	189
Other				893	839
Gross deferred tax assets				3,115	3,851
Valuation allowances	$ (1,110)	$ (1,136)	$ (1,230)	(1,163)	(1,110)	$ (1,136)
Deferred tax assets, net				1,952	2,741
Net deferred tax liabilities				3,242	4,434
Prepaid expenses and other current assets				1,546	908
Deferred income taxes				3,242	4,434
Valuation Allowance [Abstract]
Balance, beginning of year	(1,110)	(1,136)	(1,230)
Provision/(benefit)				$ 33	$ 13	$ (26)
Other additions/(deductions)	20	(39)	(68)
Balance, end of year	(1,163)	$ (1,110)	$ (1,136)
Tax Settlement, Years 2010-2011 [Member]
Income Tax Contingency [Line Items]
non cash tax benefit	$ 230

Income Taxes (Reserves Rollforward) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance, beginning of year	$ 1,885	$ 1,547
Additions for tax positions related to the current year	309	349
Additions for tax positions from prior years	86	139
Reductions for tax positions from prior years	(51)	(70)
Settlement payments	(4)	(26)
Statutes of limitations expiration	(33)	(27)
Translation and other	20	(27)
Balance, end of period	$ 2,212	$ 1,885

Share-Based Compensation Share-Based Compensation (Narrative) (Details)
shares in Millions, $ in Millions

12 Months Ended

Dec. 30, 2017

USD ($)

option / rsu

Dec. 31, 2016

USD ($)

Dec. 26, 2015

USD ($)

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Common stock, capital shares reserved for future issuance | shares

Allocated Share-based Compensation Expense

$ 292

$ 284

$ 295

Allocated Share-Based Compensation Liability Awards

Restructuring, Settlement and Impairment Provisions, Share-based Compensation

(2)

Allocated Share-based Compensation Expense, After Merger/Integration and Restructuring/Impairment

303

294

299

Income tax benefits recognized in earnings related to share-based compensation

^[1]

$ 91

$ 77

Unrecognized compensation cost related to nonvested share-based compensation grants

$ 314

Weighted-average period for recognizing unrecognized compensation

2 years

3 years

Percent of liability awards granted to senior officers

34.00%

40.00%

PEPunit

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

3 years

Restricted Stock Units (RSUs)

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Award equivalence, ratio of stock options to RSUs | option / rsu

Stock Options

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Stock option exercisable life

10 years

Award equivalence, ratio of stock options to RSUs | option / rsu

PEP Equity Performance Unit [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Percent of equity awards granted to Senior Officers as performance-based RSUs

66.00%

60.00%

[1]	Reflects tax rates effective for the 2017 tax year.

Share-Based Compensation Share-Based Compensation (Schedule of Weighted-Average Black-Scholes Fair Value Assumptions) (Details)	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Share-based Compensation [Abstract]
Expected life	5 years	6 years	7 years
Risk-free interest rate	2.00%	1.40%	1.80%
Expected volatility	11.00%	12.00%	15.00%
Expected dividend yield	2.70%	2.70%	2.70%

Share-Based Compensation Share-Based Compensation (Stock Option Activity) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]

Outstanding at December 31, 2016

^[1]

25,190

Granted

^[2]

1,481

^[1]

1,743

1,884

Exercised

^[1]

(7,136)

Forfeited/expired

^[1]

(522)

Outstanding at December 30, 2017

^[1]

19,013

25,190

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]

Outstanding at December 31, 2016 (in USD per share)

$ 69.88

Granted (in USD per share)

110.15

Exercised (in USD per share)

65.31

Forfeited/expired (in USD per share)

88.36

Outstanding at December 30, 2017 (in USD per share)

$ 74.23

$ 69.88

Outstanding at December 30, 2017 - average life

4 years 2 months 19 days

Outstanding Aggregate Intrinsic Value, at December 30, 2017

^[3]

$ 868,750

Exercisable at December 30, 2017

^[1]

14,589

Exercisable at December 30, 2017 - average price

$ 65.60

Exercisable at December 30, 2017 - average life

3 years 7 days

Exercisable Aggregate Intrinsic Value, at December 30, 2017

^[3]

$ 792,560

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

^[1]

3,994

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price

$ 102.50

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term

8 years 1 month 24 days

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value

^[3]

$ 69,578

[1]	Options are in thousands and include options previously granted under the PBG plan. No additional options or shares were granted under the PBG plan after 2009.
[2]	In thousands
[3]	In thousands.

Share-Based Compensation Share-Based Compensation (Restricted Stock Units and PEPUnits Activity) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number

^[1]

8,237

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number

^[1]

7,293

^[2]

8,237

Expected to Vest as of December 30, 2017

^[1]

6,695

Granted (b)

^[1],[3]

2,824

Converted

^[1]

(3,226)

Forfeited

^[1]

(608)

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 109.92

^[3]

$ 99.06

$ 99.17

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value

82.56

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value

100.17

Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

$ 102.30

^[2]

$ 91.81

Outstanding, average life, at December 30, 2017

^[2]

1 year 3 months 29 days

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Aggregate Intrinsic Value

^[1],[2]

$ 874,517

Expected to vest as of December 30, 2017 (in USD per share)

$ 102.00

Expected to vest, average life, at December 30, 2017

1 year 3 months 4 days

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Aggregate Intrinsic Value

^[1]

$ 802,826

Performance Shares [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares

^[1],[4]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]

Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Performance Assumption Change, Weighted Average Grant Date Fair Value, Amount per Share

^[4]

$ 100.33

Performance Shares [Member] | Maximum Award Level [Domain]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding

^[1],[2]

1,500

PepsiCo Equity Performance Unit [Domain]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number

^[5]

533

Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number

^[5]

248

^[6]

533

Expected to Vest as of December 30, 2017

^[5]

234

Converted

^[1]

(363)

Forfeited

^[5]

(13)

Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares

^[5],[7]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 68.94

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value

$ 49.11

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value

68.94

Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Performance Assumption Change, Weighted Average Grant Date Fair Value, Amount per Share

^[7]

50.74

Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

$ 68.94

^[6]

$ 59.86

Outstanding, average life, at December 30, 2017

^[6]

2 months 1 day

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Aggregate Intrinsic Value

^[5],[6]

$ 29,734

Expected to vest as of December 30, 2017 (in USD per share)

$ 68.94

Expected to vest, average life, at December 30, 2017

2 months 1 day

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Aggregate Intrinsic Value

^[5]

$ 28,034

PepsiCo Equity Performance Unit [Domain] | Target Award Level [Domain] [Domain]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding

^[1],[2]

200

PepsiCo Equity Performance Unit [Domain] | Maximum Award Level [Domain]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding

^[1],[2]

400

Target Award Level [Domain] [Domain] | Performance Shares [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding

^[1],[2]

900

[1]	In thousands.
[2]	The outstanding PSUs for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, 0.9 million and 1.5 million, respectively.
[3]	Grant activity for all PSUs are disclosed at target.
[4]	Reflects the net number of PSUs above and below target levels based on actual performance measured at the end of the performance period.
[5]	In thousands.
[6]	The outstanding PEPunits for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, 0.2 million and 0.4 million, respectively.
[7]	Reflects the net number of PEPunits above and below target levels based on actual performance measured at the end of the performance period.

Share-Based Compensation Share-Based Compensation (Other Stock-Based Compensation Data) (Details) - USD ($)
$ / shares in Units, $ in Thousands

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Phantom Units Granted Under Director Deferral Program, Shares Outstanding

250,000

254,000

Stock Options

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

^[1]

1,481,000

^[2]

1,743,000

1,884,000

Weighted-average grant-date fair value of options granted

$ 8.25

$ 6.94

$ 10.80

Total intrinsic value of options exercised (a)

^[1]

$ 327,860

$ 290,131

$ 366,188

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

^[1]

23,122

18,840

$ 21,837

LiabilityAwards [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

LiabilityAwardsNonvestedNumber

^[3]

33,200

^[4]

$ 15,670

LiabilityAwardsNonvestedBalanceSheetFairValue

^[3],[4]

$ 32,592

LiabilityAwardsNonvestedRemainingContractualTerm

1 year 8 months 23 days

LiabilityAwardsForfeituresExpirations

LiabilityAwardsGranted

^[3],[5]

$ 19,060

^[3]

(1,530)

LiabilityAwardsExpectedtoVest,Outstanding,Number

^[3]

29,590

LiabilityAwardsExpectedtoVest,BalanceSheetFairValue

^[3]

$ 29,092

LiabilityAwardsExpectedtoVest,RemainingContractualTerm

1 year 8 months 16 days

Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

^[1]

2,824,000

3,054,000

2,759,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 109.92

^[6]

$ 99.06

$ 99.17

Total intrinsic value of converted units

^[1]

$ 380,269

$ 359,401

$ 375,510

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

^[1]

264,923

257,648

$ 257,831

PEPUnit

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

^[1]

300,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$ 68.94

Total intrinsic value of converted units

^[1]

39,782

38,558

$ 37,705

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

^[1]

18,833

$ 16,572

$ 22,286

Minimum Award Level [Domain] | PEP_LiabilityAwardsPerformanceBased [Member]

LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding

Maximum | PEP_LiabilityAwardsPerformanceBased [Member]

LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding

66,400

Target Award Level [Domain] [Domain] | PEP_LiabilityAwardsPerformanceBased [Member]

LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding

$ 33,200

[1]	In thousands
[2]	Options are in thousands and include options previously granted under the PBG plan. No additional options or shares were granted under the PBG plan after 2009.
[3]	In thousands.
[4]	The outstanding long-term cash awards for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, $33.2 million and $66.4 million, respectively.
[5]	Grant activity for all long-term cash awards are disclosed at target.
[6]	Grant activity for all PSUs are disclosed at target.

Pension, Retiree Medical and Savings Plans (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Defined Benefit Plan Disclosure [Line Items]
Average remaining service period of active plan participants, pension expense		11
Defined Benefit Plan, Average remaining life expectancy of Inactive Plan Participants, Pension Expense		27
Average remaining service period of active plan participants, retiree medical expense		7
Pension strategy investment term, years		5 years
Defined Contribution Plan, Cost		$ 176	$ 164	$ 148
Pre-tax non-cash settlement charge, after-tax			162
Change in accounting estimate			125
Change in Accounting Estimate after Tax			$ 81
Change in Accounting Estimate per Share			$ 0.06
Cost Savings Related to Reorganization of U.S. Pension Plans		42
Cost Savings Related to Reorganization of U.S. Pension Plans Net of Tax		$ 27
Cost Savings Related to Reorganization of U.S. Pension Plans Net of Tax, Earnings per Share		$ 0.02
Domestic Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets		7.50%	7.50%	7.50%
Discretionary contribution to fund pension settlement			$ 452
Pre-tax non-cash settlement charge			$ 242
Pre-tax non-cash settlement charge, net of tax, per share			$ 0.11
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets		7.50%	7.50%	7.50%
Scenario, Forecast [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year	$ 175
Scenario, Forecast [Member] \| Domestic Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets	7.20%
Scenario, Forecast [Member] \| Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year	$ 75
Subsequent Event [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year	1,400
Subsequent Event [Member] \| Funded Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year	$ 800

Pension, Retiree Medical and Savings Plans (Selected Financial Information for Pension and Retiree Medical Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Pension Plans, Defined Benefit
Change in fair value of plan assets
Employer contributions/funding	$ 164	$ 659	$ 162
Retiree Medical Plan
Change in projected benefit liability
Liability at beginning of year	1,208	1,300
Service cost	28	31	35
Interest cost	36	41	52
Plan amendments	(5)	(15)
Experience loss/(gain)	21	(51)
Special termination benefits	2	1
Other, including foreign currency adjustment	4	1
Liability at end of year	1,187	1,208	1,300
Defined Benefit Plan, Plan Assets, Benefits Paid	107	100
Defined Benefit Plan, Benefit Obligation, Benefits Paid	107	100
Change in fair value of plan assets
Fair value at beginning of year	320	354
Actual return on plan assets	52	30
Employer contributions/funding	56	36	43
Fair value at end of year	321	320	354
Funded status	(866)	(888)
Amounts recognized
Other current liabilities	(75)	(54)
Other liabilities	(791)	(834)
Net amount recognized	(866)	(888)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	(189)	(193)
Prior service cost/(credit)	(71)	(91)
Total	(260)	(284)
Changes recognized in net loss/(gain) included in other comprehensive loss
Net loss/(gain) arising in current year	(9)	(57)
Amortization and settlement recognition	12	1
Foreign currency translation loss/(gain)	1	1
Total	4	(55)
Domestic Plan [Member]
Change in projected benefit liability
Liability at beginning of year	13,192	13,033
Service cost	401	393	435
Interest cost	468	484	546
Plan amendments	10	18
Experience loss/(gain)	1,529	614
Settlement/curtailment	(58)	(1,014)
Special termination benefits	60	11
Liability at end of year	14,777	13,192	13,033
Defined Benefit Plan, Plan Assets, Benefits Paid	825	347
Defined Benefit Plan, Benefit Obligation, Benefits Paid	825	347
Change in fair value of plan assets
Fair value at beginning of year	11,458	11,397
Actual return on plan assets	1,935	880
Employer contributions/funding	60	541
Defined Benefit Plan, Plan Assets, Payment for Settlement	(46)	(1,013)
Fair value at end of year	12,582	11,458	11,397
Funded status	(2,195)	(1,734)
Amounts recognized
Other assets	286
Other current liabilities	(74)	(42)
Other liabilities	(2,407)	(1,692)
Net amount recognized	(2,195)	(1,734)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	3,520	3,220
Prior service cost/(credit)	29	20
Total	3,549	3,240
Changes recognized in net loss/(gain) included in other comprehensive loss
Net loss/(gain) arising in current year	431	568
Amortization and settlement recognition	(131)	(413)
Total	300	155
Accumulated benefit obligation at end of year	13,732	12,211
Foreign Plan [Member]
Change in projected benefit liability
Liability at beginning of year	3,124	2,872
Service cost	91	80	99
Interest cost	89	94	115
Plan amendments	2
Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant	2	2
Experience loss/(gain)	5	560
Settlement/curtailment	(22)	(19)
Special termination benefits		1
Other, including foreign currency adjustment	303	(383)
Liability at end of year	3,490	3,124	2,872
Defined Benefit Plan, Plan Assets, Benefits Paid	104	83
Defined Benefit Plan, Benefit Obligation, Benefits Paid	104	83
Change in fair value of plan assets
Fair value at beginning of year	2,894	2,823
Participant contributions	2	2
Actual return on plan assets	288	409
Employer contributions/funding	104	118
Defined Benefit Plan, Plan Assets, Payment for Settlement	(18)	(22)
Other, including foreign currency adjustment	294	(353)
Fair value at end of year	3,460	2,894	$ 2,823
Funded status	(30)	(230)
Amounts recognized
Other assets	85	51
Other current liabilities	(1)	(1)
Other liabilities	(114)	(280)
Net amount recognized	(30)	(230)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	782	884
Prior service cost/(credit)	(3)	(5)
Total	779	879
Changes recognized in net loss/(gain) included in other comprehensive loss
Net loss/(gain) arising in current year	(115)	314
Amortization and settlement recognition	(60)	(46)
Foreign currency translation loss/(gain)	73	(117)
Total	(102)	151
Accumulated benefit obligation at end of year	$ 2,985	$ 2,642

Pension, Retiree Medical and Savings Plans (Components of Benefit Expense) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

United States Pension Plan of US Entity, Defined Benefit

Pre-tax non-cash settlement charge

$ 242

Service cost

$ 401

393

$ 435

Interest cost

468

484

546

Amortization of prior service cost/(credit)

(849)

(834)

(850)

(1)

(3)

Amortization of net loss/(gain)

123

168

205

Gross total

144

210

333

Settlement/curtailment loss/(gain) (a)

^[1]

245

Special termination benefits

Total

212

466

351

International

Service cost

Interest cost

115

Amortization of net loss/(gain)

(176)

(163)

(174)

Gross total

111

Settlement/curtailment loss/(gain) (a)

^[1]

Special termination benefits

Total

115

Retiree Medical Plan

Service cost

Interest cost

Amortization of prior service cost/(credit)

(22)

(24)

(27)

(25)

(38)

(39)

Amortization of net loss/(gain)

(12)

(1)

Gross total

Settlement/curtailment loss/(gain) (a)

^[1]

(14)

Special termination benefits

Total

$ 7

$ (4)

$ 24

[1]	U.S. includes a settlement charge of $242 million related to the group annuity contract purchase in 2016. See additional unaudited information in “Items Affecting Comparability” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Pension, Retiree Medical and Savings Plans (Estimated Amounts to be Amortized from Accumulated Other Comprehensive Loss into Benefit Expense in 2012 for Pension and Retiree Medical Plans) (Details) $ in Millions	Dec. 30, 2017 USD ($)
Domestic Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Net loss/(gain)	$ 179
Prior service cost/(credit)	3
Total	182
International
Defined Benefit Plan Disclosure [Line Items]
Net loss/(gain)	46
Total	46
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Net loss/(gain)	(10)
Prior service cost/(credit)	(20)
Total	$ (30)

Pension, Retiree Medical and Savings Plans (Weighted-Average Assumptions to Determine Projected Benefit Liability and Benefit Expense for Pension and Retiree Medical Plans) (Details)

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

United States Pension Plan of US Entity, Defined Benefit

Interest cost discount rate

Liability discount rate

3.70%

4.40%

4.50%

^[1]

3.70%

3.80%

Service Cost Discount Rate

^[1]

4.50%

4.60%

Expense discount rate (a)

^[1]

4.20%

Liability rate of salary increases

7.50%

3.10%

Expense rate of salary increases

3.10%

3.50%

International

Interest cost discount rate

Liability discount rate

3.00%

3.10%

4.00%

^[1]

2.80%

3.50%

Service Cost Discount Rate

^[1]

3.60%

4.10%

Expense discount rate (a)

^[1]

3.80%

Liability rate of salary increases

6.00%

6.20%

6.50%

3.70%

3.60%

Expense rate of salary increases

3.60%

Retiree Medical Plan

Interest cost discount rate

Liability discount rate

3.50%

4.00%

4.20%

^[1]

3.20%

3.30%

Service Cost Discount Rate

^[1]

4.00%

4.30%

Expense discount rate (a)

^[1]

3.80%

7.50%

[1]

Effective as of the beginning of 2016, we prospectively changed the method we use to estimate the service and interest cost components of pension and retiree medical expense. See additional unaudited information in “Our Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Pension, Retiree Medical and Savings Plans (Selected Information About Plans with Liability for Service to Date and Total Benefit Liability in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Domestic Plan [Member]
Selected information for plans with accumulated benefit obligation in excess of plan assets
Liability for service to date	$ (8,355)	$ (12,211)
Fair value of plan assets	6,919	11,458
Selected information for plans with projected benefit liability in excess of plan assets
Benefit liability	(9,400)	(13,192)
Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Fair Value of Plan Assets	6,919	11,458
Defined Benefit Plan, Fair Value of Plan Assets	12,582	11,458	$ 11,397
Foreign Plan [Member]
Selected information for plans with accumulated benefit obligation in excess of plan assets
Liability for service to date	(161)	(134)
Fair value of plan assets	119	110
Selected information for plans with projected benefit liability in excess of plan assets
Benefit liability	(1,273)	(2,773)
Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Fair Value of Plan Assets	1,158	2,492
Defined Benefit Plan, Fair Value of Plan Assets	3,460	2,894	2,823
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan Unfunded Plan Benefit Obligations	905
Retiree Medical Plan
Selected information for plans with projected benefit liability in excess of plan assets
Benefit liability	(1,187)	(1,208)
Defined Benefit Plan, Fair Value of Plan Assets	$ 321	$ 320	$ 354

Pension, Retiree Medical and Savings Plans (Estimated Future Benefit Payments) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Dec. 31, 2018

Domestic Plan [Member]

Payments for Defined Benefit Plan Settlement

$ 452

Pension Plans, Defined Benefit

Discretionary

$ 6

459

$ 0

Non-discretionary

158

200

162

890

985

825

875

925

5,210

Discretionary

Non-discretionary

$ 36

$ 43

2018

^[1]

120

2019

^[1]

120

2020

^[1]

110

2021

^[1]

110

2022

^[1]

105

2023-27

^[1]

455

Years 2023 Through 2027

Subsidies expected to be received under the 2003 Medicare Act

Maximum | Years 2018 Through 2022

Subsidies expected to be received under the 2003 Medicare Act

$ 2

Scenario, Forecast [Member]

Scenario, Forecast [Member] | Retiree Medical Plan

$ 175

Subsequent Event [Member]

Funded Plan [Member] | Subsequent Event [Member]

1,400

Unfunded Plan [Member] | Subsequent Event [Member]

800

$ 700

[1]

Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $2 million for each of the years from 2018 through 2022 and approximately $6 million in total for 2023 through 2027.

Pension, Retiree Medical and Savings Plans Pension, Retiree Medical and Savings Plans (Target Asset Allocations) (Details)	Dec. 31, 2018	Dec. 30, 2017
Fixed Income
Target Asset Allocation [Line Items]
Target investment allocation percentage		40.00%
U.S. Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage		33.00%
International Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage		22.00%
Real Estate Funds [Member]
Target Asset Allocation [Line Items]
Target investment allocation percentage		5.00%
Scenario, Forecast [Member] \| Fixed Income
Target Asset Allocation [Line Items]
Target investment allocation percentage	47.00%
Scenario, Forecast [Member] \| U.S. Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage	29.00%
Scenario, Forecast [Member] \| International Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage	20.00%
Scenario, Forecast [Member] \| Real Estate Funds [Member]
Target Asset Allocation [Line Items]
Target investment allocation percentage	4.00%

Pension, Retiree Medical and Savings Plans (Effects of 1-Percentage-Point Change in the Assumed Health Care Trend Rate) (Details) $ in Millions	12 Months Ended
	Dec. 30, 2017 USD ($)
Retirement Benefits, Description [Abstract]
One percent increase in 2016 service and interest cost components	$ 3
One percent decrease in 2016 service and interest cost components	(3)
One percent increase in 2016 benefit liability	39
One percent decrease in 2016 benefit liability	$ (34)

Pension, Retiree Medical and Savings Plans Retiree Medical Cost Trend Rates (Details)	12 Months Ended
	Dec. 30, 2017	Dec. 31, 2016
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year	6.00%	6.00%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate	5.00%	5.00%
Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate	2039	2039

Debt Obligations and Commitments (Schedule of Long and Short-Term Debt Contractual Commitments) (Details) - USD ($)
$ in Millions

Dec. 30, 2017

Dec. 31, 2016

Long-Term Debt Obligations

Commercial Paper

^[1],[2]

$ 1,385

$ 2,257

Debt, Current

^[1]

5,485

6,892

Long-term Debt

^[1]

37,816

34,454

^[1]

33,796

30,053

Debt Instrument, Unamortized Discount

155

142

Other Borrowings Short-term [Member]

Other borrowings

^[1],[2]

$ 80

$ 234

Current Maturities Of Long-Term Debt

4.70%

4.40%

Long-term Debt, Current Maturities

^[1],[2]

$ 4,020

$ 4,401

Notes Due 2017 [Member]

^[1],[2]

$ 0

$ 4,398

0.00%

1.40%

Notes Due 2018 [Member]

^[1],[2]

$ 4,016

$ 2,561

Notes Due 2018 [Member] | Variable Rate [Member]

2.40%

2.30%

^[3]

$ 1,500

Notes Due 2019 [Member]

^[1],[2]

$ 3,933

$ 2,837

Notes Due 2019 [Member] | Variable Rate [Member]

2.10%

1.70%

Notes Due 2019 [Member] | One Point Five Five Zero Percent Notes Due 2019 [Member]

^[3]

$ 350

^[3]

$ 750

1.55%

Notes Due 2020 [Member]

^[1],[2]

$ 3,792

$ 3,816

3.10%

2.60%

Notes Due 2021 [Member]

^[1],[2]

$ 3,300

$ 2,249

Notes Due 2021 [Member] | Two Point Zero Percent Notes Due 2021 [Domain]

2.40%

^[3]

$ 1,000

2.00%

Notes Due 2022 [Member]

^[1],[2]

$ 3,853

$ 2,655

Notes Due 2022 [Member] | Variable Rate [Member]

2.60%

2.80%

Notes Due 2022 [Member] | Two Point Two Five Zero Percent Notes Due 2022 [Member]

^[3]

$ 400

^[3]

$ 750

Notes Due 2023 to 2047 [Member]

2.25%

^[1],[2]

$ 18,891

$ 15,903

Other Debt Instruments due 2018 to 2026 [Domain]

3.70%

3.80%

Other notes due

^[1],[2]

$ 31

$ 35

Less: Current Maturities Of Long Term Debt Obligations [Member]

1.30%

1.40%

Long-term Debt, Current Maturities

^[1]

$ (4,020)

$ (4,401)

Notes Due 2024 [Member] | Two Point One Five Zero Percent Notes Due 2024 [Member]

^[3],[4]

$ 750

Notes Due 2027 [Domain] | Three Point Zero Percent Notes Due 2027 [Domain]

2.15%

^[3]

$ 1,500

Notes Due 2047 [Member] | Four Point Zero Percent Notes Due 2047 [Member]

3.00%

^[3]

$ 750

4.00%

[1]	Amounts are shown net of unamortized net discounts of $155 million and $142 million for 2017 and 2016, respectively.
[2]	The interest rates presented reflect weighted-average rates at year-end. Certain of our fixed rate indebtedness have been swapped to floating rates through the use of interest rate derivative instruments. See Note 9 for additional information regarding our interest rate derivative instruments.
[3]	Represents gross proceeds from issuances of long-term debt excluding debt issuance costs, discounts and premiums.
[4]	These notes, issued in Canadian dollars, were designated as a net investment hedge to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

Debt Obligations and Commitments (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 30, 2017
Debt Instrument [Line Items]
Debt Instrument, Repurchase Amount	$ 2,500.0
Gain (Loss) on Extinguishment of Debt	233.0
Extinguishment of Debt, Gain (Loss), Net of Tax	$ 156.0
Extinguishment of Debt, Gain (Loss), Per Share, Net of Tax	$ 0.11
International Divisions
Debt Instrument [Line Items]
Line of Credit Facility, Amount Outstanding		$ 73.0
Notes Due 2017 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	1.40%	0.00%
Notes Due 2018 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.30%	2.40%
Notes Due 2019 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	1.70%	2.10%
Notes Due 2020 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.60%	3.10%
Notes Due 2021 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.40%	2.40%
Notes Due 2022 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.80%	2.60%
Notes Due 2023 to 2047 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.80%	3.70%
Other Debt Instruments due 2018 to 2026 [Domain]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	1.40%	1.30%
Five-Year Unsecured Revolving Credit Agreement (Five-Year Credit Agreement) [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	$ 3,722.5	$ 3,750.0
Line of Credit Facility, Maximum Borrowing Capacity		$ 4,500.0
Commercial Paper One Point Three Percentage_ [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage		1.30%
Commercial Paper Zero Point Six Percentage_ [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	0.60%
Seven Point Nine Zero Percent Notes Due 2018 [Member] \| Notes Due 2018 [Member]
Debt Instrument [Line Items]
Interest rate on debt	7.90%
Debt Instrument, Repurchased Face Amount	$ 1,500.0
Five Point One Two Five Percent Notes Due 2019 [Member] \| Notes Due 2019 [Member]
Debt Instrument [Line Items]
Interest rate on debt	5.125%
Debt Instrument, Repurchased Face Amount	$ 750.0
364-Day Unsecured Revolving Credit Agreement (364-Day Credit Agreement) [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	$ 3,722.5	$ 3,750.0
Line of Credit Facility, Maximum Borrowing Capacity		$ 4,500.0

Financial Instruments (Narrative) (Details) - USD ($)	4 Months Ended	12 Months Ended
Financial Instruments (Narrative) (Details) - USD ($)	Dec. 30, 2017	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Derivatives, Fair Value [Line Items]
Gain (Loss) on Sale of Equity Investments		$ 95,000,000
Gain (Loss) on Sale of Equity Investments, after tax		$ 85,000,000
Gain (Loss) on Sale of Equity Investments, net of tax, per share amount		$ 0.06
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax			$ 72,000,000
indirect equity investment percentage	5.00%	5.00%
indirect equity investment	$ 166,000,000	$ 166,000,000
Call Option For Indirect Equity Percentage				20.00%
Charges related to the transaction with Tingyi		0	$ 373,000,000	$ 73,000,000
Tingyi Charge per share			$ 0.26	$ 0.05
Debt instrument, fair value	41,000,000,000	41,000,000,000	$ 38,000,000,000
Expected reclassification of net gain/(losses) related to hedge from accumulated OCI into net income within the next 12 months		(33,000,000)
Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Long-term Debt, Percentage Bearing Variable Interest, Amount	$ 0.43	0.43	0.38
Commodity Contracts
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	3 years
Derivative, Notional Amount	$ 900,000,000	$ 900,000,000	800,000,000
Foreign Exchange Contract
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date		2 years
Derivative, Notional Amount	1,600,000,000	$ 1,600,000,000	1,600,000,000
Net Investment Hedging [Member]
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	1,500,000,000	1,500,000,000	800,000,000
Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	$ 14,200,000,000	$ 14,200,000,000	$ 11,200,000,000
Revenue Outside U.S. [Domain]
Derivatives, Fair Value [Line Items]
Percent of Revenue		42.00%
Top Five International Countries [Domain]
Derivatives, Fair Value [Line Items]
Percent of Revenue		20.00%

Financial Instruments (Fair Values of Financial Assets and Liabilities) (Details) - USD ($)
$ in Millions

Dec. 30, 2017

Dec. 31, 2016

Total asset derivatives at fair value

$ 8,900

$ 6,967

^[1],[2]

136

182

Total liability derivatives at fair value

^[1],[2]

410

529

Total Financial Assets at Fair Value

^[1]

14,901

11,851

Total Financial Liabilities at Fair Value

^[1]

913

1,001

Derivatives Designated As Cash Flow Hedging Instruments Assets [Member]

Derivatives designated as hedging instruments, Assets, Total

^[1]

Derivatives Designated As Cash Flow Hedging Instruments Liabilities [Member]

Derivatives designated as hedging instruments, Liabilities, Total

^[1]

246

417

Derivatives Not Designated As Hedging Instruments Assets [Member]

Derivatives not designated as hedging instruments, Assets, Total

^[1]

Derivatives Not Designated As Hedging Instruments Liabilities [Member]

Derivatives not designated as hedging instruments, Liabilities, Total

^[1]

Assets [Member]

^[1]

14,510

11,451

Liability [Member]

Cash and Cash Equivalents [Member]

^[1]

Short-term Investments [Member]

5,800

4,600

Fair Value, Inputs, Level 1 [Member] | Derivatives Designated As Cash Flow Hedging Instruments Assets [Member]

8,700

6,800

Fair Value, Inputs, Level 1 [Member] | Derivatives Designated As Cash Flow Hedging Instruments Liabilities [Member]

^[1],[3]

Fair Value, Inputs, Level 1 [Member] | Derivatives Not Designated As Hedging Instruments Assets [Member]

^[1],[3]

Fair Value, Inputs, Level 1 [Member] | Derivatives Not Designated As Hedging Instruments Liabilities [Member]

^[1],[3]

Fair Value, Inputs, Level 1 [Member] | Assets [Member]

^[1],[3]

Fair Value, Inputs, Level 1 [Member] | Assets [Member] | Common Stock

^[1],[4]

228

193

Fair Value, Inputs, Level 1 [Member] | Liability [Member]

^[1],[5]

Fair Value, Inputs, Level 1 [Member] | Liability [Member] | Common Stock

^[1],[4]

Fair Value, Inputs, Level 2 [Member] | Derivatives Designated As Fair Value Hedging Instruments Assets [Member]

^[1],[5]

Fair Value, Inputs, Level 2 [Member] | Derivatives Designated As Fair Value Hedging Instruments Liabilities [Member]

^[1],[6]

Fair Value, Inputs, Level 2 [Member] | Derivatives Designated As Cash Flow Hedging Instruments Assets [Member]

^[1],[6]

130

^[1],[7]

^[1],[7]

Fair Value, Inputs, Level 2 [Member] | Derivatives Designated As Cash Flow Hedging Instruments Liabilities [Member]

^[1],[8]

^[1],[7]

^[1],[7]

213

408

Fair Value, Inputs, Level 2 [Member] | Derivatives Not Designated As Hedging Instruments Assets [Member]

^[1],[8]

^[1],[7]

Fair Value, Inputs, Level 2 [Member] | Derivatives Not Designated As Hedging Instruments Liabilities [Member]

^[1],[8]

^[1],[7]

Fair Value, Inputs, Level 2 [Member] | Assets [Member]

^[1],[8]

Fair Value, Inputs, Level 2 [Member] | Liability [Member]

^[1],[9]

14,510

11,369

Fair Value, Inputs, Level 2 [Member] | Assets [Member]

^[1],[9]

Prepaid Forward Asset Fair Value

^[1],[10]

Deferred compensation

^[1],[11]

Fair Value, Inputs, Level 2 [Member] | Liability [Member]

Prepaid Forward Asset Fair Value

^[1],[10]

Deferred compensation

^[1],[11]

$ 503

$ 472

[1]	Fair value hierarchy levels are defined in Note 7. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.
[2]	Unless otherwise noted, derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on the balance sheet as of December 30, 2017 and December 31, 2016 were not material. Collateral received against any of our asset positions was not material.
[3]	Based on quoted contract prices on futures exchange markets.
[4]	Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.
[5]	Based on the price of common stock. These equity securities were classified as investments in noncontrolled affiliates.
[6]	Based on LIBOR forward rates.
[7]	Based on recently reported market transactions of spot and forward rates.
[8]	Based on recently reported market transactions of swap arrangements.
[9]	Based on quoted broker prices or other significant inputs derived from or corroborated by observable market data. As of December 30, 2017, $5.8 billion and $8.7 billion of debt securities were classified as cash equivalents and short-term investments, respectively. As of December 31, 2016, $4.6 billion and $6.8 billion of debt securities were classified as cash equivalents and short-term investments, respectively. All of our available-for-sale debt securities have maturities of one year or less.
[10]	Based primarily on the price of our common stock.
[11]	Based on the fair value of investments corresponding to employees’ investment elections.

Financial Instruments (Effective Portion of Pre-Tax (Gains)/Losses on Derivative Instruments) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Fair Value/Non-Designated Hedges

^[1]

$ 38

$ 127

Cash Flow Hedges

Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss

Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)

^[2]

(171)

150

Forward Exchange Contracts | Fair Value/Non-Designated Hedges

Forward Exchange Contracts | Cash Flow Hedges

^[1]

(15)

Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss

(24)

Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)

^[2]

(44)

Interest Rate Contracts | Fair Value/Non-Designated Hedges

Interest Rate Contracts | Cash Flow Hedges

^[1]

101

105

Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss

(195)

Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)

^[2]

(184)

187

Commodity Contracts | Fair Value/Non-Designated Hedges

Commodity Contracts | Cash Flow Hedges

^[1]

(48)

(52)

Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss

Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)

^[2]

Net Investment Hedging [Member] | Cash Flow Hedges

Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss

$ 157

$ (39)

[1]

[2]

Foreign exchange derivative losses/gains are primarily included in cost of sales. Interest rate derivative losses/gains are included in interest expense. Commodity derivative losses/gains are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.

Net Income Attributable to PepsiCo per Common Share (Out-of-the-money options) (Details) - $ / shares

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Out-of-the-money options excluded from earnings per share

^[1]

0.4

0.7

1.5

Out-of-the-money options average exercise price

$ 110.12

$ 99.98

$ 99.25

[1]	In millions.

Net Income Attributable to PepsiCo per Common Share (Basic and Diluted Net Income Attributable to PepsiCo per Common Share) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Net income available for PepsiCo common shareholders - Value

$ 4,857

$ 6,329

$ 5,452

Dividends

(1)

Redemption premium

(4)

(5)

$ 4,853

$ 6,323

$ 5,446

Net income available for PepsiCo common stockholders - Shares

^[1]

1,425

1,439

1,469

Basic net income attributable to PepsiCo per common share

$ 3.40

$ 4.39

$ 3.71

Stock options and RSUs - Shares

^[1]

Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units

$ 0

$ 1

$ 0

ESOP convertible preferred stock - Value

$ 4

$ 5

$ 6

ESOP convertible preferred stock - Shares

^[1]

Diluted shares - Value

$ 4,857

$ 6,329

$ 5,452

Diluted shares - Shares

^[1]

1,438

1,452

1,485

Diluted net income attributable to PepsiCo per common share

$ 3.38

$ 4.36

$ 3.67

[1]	Weighted-average common shares outstanding (in millions).

Preferred Stock (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 30, 2017	Dec. 31, 2016	Dec. 26, 2015
Preferred Stock [Line Items]
Common Stock, Shares, Issued		1,420,000,000	1,428,000,000
Preferred Stock
Preferred Stock [Line Items]
Preferred stock, authorized (in shares)		3,000,000	3,000,000
Preferred Stock, Shares Issued		803,953	803,953	800,000
Outstanding preferred shares, fair value		$ 68	$ 64
Preferred shares, outstanding		114,753	122,553
Subsequent Event [Member]
Preferred Stock [Line Items]
Common Stock, Shares, Issued	550,102

Accumulated Other Comprehensive Loss Attributable to Pepsico (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Dec. 27, 2014

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Currency translation adjustment

^[1]

$ (10,277)

$ (11,386)

$ (11,080)

$ (8,255)

Cash flow hedges, net of tax

^[1]

Unamortized pension and retiree medical, net of tax (b)

^[2]

(2,804)

(2,645)

(2,329)

(2,500)

Unrealized gain on securities, net of tax

^[1]

(4)

Accumulated other comprehensive loss attributable to PepsiCo

^[1]

(19)

(35)

(13,057)

^[1]

(13,919)

(13,319)

(10,669)

Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax

1,049

^[3]

(313)

(2,936)

^[2]

Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax

1,049

(313)

(2,825)

Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax

(41)

Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax

(217)

(343)

178

Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax

(74)

(43)

Other Comprehensive Income, Other, Before Tax

Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent

717

(623)

(2,642)

Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax

130

^[3]

(74)

(95)

^[2]

Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax

(375)

^[3]

(750)

(88)

^[2]

Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, before Tax

^[3]

(43)

^[2]

Other Comprehensive Income (Loss), before Reclassifications, before Tax

^[3]

^[2]

OCI, before Reclassifications, before Tax, Attributable to Parent

829

^[3]

(1,180)

(3,116)

^[2]

Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax

111

Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax

(171)

150

Other Comprehensive (Income)/Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax, including Venezuela

266

Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax

158

407

246

Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax

(99)

Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax

Reclassification from AOCI, Current Period, before Tax, Attributable to Parent

(112)

557

474

Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax

Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax

(30)

Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax

(7)

Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax

(2)

Other Comprehensive Income, Other, Taxes

Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent

145

(8)

Net of taxes decrease to opening balance of accumulated other comprehensive loss attributable to Pepsico

$ 1,338

$ 1,280

$ 1,253

$ 1,260

[1]	Pension and retiree medical amounts are net of taxes of $1,260 million in 2014, $1,253 million in 2015, $1,280 million in 2016 and $1,338 million in 2017.
[2]	Currency translation adjustment primarily reflects the depreciation of the Russian ruble, Brazilian real and Canadian dollar.
[3]	Currency translation adjustment primarily reflects the appreciation of the euro, Russian ruble, Pound sterling and Canadian dollar.

Accumulated Other Comprehensive Loss Attributable to Pepsico Reclassification of Accumulated Other Comprehensive Loss to the Condensed Consolidated Statement of Income (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Dec. 27, 2014

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Post retirement Plans Taxes

$ 1,338

$ 1,280

$ 1,253

$ 1,260

Reclassification associated with Venezuela impairment charges

(111)

Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]

Reclassification of net losses to net income, pre-tax amount

(171)

150

Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax

(63)

(47)

Net derivative losses

(107)

Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax

^[1]

(24)

(39)

(41)

Amortization and settlement of (losses)/gains

^[1]

167

209

281

Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax

^[1]

237

Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax

158

407

246

Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax

(44)

(144)

(74)

Remeasurement of net liabilities and translation

114

263

172

Reclassification associated with Venezuela impairment charges - Pension

(20)

reclassification associated with Venezuela impairment charge, tax amount - Pension

(4)

reclassification associated with venezuela impairment charges, net of tax - pension

(16)

Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax

(99)

Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax

Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax

(89)

Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax

(82)

350

349

Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

^[2]

(171)

150

Forward Exchange Contracts | Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

^[2]

(44)

Forward Exchange Contracts | Sales Revenue, Net [Member] | Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

(2)

Forward Exchange Contracts | Cost of Sales | Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

(10)

Interest Rate Contracts | Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

^[2]

(184)

187

Interest Rate Contracts | Interest Expense | Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

184

(187)

(174)

Commodity Contracts | Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

^[2]

Commodity Contracts | Cost of Sales | Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

(4)

(3)

(9)

Commodity Contracts | Selling, General and Administrative Expenses | Cash Flow Hedges

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net

$ 1

$ (4)

$ (11)

[1]	These items are included in the components of net periodic benefit cost for pension and retiree medical plans (see Note 7 for additional details).
[2]	Foreign exchange derivative losses/gains are primarily included in cost of sales. Interest rate derivative losses/gains are included in interest expense. Commodity derivative losses/gains are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.

Supplemental Financial Information (Schedule of Supplemental Balance Sheet Information) (Details) - USD ($)

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015

Allowance, beginning of year

Inventory, LIFO Reserve

$ 0.05

Accounts and notes receivable

Trade receivables

5,956,000,000

$ 5,709,000,000

Other receivables

1,197,000,000

1,119,000,000

Total receivables

7,153,000,000

6,828,000,000

Analysis of valuation allowances

134,000,000

130,000,000

$ 137,000,000

Net amounts charged to expense

26,000,000

37,000,000

43,000,000

Deductions

^[1]

(35,000,000)

(30,000,000)

(27,000,000)

Noncurrent notes and accounts receivable

^[2]

4,000,000

(3,000,000)

(23,000,000)

Allowance, end of year

129,000,000

134,000,000

130,000,000

Net receivables

7,024,000,000

6,694,000,000

Inventories (c)

Raw materials

^[3]

1,344,000,000

1,315,000,000

Work-in-process

^[3]

167,000,000

150,000,000

Finished goods

^[3]

1,436,000,000

1,258,000,000

Inventories

^[3]

2,947,000,000

2,723,000,000

Other assets

59,000,000

105,000,000

Deferred marketplace spending

134,000,000

140,000,000

Prepaid Expense and Other Assets, Noncurrent

^[4]

374,000,000

53,000,000

Accounts payable and other current liabilities

346,000,000

338,000,000

Other Assets

913,000,000

636,000,000

Accounts payable

6,727,000,000

6,158,000,000

Accrued marketplace spending

2,390,000,000

2,444,000,000

Accrued compensation and benefits

1,785,000,000

1,770,000,000

Dividends payable

1,161,000,000

1,097,000,000

Other current liabilities

2,954,000,000

2,774,000,000

Accounts payable and other current liabilities

15,017,000,000

14,243,000,000

Income Taxes Paid, Net

$ 1,962,000,000

$ 1,393,000,000

$ 1,808,000,000

[1]	Includes accounts written off.
[2]	Includes adjustments related primarily to currency translation and other adjustments.
[3]	Approximately 5% of the inventory cost in 2017 and 2016 were computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material.
[4]	See Note 7 for additional information regarding our pension plans.

Supplemental Financial Information (Schedule of Other Supplemental Information) (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 30, 2017

Dec. 31, 2016

Dec. 26, 2015